Conditional Knockout of the L-Type Voltage-gated Calcium Channel CaV1.3 via the FLEX Switch by Bartels, Katrin
  
 
DISSERTATION 
submitted to the 
Combined Faculties for the Natural Sciences and for Mathematics 
of the Ruperto-Carola University of Heidelberg, Germany 
for the degree of 
Doctor of Natural Sciences 
 
 
 
 
 
 
 
 
 
 
 
 
Presented by 
 
Diplom-Biologist Katrin Bartels 
born in Heidelberg, Germany 
 
 
 
Oral-examination: ______________ 
  
 
 
Conditional Knockout of the L-Type Voltage-gated 
Calcium Channel CaV1.3 via the FLEX Switch 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Referees: Prof. Dr. Hilmar Bading 
 Prof. Dr. Dusan Bartsch 
  
 
Hiermit erkläre ich gemäß § 8 (3) b) und c) der Promotionsordnung, dass ich die vorgelegte 
Dissertation selbst verfasst und mich dabei keiner anderen als der von mir ausdrücklich 
bezeichneten Quellen und Hilfen bedient habe. 
 
I hereby declare according to § 8 (3) b) and c) of the doctoral degree regulations that I have 
written the submitted dissertation myself and in this process I have used no other sources or 
materials than those expressly indicated. 
 
 
Mannheim, 23. Juli 2009                                        _________________________ 
              Katrin Bartels 
 Acknowledgements 
 
This work was performed at the Central Institute of Mental Health Mannheim (ZI) in the 
laboratory and under supervision of Prof. Dr. Dusan Bartsch. 
 
Foremost, I would like to express my special thanks to Prof. Dr. Dusan Bartsch for giving me 
the opportunity to work for my Ph.D. thesis in his laboratory under excellent working 
conditions and for providing me the interesting project, for his helpful suggestions and his 
encouragement.  
 
I am very grateful to Hilmar Bading for the supervision and the evaluation of my thesis. 
 
Furthermore I would like to thank: 
Kai Schönig for his scientific support regarding theoretical and technical aspects during the 
thesis. 
Tillmann Weber for his mentoring in the first years, the introduction in the lab work and his 
ongoing scientific support.  
Vera Baier for her helpful remarks concerning the immunofluorescence techniques and for 
her moral support. 
Ariana Frömmig for generating the knockout animals. 
Thorsten Lau for his scientific support in ES cell differentiation and microscopy. 
Claus Beck and Uwe Leimer for the introduction in ES cell culturing. 
Celine Lentrodt for her help during the cloning of the targeting construct. 
All former and recent lab members for the scientific support, continuous help and for the 
nice time in the lab. 
All animal care takers at the ZI, especially Peter Siegel, taking care of the transgenic mice. 
All members of the graduate college 791 for their support in technical or scientific questions. 
The graduate college 791 for the financial support. 
 
Summary 
 
Summary 
L-type voltage-gated calcium channels (VGCCs) play a central role in regulating intracellular 
calcium (Ca2+) concentrations, thereby contributing to signal transduction in many 
electrically excitable cells. The L-type channel CaV1.3 is expressed in neurons, in hair cells of 
the inner ear, in heart tissue and in pancreatic ß-cells. Mice with a ubiquitous deletion of the 
pore-forming α1-subunit (CaV1.3-/-) showed that CaV1.3 has cardiac pace maker activity and 
controls the neurotransmitter release in the cochlea. Furthermore, Ca2+ influx through this 
channel was proposed to be involved in anxiety-related behaviour and in consolidation of 
contextually conditioned fear. Aim of my work was to gain more insight into the 
physiological role of CaV1.3 in different cell types and tissues, especially in neurons. To 
circumvent the phenotypes of the conventional knockout mice like deafness and heart 
insufficiency which may interfere with behavioural analysis, we decided to generate a 
conditional CaV1.3α1 knockout mouse using the Cre/loxP-based FLEX switch system. By a 
Cre-mediated inversion of the targeted locus, this strategy coupled the ablation of the 
CaV1.3α1 gene to the expression of the reporter gene eGFP, thereby mirroring the exact 
expression pattern of the endogenous CaV1.3 gene in all tissues. Heterozygous CaV1.3-GFPflex 
mice were bred with “Cre-deleter” mice in which the Cre recombinase is ubiquitously 
expressed. We could show that, after Cre expression, the FLEX switch occurred efficiently in 
vitro and in vivo and that the reporter gene was driven by the endogenous CaV1.3α1 
promoter. Immunohistochemical analysis revealed eGFP expression in heart tissue as well as 
in many brain areas like the olfactory bulb, the cerebellum, superior colliculus, brain regions 
associated with emotional behaviour and sensory processing. In contrast to previously 
reported CaV1.3 expression, only moderate eGFP staining was found in hippocampal 
regions. An unexpected observation was the intense eGFP expression in the peri- and 
subventricular zone, suggesting a role of CaV1.3α1 in adult neurogenesis and neural stem cell 
proliferation. In parallel, we crossed CaV1.3-GFPflex mice to CaMKIIa-mice, thereby obtaining 
specific eGFP expression in the forebrain according to the expression of the CaMKIIa 
promoter.  
This mouse model offers a great potential to further investigate the distribution and function 
of the L-type Ca2+ channel CaV1.3 in various tissues. 
 
 
Zusammenfassung 
 
Zusammenfassung 
L-typ spannungsgesteuerte Calciumkanäle (VGCC) spielen eine zentrale Rolle in der Regulierung 
der intrazellulären Ca2+ Konzentration und tragen somit zur Signalverarbeitung in vielen 
elektrisch erregbaren Zellen bei. Der L-typ Kanal CaV1.3 wird in Neuronen, in Haarzellen des 
Innenohrs, im Herzgewebe und in ß-Zellen des Pankreas exprimiert. Mäuse mit einer ubiquitären 
Deletion der porenbildenden α1-Untereinheit (CaV1.3-/-) zeigten, dass der CaV1.3 Kanal 
Herzschrittmacher-Funktionen besitzt und die Neurotransmitter-Ausschüttung in der Cochlea 
kontrolliert. Des Weiteren wird dieser Kanal mit dem Ängstlichkeitsverhalten und 
Konsolidierung von kontextabhängig konditionierter Angst in Verbindung gebracht. Ziel dieser 
Arbeit war es, weitere Einblicke in die physiologische Rolle von CaV1.3 in verschieden Zelltypen 
und Geweben, im Besonderen in Neuronen, zu erhalten. Da konventionelle Knockout-Mäuse 
Phänotypen wie Taubheit und Herzinsuffizienz zeigen, die Verhaltensanalysen beeinträchtigen 
können, haben wir uns entschlossen, diese zu umgehen und eine konditionale CaV1.3α1 
Knockout-Maus mithilfe des Cre/loxP-basierten „FLEX switch“ Systems zu generieren. Durch ein 
Cre-vermitteltes Invertieren des „gefloxten“ Allels koppelt diese Strategie die Inaktivierung des 
CaV1.3α1 Gens an die Expression des Reportergens eGFP, wodurch das exakte 
Expressionsmuster des endogenen CaV1.3α1 Gens in allen Geweben gespiegelt wird. 
Heterozygote CaV1.3-GFPflex Mäuse wurden mit “Cre-Deleter”-Mäusen verpaart, welche die Cre-
Rekombinase ubiquitär exprimieren. Wir konnten zeigen, dass nach Cre-Expression der FLEX 
„switch“ in vitro und in vivo effizient erfolgte und dass das Reportergen von dem endogenen 
CaV1.3α1 Promotor getrieben wurde. Immunhistochemische Analysen ließen eGFP-Expression 
im Herzgewebe und vielen Hirnarealen erkennen, wie dem olfaktorischen Bulbus, Cerebellum, 
Superior Colliculus und Regionen, die mit emotionalem Verhalten und sensorischer 
Verarbeitung assoziiert sind. Im Gegensatz zu der bekannten CaV1.3 Expression, zeigte sich in 
den hippokampalen Hirnregionen nur eine gemäßigte eGFP-Färbung. Eine unerwartete 
Beobachtung war die intensive eGFP-Expression in der peri- und subventrikulären Zone, was auf 
eine Funktion von CaV1.3 in adulter Neurogenese und neuronaler Stammzellproliferation 
hinweisen könnte. Parallel verpaarten wir CaV1.3-GFPflex Mäuse mit CaMKIIa-Mäusen, wobei wir 
eine spezifische eGFP-Expression im Vorderhirn in Übereinstimmung mit der Expression des 
CamKIIa-Promoters ausmachen konnten.  
Das CaV1.3-GFPflex Mausmodel stellt somit ein großes Potential dar, die Funktion and 
Verbreitung des L-typ Kalziumkanals CaV1.3 weiter aufzuklären. 
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1 Introduction 
1.1 Calcium as Second Messenger 
Cytosolic calcium (Ca2+) is a ubiquitous intracellular signal which is essential in many signal 
transduction pathways, controlling a wide range of cellular activities. The significance of Ca2+ 
in cell biology was recognized in 1883 by Sydney Ringer. He demonstrated that the presence 
of Ca2+ in the bathing solution was necessary to maintain contraction of frog heart muscles 
(Ringer, 1883). This observation opened an entire field of studies regarding the role of 
calcium in molecular, cellular and organismal function. By the end of the 19th century the list 
of described functions for calcium included its role in egg fertilization and development of 
tissues (Ringer, 1890) and conduction of nerve impulse to muscle, cell adhesion and plant 
growth. An important discovery in the 20th century was the identification of change in the 
concentration of free Ca2+ ions in response to hormone treatment. In 1947 Lewis Victor 
Heilbrunn demonstrated by injecting various cations into frog muscle cells that only calcium 
caused muscle fibre to contract (Heilbrunn and Wiercinski, 1947). Later, Sandow proposed 
the term excitation-contraction coupling for this phenomenon (Sandow, 1965).  
Calcium ions play a major role in controlling the function of all cells in the body by acting as 
carriers of intracellular messages. Cells receive external signals through neurotransmitters 
and hormones which bind to receptors on their surface. These signals are transferred to the 
inside of the cell by opening channels in the cell membrane, allowing external Ca2+ ions to 
enter the cell, or by releasing Ca2+ ions from internal stores (endoplasmic reticulum, ER) into 
the cytoplasm. Calcium ions as second messenger mediate a wide range of cellular functions 
as muscle contraction, neurotransmitter and hormone release, metabolism, cell division and 
differentiation.  
In the evolution of eukaryotic cells, the calcium ion has been selected as a second messenger 
in preference to other intracellular ions like sodium, potassium, chloride or magnesium ions 
(Carafoli and Penniston, 1985). As a double charged ion, Ca2+ binds more tightly to the 
protein binding sites than single charged ions of sodium, potassium and chlorine 
(Hardingham and Bading, 1998). Furthermore, it is energetically favourable for the cell to 
utilise calcium as a second messenger. The concentration of free calcium ions in the 
cytoplasm of a resting cell is extremely low (~100 nM), several orders of magnitude below the 
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extracellular Ca2+ concentration. For this reason a relatively small amount of calcium needs to 
pass into the cell to increase significantly the intercellular Ca2+ concentration. Consequently, 
to return the ion concentration to the basal level, relatively little energy is required to pump 
calcium ions either out of the cell or into internal stores like the ER. 
Many different cell types rely on an elevation of intracellular Ca2+ to activate essential 
biological function. Calcium is, for example, immensely important in the earliest stages of 
development – in fertilization. When the sperm enters the egg, it causes a local increase in 
cytosolic Ca2+, which spreads through the cell in a wave. This oscillation activates the egg to 
start development (Shen, 1995). Ca2+ is also required for acute cellular responses, such as 
contraction or secretion. Released by internal stores, Ca2+ mediates the contraction of muscles 
by interacting with troponin and tropomyosin (Eisenberg and Hill, 1985). Ca2+ is the major 
component of the signalling pathways that regulate epithelial cell secretion, including both 
discharge of proteins and regulation of transepithelial secretion of salts and water, and 
carbohydrate metabolism in the liver, including glycogenolysis and gluconeogenesis (Siegel 
et al., 1999). Furthermore, Ca2+ ions play a role in necrosis and apoptosis. The earliest change 
in cells undergoing apoptosis is a rapid, sustained increase in intracellular calcium 
concentrations (Schwartzman and Cidlowski, 1993). Inhibition of this increase prevents 
stimulus-induced cell death in various cell types. Ca2+ influx through extrasynaptic NMDA 
receptors causes a loss of mitochondrial membrane potential and cell death in neurons 
(Hardingham et al., 2002). Also T-lymphocytes rely on an elevation of intracellular calcium 
to trigger their activation in response to antigen presentation to the T-cell receptor (Cardenas 
and Heitman, 1995). In neurons, Ca2+ plays a pivotal role in the reception of signals (input), 
signal transmission (output), the regulation of neuronal excitability as well as the cellular 
changes that underlie synaptic plasticity and learning and memory. To support long-term 
cellular changes, calcium signalling has a central role in regulation of activity-dependent 
gene expression. Calcium-mediated gene expression can lead to a variety of enduring 
changes in cell functions, as modifications of protein synthesis underlie such diverse 
processes like cell survival, differentiation and synaptic plasticity (Ghosh et al., 1994).  
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1.1.1 Ca2+ Signalling 
Calcium signalling comprises molecular and physiological events that link an external 
stimulus to the expression of intracellular response through an increase in cytoplasmic Ca2+ 
concentration. The external stimulus can be neurotransmitters, growth factors or hormones. 
It is known that increase in cytosolic Ca2+ concentration is temporally and spatially complex. 
Depending on cell type and nature of stimulation, Ca2+ signals can be transient or oscillatory, 
and can occur as localised or global event (Bootman et al., 2001b). 
 
1.1.1.1 Release of Ca2+ from Internal Stores 
Ca2+ is stored intracellularly in specialised compartments such as the endoplasmic reticulum 
(ER) and the sarcoplasmic reticulum (SR). The binding of many hormones and growth 
factors to specific receptors on the plasma membrane leads to the activation of phospholipase 
C (PLC) which catalyses the hydrolysis of phosphatidylinositol 4,5-biphosphate (PIP2) to 
produce the intracellular messengers inositol 1,4,5-triphosphate (IP3) and diacylglycerol 
(DAG) (Bootman et al., 2001a). IP3 diffuses into the cell interior and binds to specific IP3 
receptors (IP3Rs) in the ER/SR. After conformational change the receptors are opened, 
allowing the Ca2+ that is stored in the ER/SR at high concentrations to enter the cytoplasm. 
Beside IP3, a variety of established intracellular messengers exist which increase intracellular 
Ca2+ concentration: cyclic adenosine 5’-diphosphoribose (cADPR) which activates ryanodine 
receptors (RyRs), nitric oxide (NO), hydrogen peroxide (H2O2), diacylglycerol (DAG), 
arachidonic acid (AA), sphingolipids and Ca2+ itself (Bootman et al., 2002). Similar to the IP3R 
are the ryanodine receptors (RyRs), a class of intracellular Ca2+ release channels found in 
excitable tissues as neurons and muscles. These receptors are named after the plant alkaloid 
ryanodine that binds to the channel with high affinity. RyRs mediate the calcium release 
from internal Ca2+ stores, which is an essential step in muscle contraction. In cardiac muscles, 
channel activation occurs via calcium-induced calcium release (CICR), a mechanism by 
which local elevations of intracellular Ca2+ are amplified by Ca2+ release from ryanodine-
sensitive Ca2+ stores (Fabiato, 1983). A recent study pointed out that the ryanodine receptor 
type 2 (RyR2) even interacts with the L-type calcium channel CaV1.3 with implications in 
translating synaptic activity into alterations in gene expression (Kim et al., 2007). 
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1.1.1.2 Calcium Influx through Voltage- or Ligand-Gated Ion Channels 
Extracellular Ca2+ can enter the cell via several different types of Ca2+ influx channels, which 
can be grouped on the basis of their activation mechanism. Voltage-gated Ca2+ channels 
(VGCC) are found in a variety of excitable cell types, including neurons, muscles and 
endocrine and neuroendocrine cells (Miller, 1992). Five different types of voltage-gated Ca2+ 
channels could be classified, based on their electrophysiological and pharmacological 
properties, as L-, T-, N-, P-, Q- and R-type (Catterall, 2000). These channels can be activated 
by membrane depolarization, either by a propagated action potential or by the opening of 
other ligand-gated channels. Calcium influx through VGCC is linked to many Ca2+ 
dependent processes like contraction of smooth muscles, secretion, neurotransmitter release 
and gene expression.  
Besides VGCC, Ca2+ ions enter the cell through ligand-gated receptors, such as N-methyl-D-
aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
glutamate receptors. Upon binding glutamate the NMDA receptor allows the influx of 
divalent cations as Ca2+ and Na+. The elevation of cytoplasmic Ca2+ may lead to the transient 
activation of a variety of Ca2+-activated enzymes, including Ca2+/calmodulin-dependent 
protein kinase II, calcineurin, PKC and phospholipase A2. The Ca2+ influx through these 
receptors is thought to be a necessary first step for long-term potentiation (LTP), a form of 
synaptic plasticity (Ghosh et al., 1994). Also AMPA glutamate receptors can contribute to 
Ca2+ influx. The permeability of the AMPA receptor to calcium is governed by the GluR2 
subunit; AMPA receptors lacking this subunit are permeable to Ca2+, Na+ and K+ (Geiger et 
al., 1995).  
 
1.1.2 Ca2+ Signalling in Neuronal Cells 
Calcium plays an important role in regulating a variety of neuronal processes like 
neurotransmitter release, generation of dendritic Ca2+ spikes, neuronal plasticity or 
regulation of activity-dependent gene expression. Like in other cells, neurons use multiple 
mechanisms to increase the intracellular calcium concentration.  
One function of calcium in neurons is the propagation of an electrical signal from one neuron 
to another. An action potential, which travels through the neuron, will arrive the axon where 
it triggers calcium-mediated neurotransmitter release. This neurotransmitter release is 
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mediated by N-type (CaV2.2) and P/Q-type (CaV2.1) VGCCs, which are primarily located in 
the presynaptic terminals (Dunlap et al., 1995). Strong depolarization by an action potential 
causes these channels to open and allow influx of Ca2+, initiating vesicle fusion with the 
presynaptic membrane and releasing their contents into the synaptic cleft. The 
neurotransmitter causes again an electrical change in the postsynaptic neuron through the 
activation of neurotransmitter-gated ion channels. Thus, calcium is involved in coupling 
action potentials to neurotransmitter release and enables information to be passed from 
neuron to neuron.  
Calcium is a critical component in signalling processes from synapse to nucleus. Increase in 
intracellular calcium concentration activates various signalling pathways that lead to the 
expression of genes essential for dendritic development, neuronal survival and synaptic 
plasticity. It is well established that in response to physiological synaptic activity  Ca2+ entry 
through both glutamate-gated NMDA receptors and L-type Ca2+ channels initiates nuclear 
signalling to the transcription factor CREB (cAMP response-element binding protein) (Bito et 
al., 1996; Deisseroth et al., 1996). CREB is strongly implicated in synaptic plasticity, long term 
memory and long-lasting, protein synthesis dependent LTP (Kandel, 2001). CREB is 
activated by phosphorylation on its Ser 133 residue, which allows recruitment of CREB 
binding protein (CBP) and initiation of transcription (Chrivia et al., 1993). The synapse-to-
nuclear signalling involves different pathways, including CREB activation through the CaM-
CaMKIV, the Ras/MAPK and the CaM/AC/PKA pathway (Deisseroth et al., 2003). 
Additionally, Ca2+ itself may enter the nucleus and activate nuclear kinases that lead to CREB 
phosphorylation in the nucleus (Hardingham et al., 2001). 
The mode of calcium entry determines which signalling pathways are activated and thus 
specifies the cellular response. Calcium influx specifically through L-type VGCCs triggered 
by KCl (50-90 mM) depolarization or high-frequency (50 Hz) stimulation appears crucial for 
stimulating CREB phosphorylation and subsequent expression of the immediate early gene 
c-fos (Hardingham et al., 1999; Zhao et al., 2007). Furthermore, blocking the L-type channels 
by dihydropyridine (DHP) selectively eliminates CREB phosphorylation (Dolmetsch et al., 
2001). Among the L-type VGCCs, CaV1.2 and CaV1.3 are the most widely expressed L-type 
channels in neurons (Lipscombe et al., 2004). However, little is known about the neuronal 
function of CaV1.3, as most molecular studies of L-type calcium channels concentrate on 
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CaV1.2. Due to the lack of pharmacological tools to distinguish CaV1.2 and CaV1.3 subtypes it 
is difficult to dissect their specific roles. Here we want to elucidate the neuronal function and 
distribution of CaV1.3 in the CNS using a transgenic mouse model. 
 
1.2 The L-type Voltage-gated Calcium Channel CaV1.3 
Voltage-gated calcium channels (VGCCs) are transmembrane proteins in electrically 
excitable cells, which play a key role in the regulation of intracellular Ca2+ concentration. 
Their activity is essential to couple electrical signals on the cell surface to physiological 
events in the cell. They are activated upon membrane depolarization and mediate calcium 
influx down an electrical gradient in response to action potentials and sub-threshold 
depolarization signals. Ca2+ entering the cell through VGCCs serves as second messenger of 
electrical signalling, initiating a number of intracellular processes such as muscle contraction, 
secretion, neurotransmitter and hormone release and gene expression. VGCCs are members 
of a gene superfamily of transmembrane ion channel proteins that also include Na+ and K+ 
channels (Yu and Catterall, 2004). They are multi-subunit complexes, comprising a α1, a α2-δ, 
a β and, in some cases, a γ subunit. The Ca2+ channels can be classified according to their 
electrophysiological and pharmacological properties.  
 
1.2.1 Calcium Channel Diversity 
The pharmacological and electrophysiological diversity arises primarily from the existence of 
multiple forms of α1 subunits. Mammalian α1 subunits are encoded by at least ten distinct 
genes, nine expressed in the nervous system. In 1994, Birnbaumer et al. proposed a unified 
nomenclature in which the α1 subunit was referred to as α1S for the original skeletal muscle 
isoform and α1A  to α1I  for those discovered subsequently (Birnbaumer et al., 1994). More 
recently, a rational nomenclature was adopted, defining the calcium channels into three 
structurally and functionally related subfamilies CaV1, CaV2 and CaV3 (Ertel et al., 2000). 
Based on their electrophysiological properties, voltage-gated calcium channels can be 
divided into high voltage-activated (HVA) and low voltage-activated (LVA) channels (Fig. 
1). Among the HVA channels there are two groups (L-type and non-L-type channels) based 
on the sensitivity to dihydropyridines (DHPs). L-type (“Long-lasting”) VGCCs are formed 
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by the CaV1 family, which comprise the isoforms CaV1.1, CaV1.2, CaV1.3 and CaV1.4, 
containing α1S, α1C, α1D and α1F subunits, respectively. The first L-type Ca2+ currents were 
measured in cardiac myocytes (Reuter, 1967). They require a strong depolarization and are 
long-lasting which contributed to their name L-type (Nowycky et al., 1985). Furthermore, 
they can be characterized by large single-channel conductance, slow voltage-dependent 
inactivation and regulation by cAMP-dependent protein phosphorylation pathways. One 
special property of L-type currents is their high sensitivity to calcium antagonist drugs as 
dihydropyridines (DHPs), phenylalkylamines and benzodiazepines (Reuter, 1983), even 
though there are differences among the L-type channel isoforms in their affinity for DHPs 
(Lipscombe et al., 2004). L-type VGCCs display a broad expression profile. Whereas CaV1.1 
and CaV1.4 expression is restricted to skeletal muscles and the retina, respectively, the other 
two channels are found in a variety of tissues. CaV1.2 and CaV1.3 channels are expressed in 
neurons, neuroendocrine cells (including pancreatic ß-cells), sensory cells such as retinal 
neurons and cochlear hair cells, in the cardiovascular system and in smooth muscle cells 
(Striessnig et al., 2006). 
Non-L-type HVA channels belong to the CaV2 family (CaV2.1 – CaV2.3) containing the 
subunits α1A, α1B and α1E. They mediate P/Q-type, N-type and R-type calcium currents, 
respectively. P-type (“Purkinje”) currents were first recorded in Purkinje neurons (Llinas et 
al., 1989) and can be distinguished by high sensitivity to the spider toxin ω-agatoxin IVA. N-
type (“non-L-type” or “Neural”) currents were distinguished by their intermediate voltage 
dependence and rate of inactivation – more negative and faster than L-type but more 
positive and slower than T-type (Nowycky et al., 1985). They are primarily found in 
presynaptic terminals and are involved in neurotransmitter release. R-type (“Residual”) 
currents in cerebellar granule cells are resistant to the subtype-specific organic and peptide 
Ca2+ channel blockers (Randall and Tsien, 1995). Non-L-type currents also require strong 
depolarization for activation. Unlike L-type channels they are relatively unaffected by 
dihydropyridines and other L-type channel specific drugs but are blocked by specific 
polypeptide toxins from snail and spider venoms (Catterall et al., 2005). They are mainly 
expressed in neurons where they initiate neurotransmitter release and mediate Ca2+ entry 
into dendrites and cell bodies. 
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Low-voltage activated channels include the CaV3 subfamily (CaV3.1–CaV3.3), which contains 
channels with the subunits α1G, α1H and α1I, mediating T-type (“Transient”) currents. T-type 
currents have transient kinetics and are activated at much more negative potential than L-
type currents. They inactivate rapidly, deactivate slowly and have small single-channel 
conductance (Nowycky et al., 1985). They are resistant to both organic antagonist drugs like 
DHPs and to snake and spider toxins. T-type currents are expressed in a variety of cells, 
mainly in neurons and cardiac myocytes, where they are involved in pacemaking and 
controlling patterns of repetitive firing. 
 
 
Fig. 1: Phylogenic tree of voltage-gated calcium channel α1 subunit, showing the per cent identity 
between the different cloned calcium channels. 
 
1.2.2 Structural Organization of L-type CaV1.3 Channels 
L-type VGCCs have been first purified from the transverse tubule membrane of skeletal 
muscle (Curtis and Catterall, 1984). Biochemical analyses have characterized them as 
heteromeric proteins composed of 4-5 subunits encoded by multiple genes: the pore forming, 
transmembrane α1 subunit of ~ 190-250 kDA, a transmembrane, disulfide-linked dimer of α2 
and δ subunits, an intracellular β subunit and, in some tissues, a transmembrane γ subunit. 
The pore-forming α1 subunit consists of four homologous repeats (I-IV), each of which 
composed of six transmembrane segments (S1-S6) (Catterall, 2000) (Fig. 2). The S4 segments 
of each homologous domain serve as voltage sensors. Positively charged residues on one 
side of each S4 α-helix initiate voltage-dependent conformational changes from non-
conducting to conducting states of the channel (Bezanilla, 2002). The asymmetric channel 
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pore is formed by the segments S5 and S6 together with the hydrophobic linker sequence in 
between which is called pore (P-) loop. Each of these loops contains a conserved glutamate 
residue (EEEE) as selectivity filter and for permeation of Ca2+ ions (Yang et al., 1993). The P-
loop can either bind one Ca2+ ion with high affinity or two ions with low affinity. Thus, 
monoligand binding with high affinity for Ca2+ provides the molecular basis for selectivity. 
Permeation, in contrast, requires at least two ions in the pore, since double occupancy 
destabilizes the complex and allows one of the bound Ca2+ ion to dissociate into the 
cytoplasm (Striessnig, 1999). The L-type specific drugs dihydropyridines, phenylalkylamines 
and benzodiazepines bind to three separate sites of the α1 subunit, namely the IIIS5, IIIS6 
and IVS6 transmembrane segments (Hockerman et al., 1997). Consequently, drug binding 
occurs near the pore and close to the calcium selectivity filter. 
 
Fig. 2: Structural organisation of L-type VGCCs. The primary structure of the α1 subunit is 
composed of four homologous repeats (motifs I – IV), each of which consists of six transmembrane 
segments (S1-S6). Adopted from Bodi I. et al., JCI, 2005 
 
 
Expression of the α1 subunit is sufficient for the functionality of the channels, but co-
expression of α2-δ and especially the β subunit enhances the level of expression, kinetics and 
voltage dependence of Ca2+ channel current (Miller, 1992). The α2-δ subunit is closely 
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associated with the α1 subunit by surface interaction. The α2-δ subunit is a glycosylated 
protein which is highly conserved in most tissues. The transmembrane δ subunit anchors the 
extracellular α2 protein by disulfide bridges to the plasma membrane (Hofmann et al., 1994). 
The δ peptide is sufficient to stabilize the gating properties of the channels, whereas α2 is 
required to stabilize DHP binding to the α1 subunit (Gurnett et al., 1997). The intracellular β 
subunit is the most important subunit for fine-tuning of L-type VGCC activity. It also 
stabilizes the pore region and facilitates conformational changes which open the channel 
once the voltage-sensor movement is completed. Moreover, all four isoforms of the β subunit 
(β1b, β2a, β4, and β4) increase L-VGCC membrane density by modulating α1 subunit 
expression (Neely et al., 1993). The γ subunit was first found only in skeletal muscle calcium 
channels. However, recently also a neuronal γ subunit isoform has been identified 
(Striessnig, 1999). Although these auxiliary subunits modulate the properties of the channel 
complex, the pharmacological and electrophysiological diversity of calcium channels arises 
primarily from the existence of multiple α1 subunits.  
 
1.2.3 L-type CaV1.3 Channel Properties 
1.2.3.1 CaV1.3 Gene 
The human CaV1.3α1 gene CACNA1D is located at chromosome 3p14.3 and spans 
approximately 400 kb of human genomic sequence (Seino et al., 1992).  It is encoded by up to 
52 exons, and at least seven of these exons can be alternatively spliced. Sites of alternative 
splicing are the exons 8a/8b in transmembrane IS6, exon 11 in the intracellular loop I-II, 
exons 31a/31b of transmembrane IVS3, exon 32 in the IVS3-IVS4 extracellular linker, and 
exon 42a in the C-terminus (Lipscombe et al., 2002). The murine gene (Cacna1d) for the 
CaV1.3α1 subunit is mapped to a position 7.5 cM proximal to Np-1 of mouse chromosome 14 
(Chin et al., 1991). Depending on the transcript variant, the murine CaV1.3α1 gene comprises 
47-49 exons and spans over 311-450 kb. Two forms of exon 1 are known, an adult exon 1a 
and an embryonic exon 1b (Klugbauer et al., 2002). Alternative splicing of rodent CaV1.3α1 
has been described in hair cells, the rat heart, rat neurons, and endocrine cells (Kollmar et al., 
1997; Koschak et al., 2001; Safa et al., 2001; Takimoto et al., 1997). Presently, only a limited 
number of studies address the functional significance of alternative splicing of CaV1.3α1. The 
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splice variant α1-D8A, containing exon 8a sequence in repeat I, yielded α1-D protein and L-
type currents, whereas no intact protein and L-type currents were observed when exon 8b 
was expressed (Koschak et al., 2001). The splice variant CaV1.3a with the long C-terminal 
contains PDZ-binding motifs which are required for interaction with the PDZ domain of the 
scaffolding protein Shank and Erbin (Calin-Jageman et al., 2007; Zhang et al., 2005a). 
 
1.2.3.2 CaV1.3 Expression and Localization 
The expression pattern of each CaVα1 gene is tightly regulated, depending on cell-specific 
and developmental factors that, together with characteristic structural features, permit 
coupling to specific effector proteins and second messenger systems. CaV1.3 is expressed in 
neurons (Hell et al., 1993), the cardiac atrial myocytes and pacemaker cells (Takimoto et al., 
1997), pancreatic ß-cells (Iwashima et al., 1993), in cochlear hair cells (Green et al., 1996) and, 
possibly, even in immune cells (Gomes et al., 2004). This expression pattern is very similar to 
the α1-C subunit containing CaV1.2 VGCC; the two isoforms are expressed even in the same 
cells. In the brain, CaV1.3 is less abundant than CaV1.2, as in a study by Hell et al. antibodies 
against the α1-D subunit immunoprecipitated 20% and antibodies against the α1-C subunit 
immunoprecipitated 75% of all L-type Ca2+ channels solubilised from rat cortex and 
hippocampus. Nevertheless, the presence of CaV1.3/α1-D L-type Ca2+ channels was 
demonstrated in most brain regions, including cortical neurons, hippocampal pyramidal 
cells, dentate granule neurons, cerebellar Purkinje cells, many interneurons and several other 
classes of central neurons (Hell et al., 1993). Within individual neurons, CaV1.3 channels are 
distributed over the surface of the somata with accumulation at the base of major dendrites 
and a diminishing density on more distal regions of dendrites. The relatively high 
concentration of CaV1.3 L-type channels in cell bodies and proximal dendrites suggests an 
involvement of these channels in general cellular functions like regulation of cellular 
signalling pathways and gene function. 
 
1.2.3.3 CaV1.3 Pharmacological Properties and Kinetics  
The traditional view of L-type calcium channels is that they are high-voltage activating and 
have slow activation kinetics. Their unique high sensitivity to dihydropyridine agonists and 
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antagonists has proved critical for their identification in physiological assays and for their 
biochemical isolation. Contrary to the general characteristics of L-type channels, CaV1.3 
channels start to activate at about -55 mV, a voltage that is approximately 20-25 mV more 
hyperpolarized as compared to CaV1.2. This low-threshold activation is a prominent feature 
of all CaV1.3 clones isolated, independent of tissue of origin and of auxiliary subunits 
(Koschak et al., 2001; Xu and Lipscombe, 2001). Also the activation kinetics differs from the 
prevalent textbook view, as CaV1.3 L-type currents open with rapid kinetics. In addition to 
biophysical criteria, L-type calcium channels are defined by their high sensitivity to 
dihydropyridine (DHP) agonists and antagonists. However, CaV1.3α1 currents are ~ 20-fold 
less sensitive to inhibition by nimodipine compared to CaV1.2α1 (Xu and Lipscombe, 2001). 
Inhibition of CaV1.3 channels by DHPs seems to be state-dependent: the inhibition is 
enhanced at depolarized membrane potentials that open the channel, and reduced at 
hyperpolarized membrane potentials (Berjukow et al., 2000).  
These properties of fast, sub-threshold calcium signalling strongly implicate CaV1.3 L-type 
channels in driving oscillatory activity. CaV1.3 channels could also mediate sustained 
calcium entry during action potential plateaus, as calcium-dependent and voltage-dependent 
inactivation is minimal at depolarized voltages (Lipscombe et al., 2004). These characteristics 
make CaV1.3 Ca2+ channels to be activated in response to physiological stimuli that do not 
open other L-type channels. 
 
1.2.3.4 CaV1.3 Interactions 
In recent years diverse studies revealed the existence of binding motifs in the CaV1.2α1 and 
CaV1.3α1 subunit which can associate with adaptor proteins. These interactions play an 
important role for Ca2+ signalling mediated by L-type calcium channels. 
First interaction studies were done on CaV1.2 channels. The α1C subunit contains an 
isoleucin-glutamine (“IQ”) motif in the C-terminus that binds Ca2+/calmodulin which is 
critical for MAPK-dependent CREB phosphorylation and CRE-dependent transcription 
(Dolmetsch et al., 2001). In addition to the IQ motif, the C-termini of both CaV1.2 (α1C) or 
CaV1.3 (α1D) channels contain unique class I PDZ [postsynaptic density-95 (PSD-95)/Discs 
large/zona occludens-1 (ZO-1)] interaction sequences, that have been shown to associate with 
various scaffolding proteins that contain PDZ domains (Kurschner et al., 1998; Kurschner 
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and Yuzaki, 1999). Association with PDZ proteins plays an important role in coupling L-type 
VGCCs to phosphorylation of nuclear CREB (Weick et al., 2003). It has been shown that L-
type channels containing the CaV1.3 subunit regulate CREB activation via association with 
the Shank PDZ domain (Zhang et al., 2005a).  CaV1.3 channels exist in two splice variants that 
differ at their C-terminus (Safa et al., 2001): a short isoform (CaV1.3b) that terminates 
immediately after the calmodulin-binding IQ (isoleucin-glutamine) motif, and a long splice 
variant (CaV1.3a) that extends additional 512 amino acids containing a PDZ binding motif. 
Zhang et al. demonstrated that CaV1.3a interacts with the postsynaptic adapter protein Shank 
via the PDZ interaction sequence ITTL as well as a proline-rich region in the C-terminus that 
bind to the Src homology 3 (SH3) domain of Shank. In cultured hippocampal neurons, the 
presence of the Shank-binding motifs in CaV1.3a sequence is both necessary and sufficient for 
synaptic clustering of CaV1.3 L-type VGCCs. The association of CaV1.3 and Shank plays also 
an important role in CaV1.3-mediated signalling to CREB especially at low levels of 
stimulation. Compared to CaV1.2 Ca2+ channels, CaV1.3 channels activate at significantly 
more hyperpolarized membrane potential (Koschak et al., 2001; Xu and Lipscombe, 2001). 
This unique voltage dependence of activation implies that CaV1.3 L-type Ca2+ channels 
mediate cellular processes that depend on calcium influx in response to relatively small 
membrane depolarization. 
Moreover, a recent study indicated that interactions of CaV1.3 may also be critical to inner 
hair cell functions in the cochlea. A Ca2+-dependent association of the II-III cytoplasmic loop 
of CaV1.3 and the C2 domain of otoferlin may mediate the regulation of hair cell synaptic 
exocytosis by otoferlin (Ramakrishnan et al., 2009). This could be of great importance, since a 
mutation in the C2D domain that causes deafness in humans ablates the binding to CaV1.3. 
 
1.2.3.5 Physiological Functions of CaV1.3 
CaV1.3 and CaV1.2 L-type channels display a very similar expression pattern. Even though 
CaV1.3 channels are less sensitive to dihydropyridine agonists and antagonists than CaV1.2, 
currently available L-type calcium channels blockers are unsuitable pharmacological tools 
for dissecting the functions of CaV1.3 and CaV1.2. The physiological properties of CaV1.3 
could be first revealed by conventional knockout mice (CaV1.3-/-) lacking the α1D subunit 
(Platzer et al., 2000). The knockout indicates that CaV1.3 channels control neurotransmitter 
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release in the cochlea, since CaV1.3-/- mice are deaf due to the complete absence of L-type 
currents in cochlear inner hair cells (IHCs) and degeneration of outer (OHCs) and inner hair 
cells between postnatal days 14 and 35 (Michna et al., 2003). Patch clamp analysis of IHCs 
revealed that CaV1.3α1 contributes more than 90% of VGCC currents. Electrocardiogram 
recordings in these mice exhibited sinoatrial node (SAN) dysfunction with bradycardia and 
arrhythmia which shows that CaV1.3 L-type channels are required for generation of cardiac 
pacemaking activity (Mangoni et al., 2003). The role of CaV1.3 in pancreatic ß-cells for Ca2+ 
currents and insulin secretion has been discussed controversially. Three different mouse 
models as well as biochemical data have provided evidence both for a role of CaV1.3 in ß-
cells (Namkung et al., 2001; Yang et al., 1999) as well as against it (Barg et al., 2001). 
Nevertheless, more recent data support the view that Ca2+ entry involved in insulin secretion 
is mediated by CaV1.2 channels (Schulla et al., 2003; Sinnegger-Brauns et al., 2004).  
 
1.2.3.6 Role of CaV1.3 in Brain Function and Behaviour 
The most abundant L-type calcium channel subtypes expressed in the brain are encoded by 
the CaV1.2 and CaV1.3 subunit. As mentioned above, L-type calcium channels are important 
in translating synaptic activity into alteration in gene expression and neuronal function by 
mediating the activation of the transcription factor CREB. CREB is involved in learning and 
memory in general and formation of long-term fear memories in particular. In addition, its 
role was implied in depression-like states and the long-term effects of antidepressants 
(Blendy, 2006). The role of CaV1.3 in signalling to CREB could be directly confirmed in 
primary cultures of cortical, hippocampal and striatal medium spiny neurons of CaV1.3-/- 
mice. CaV1.3 channels preferentially mediate nuclear CREB signalling in hippocampal 
neurons at low, but not at high, levels of stimulation which reflects the ability of these 
channels to open at lower levels of depolarization (Zhang et al., 2006).  
L-type channels affect neuronal resting potential and stabilise plateau potentials in many 
neurons. Direct evidence that such upstate potentials and the subsequent spontaneous firing 
activity are mediated by CaV1.3 channels has been obtained in striatal spiny neurons of 
CaV1.3 knockout mice, where this activity was completely absent (Olson et al., 2005). This 
correlates well with the observation made by Chan et al. who showed that CaV1.3 channels 
are required for pacemaking activity especially in dopaminergic neurons which could be 
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possibly connected to Parkinson’s disease (Chan et al., 2007). The reliance on CaV1.3 
increases with age, as juvenile dopaminergic neurons use pacemaking mechanisms common 
to other neurons, mediated by Na+ and HCN channels. DHP-mediated blocking of CaV1.3 
channels in adult neurons induced a reversion to the juvenile form of pacemaking. This 
“rejuvenation” protects dopaminergic neurons in both in vitro and in vivo animal models of 
Parkinson’s disease. 
By conducting low-voltage activated L-type Ca2+ currents CaV1.3 channels can shape 
neuronal firing patterns. This reveals a key role of CaV1.3 in neuronal activity and plasticity, 
and prompts questions about the physiological role of this channel for neuronal function and 
animal behaviour in vivo. An interesting approach to study and dissect the in vivo function of 
CaV1.2 and CaV1.3 is a transgenic mouse model (CaV1.2DHP-/-), whose CaV1.2α1 subunit lacks 
high sensitivity to DHP agonists and antagonists (Sinnegger-Brauns et al., 2004). This model 
allows investigating the direct DHP effect on CaV1.3 channels. By using c-fos activation as a 
marker for neuronal activation, the neuronal circuits stimulated by CaV1.3 activation could 
be displayed. Significant Fos expression induced by DHP agonist BayK 8644 was detectable 
only in a small subset of brain regions, particularly in the central amygdala, the BNST (bed 
nucleus of the stria terminalis), the PVN (paraventricular hypothalamic nucleus), the lateral 
preoptic area, in the locus coeruleus and in the nucleus of solitary tract (Hetzenauer et al., 
2006). This indicates that selective stimulation of CaV1.3 restricts neuronal activation to a 
specific set of limbic, hypothalamic and brainstem areas, which are associated with brain 
functions concerning integration of emotion-related behaviour and processing of stress. 
Some of these regions, such as the amygdala, the PVN, the BNST or the ventral striatum, are 
part of anatomical circuits associated with depression-related behaviour (Manji et al., 2001). 
These findings are supported by behavioural experiments with CaV1.3-/- knockout mice 
which show a significantly suppressed anxiety- and depression-related behaviour (Nguyen 
et al., 2005). 
A recent study also indicates a role of CaV1.3 channels in Pavlovian fear conditioning in mice. 
McKinney et al. used CaV1.3 knockout mice to elucidate the contribution of the channel in 
consolidation and extinction of conditioned fear (McKinney and Murphy, 2006). They found 
that these mice exhibit significant impairments in consolidation of contextually conditioned 
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fear, whereas their extinction of contextually conditioned fear was not altered compared to 
wildtype mice. 
Ca2+ influx through postsynaptic L-type VGCCs and NMDA receptors (NMDAR) can lead to 
long-term potentiation (LTP), which is an activity-dependent enhancement in synaptic 
efficacy and a favoured candidate for a cellular mechanism of hippocampus-dependent 
forms of memory (Bauer et al., 2002). Induction of NMDAR-independent LTP seems to 
require activation of the L-type channel isoform CaV1.2 (Moosmang et al., 2005) and CaV1.3 
channels are likely to play a role in working memory impairment in aging. In aged rats the 
increased expression of CaV1.3 channels correlates with age-related working memory decline 
in the area CA1 in the hippocampus and chronic treatment with nimodipine ameliorates the 
memory deficits (Veng et al., 2003).  
These summarised data support an important role of the CaV1.3 channel in various brain 
functions and in behaviour. However, since conventional CaV1.3α1 knockout mice ablate the 
CaV1.3α1 subunit in all tissues and thus show phenotypes like deafness and heart 
insufficiency which might interfere with behavioural analysis, it would be important to 
investigate its function selectively in different types of neurons and brain areas required for 
learning and memory and mood.  
 
1.3 Conditional Knockout of the CaV1.3 α1 Subunit Gene 
The development of gene knockout technologies in mammals was crucial for the 
investigation of physiological functions of a gene. The mouse has become an important 
model for studying genetics and disease as it shares genomic, anatomical and physiological 
similarities with humans. In the early 1980s the isolation of embryonic stem (ES) cells from 
mouse embryos and their undifferentiated maintenance in cell culture (Evans and Kaufman, 
1981; Martin, 1981) presented the first prerequisites for targeted gene inactivation in mice. 
The appearance of gene targeting technology – the replacement of endogenous genomic 
DNA with a mutant version of this DNA sequence based on homologous recombination – in 
mouse ES cells has led to a first generation of so-called knockout (KO) animals (Capecchi, 
1989) and  presents a powerful approach to introduce a variety of mutations in many 
different loci. Phenotyping of these null mutant mice has provided valuable information 
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about gene function and a variety of these knockout mice serves as animal models of human 
diseases.  
The conventional knockout technology, however, has limited utility in several situations. The 
gene of interest could be essential for development and survival, and the gene knockout may 
lead to a lethal phenotype. Furthermore, the targeted gene could be important for normal 
development and share functional redundancy with other genes. In this case the phenotype 
could be hardly detectable and would likely result from compensatory mechanisms that may 
be difficult to elucidate.  
 
1.3.1 The Cre-loxP Recombination System 
To circumvent the difficulties associated with the complete deletion of a specific gene, 
sequence-specific recombination systems have been developed. These systems made it 
possible to obtain spatial and temporal control of the gene knockout, which is referred to as 
conditional knockout. Several such recombinase systems have been established in mice, two 
most common provide the basic tools for in vivo genetic engineering: the Cre/loxP system 
derived from the bacteriophage P1 (Sauer and Henderson, 1989) and the Flp/FRT system 
from the yeast Saccharomyces cerevisiae (O'Gorman et al., 1991). Both Cre and Flp recombinases 
belong to the λ integrase superfamily of site-specific recombinases that recognise a minimal 
target site of 34 bp where the recombination reaction takes place. The recombination reaction 
is carried out with absolute fidelity, such that not a single nucleotide is gained or lost, and no 
cofactors are required, making these recombination systems quite adaptable for use in a 
variety of heterologous organisms. 
The Cre/loxP technology, which is the most established and popular approach to control 
targeted genetic inactivation in mice, was first reported by Rajewski et al. to knock out the 
DNA polymerase beta gene specifically in T-lymphocytes. The Cre (Causes recombination) 
recombinase catalyses the site-specific recombination between two recognition sites called 
loxP (locus of cross-over (x) in P1). The 34 bp long loxP site consists of two 13 bp inverted 
repeats and an 8 bp asymmetrical core spacer sequence, which determines the orientation of 
the site (Fig. 3 A). Depending on the orientation of the flanking loxP sites, a DNA fragment is 
excised ( loxP sites oriented head-to-tail) (Fig. 3B) or inverted (loxP sites oriented head-to-
head) (Fig. 3C) by the Cre-recombinase (Rajewsky et al., 1996). Cre catalyses the exchange 
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between the pair of loxP sites in the core spacer region by combined cleavage, exchange and 
rejoining reaction. A cis recombination event between two sites will lead to excision or 
inversion of the loxP-flanked (“floxed”) DNA sequence. Recombination between two loxP 
sites in trans will lead to the reciprocal exchange of the regions that flank the loxP sites. Cre 
can also induce these recombination events when the loxP sites are located several 
megabases apart on the same chromosome, or on two homologous or non-homologous 
chromosomes (Ramirez-Solis et al., 1995). The equilibrium of the reactions of the deletion, 
inversion, exchange and integration of loxP-flanked DNA sequences can be pushed in the 
desired direction by using suitable selection markers. The mechanism of Cre-mediated 
recombination is as follows: after one recombinase monomer binds each palindromic 13 bp 
repeat, two such target sites are brought together in a synaptic complex. The subsequent 
events occur in the core spacer region where the DNA strands are cleaved, exchanged and 
ligated via a Holliday intermediate. In the final recovered product, the symmetry arms of the 
two target sites have been exchanged and the core regions of the two recombinants are 
heteroduplex.  
 
 
 
Fig. 3: The loxP site consists of an asymmetrical 8 bp spacer and two 13 bp inverted repeats (A). 
Depending on the orientation of the loxP sites the flanked region is excised (B) or inverted (C). 
Adopted from Hofker MH, van Deursen J, Methods in Mol. Biology, vol.209 
 
Conditional targeting of loxP-flanked genes or gene segments can be achieved by crossing 
the mouse with loxP-flanked (“floxed”) alleles with a “Cre” mouse expressing Cre-
recombinase in a cell-type-specific or inducible manner. The floxed mouse is obtained by 
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homologous recombination in ES cells and displays wildtype phenotype since the loxP sites 
should not disturb gene transcription. The “Cre” mouse classically is a transgenic mouse, 
produced by pronuclear injection of a cDNA encoding Cre-recombinase under the control of 
a specific promoter. The transgene integrates randomly into the genome, and distribution of 
Cre activity requires careful characterization. In offspring derived from intercross between 
these two lines, Cre/loxP site dependent recombination will occur only in Cre-expressing 
cells, leading to an excision or inversion and consequently inactivation of the gene. In 
contrast, the target gene should remain functional in cells of all other tissues where the Cre 
transgene is not expressed as the promoter controlling the recombinase is inactive. The DNA 
excising capability of Cre-recombinase can also be used to turn on a gene by cutting out an 
intervening loxP-stop-loxP cassette between the promoter and the coding region of the 
transgene (Tsien et al., 1996). An elegant way to achieve temporal control of Cre-mediated 
recombination is by using an inducible Cre version. This Cre-ERT2 recombinase, fused to an 
estrogen-mutated ligand binding site, is inactive at first. At time of experiment, Cre activity is 
induced by the systemic administration of the synthetic steroid ligand tamoxifen (Metzger 
and Chambon, 2001). All these features make the Cre/loxP system a valuable tool for 
molecular biology in that it allows the isolation of individual genes and their functions by 
establishing tissue specific gene ablation.  
 
1.3.2 Conditional Gene Inactivation via the FLEX Switch 
The development of the Cre/loxP system presents an opportunity to induce gene alterations 
both at precise time points and in specific cell types. Unfortunately, a frequent problem in 
transgenic mice expressing Cre-recombinase is position effect variegation that leads to a 
mosaic expression of the transgene. To address this problem, a so called reporter mouse line 
is used whose expression of a reporter gene (e.g. ß-galactosidase) is dependent on a Cre-
mediated event excising a functionally silencing cassette (Branda and Dymecki, 2004). 
However, the excision pattern for a conditional allele cannot be accurately concluded from 
that of a reporter transgene. Moreover, their use to monitor gene ablation at the level of 
individual cells is often limited, as in some tissues the reporter gene may be silenced or 
reside in a chromatin configuration inaccessible for recombination. Therefore a direct 
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approach that allows to identify individual cells that are recombined at a given gene locus 
was required. 
An elegant way is to directly couple reporter expression to gene ablation, thereby permitting 
a clear identification of each cell in which site-specific recombination has taken place. This is 
accomplished by the FLEX (Flip Excision) switch, through which the expression of a gene of 
interest is turned off, while the expression of another (e.g. reporter gene) is simultaneously 
turned on (Schnutgen et al., 2003). The FLEX switch is based on the ability of the Cre-
recombinase to invert or excise a DNA fragment, depending on the orientation of the flanked 
loxP sites, and the availability of wildtype (WT) and mutated loxP sites. A FLEX allele 
contains two pairs of heterotypic loxP sites (e.g. loxP and loxP257) which are alternately 
arranged in head-to-head orientation. The mutated loxP site differs from the WT loxP site by 
one to three nucleotides in the core spacer sequence but is still recognized by the Cre 
recombinase. Thus, the two different loxP sites are incompatible to each other, indicating that 
for example the loxP sites cannot recombine with the loxP257 sites but efficiently with 
themselves. By now various mutated loxP sites are available. Whereas loxP511 differs from 
the WT loxP site in only one nucleotide and loxP2272 and loxP5171 in two nucleotides in the 
8bp spacer region (Siegel et al., 2001), the loxP257 or here referred to as L3 site contains 
aberrant nucleotides at three positions in the core region (Fig. 4). 
 
Fig. 4: Sequence of the 8 bp spacer region within the loxP site. Underlined nucleotides represent the 
base changes that differ from the original loxP sequence. Changes in the spacer sequence generate loxP 
sites that recombine with themselves but not with other loxP sites. 
 
The combination of WT loxP and L3 has been successfully used with high efficiency and 
without detection of any Cre-recombination between the two heterotypic loxP sites (Wong et 
al., 2005). For this strategy the application of heterotypic loxP sites is fundamental, since 
flanking an exon of the gene of interest by only one pair of homotypic loxP sites in head-to-
head orientation would result in repeated rounds of recombination and inversions. In living 
cells, this would finally result in equilibrium, with half of the loxP-flanked DNA being in 
sense, the other half in antisense orientation (Abremski et al., 1983). 
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Beside the heterotypic loxP sites the FLEX switch allele contains an exon of a gene to be 
inactivated and a promoterless reporter gene with a universal splice acceptor and a 
polyadenylation (polyA) site in antisense orientation (Fig. 5). After Cre expression, each pair 
of loxP sites recombines with the corresponding pair, thereby inverting the floxed cassette in 
an irreversible way. By inverting, the expression of the reporter gene eGFP is switched on, 
while the exon of interest is inactivated. The cassette is now transcribed from the 
endogenous promoter in form of a fusion transcript in which the exon upstream of the 
insertion locus is spliced in frame to eGFP. This fusion transcript forms a nonfunctional and 
truncated version of the gene, since transcription is terminated by the polyadenylation site. 
Thus the FLEX switch presents a strategy to simultaneously inactivate the gene of interest 
and visualises the inactivation by expression of a “knock-in” reporter gene driven by the 
endogenous promoter. 
 
 
Fig. 5: Schematic drawing of the FLEX switch. The FLEX switch uses two pairs of heterotypic, 
antiparallel loxP recombination sites, which first undergo a Cre-mediated inversion of the coding 
sequence (exon 2), followed by excision of two sites, leading to one of each heterotypic recombination 
site oppositely orientated and incapable of further recombination. Note that it does not make any 
difference for the stable end product whether the inversion occurs at loxP and the excision at L3 sites 
or the other way round. After the switch the exon of interest is inactivated whereas the reporter gene 
is driven by the endogenous promoter in form of a fusion transcript. 
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1.4 Aim of the Thesis 
CaV1.3 voltage-gated calcium channels are widely expressed in the brain where they are 
involved in activity-dependent gene activation in neurons, CREB-signalling and behaviour. 
They have been also detected in many non-neuronal tissues like the heart atria, pancreatic ß-
cells and cochlear hair cells. Conventional knockout mice of CaV1.3α1 with a deleted channel 
in all tissues displayed important phenotypes. The mice were deaf due to the complete loss 
of cochlear hair cells and they exhibited sinoatrial dysfunction with bradycardia and 
arrhythmia. Furthermore, Ca2+ influx through CaV1.3 was proposed to be involved in 
memory formation, impairments in anxiety-related behaviour and in consolidation of 
contextually conditioned fear. 
Here, we are interested to gain more insights into the role of CaV1.3 channels in neuronal 
tissues. We want to analyse the neurological functions and distribution of the L-type voltage-
gated Ca2+ channel (VGCC) isoform CaV1.3α1 in the brain using genetically modified mice. 
Since conventional CaV1.3α1 knockout mice ablate the CaV1.3α1 subunit in all tissues and 
thus show phenotypes like deafness and heart insufficiency which interfere with behavioural 
analysis, we generate conditional knockout mice via Cre/loxP mediated recombination with a 
tissue-specific deletion of the channel in brain areas required for learning and memory and 
mood. Furthermore, the knockout can be temporally controlled to rule out the possibility 
that genetic compensation could affect the neural phenotype in the CaV1.3α1 knockout. 
Aim of this study was to generate a conditional CaV1.3α1 KO mouse line. This CaV1.3-GFPflex 
mouse line is generated using a special knockout strategy, the Cre-mediated FLEX switch 
system, by which the CaV1.3α1 gene is turned off while the reporter gene eGFP is switched 
on. With this knockout-strategy the expression pattern of the channel and the extent and 
time course of its ablation can be monitored, since so far no reliable working antibodies 
against CaV1.3 are available for immunohistochemical detection. The eGFP labelled neurons 
allow performing single cell electrophysiological recording and molecular studies within all 
CaV1.3 tissues. Furthermore, crossed by the germline “Cre-deleter” mouse, replacing by eGFP 
will reveal the exact expression pattern of CaV1.3α1 in all tissues. With this floxed CaV1.3α1 
mouse line, crossed with animals expressing Cre under the control of a tissue-specific 
promoter, we can produce conditional-null mutants for a wide range of tissues with the 
possibility of direct cellular monitoring of the gene ablation.  
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2 Material 
2.1 Laboratory Equipment 
Accurate scales BP210S, Satorius 
Autoclave Fritz Gössner 
Incubator Heraeus 
Centrifuge Tubes Beckman-Coulter 
Electroporator ECM630, BTX 
Magnetic stirrer MR3001, Heidolph 
Thermal Cycler I-cycler, BioRad 
 Primus 96, MWG Biotech 
 UNO II Biometra 
Pipetting controller Pipetus akku, Hirschmann Laborgeräte 
pH-meter pH537, WTW 
Refrigerator Liebherr 
-80°C freezer Sanyo 
Shaker Duomax 1030, Pharmacia Biotech 
Spectrophotometer  Ultrospec 200, Pharmacia Biotech 
 NanoDrop ND-1000, MWG Biotech 
Vacuum concentrator Speed Vac SC110, Savant 
Tabletop centrifuge Centrifuge 5415D, Eppendorff 
 Centrifuge 5415R, Eppendorff 
 Multifuge 3 S-R, Heraeus 
 CS-6, Beckman-Coulter 
Thermo block Thermomixer comfort, Eppendorff 
Ultracentrifuge Optima L-70, Beckman-Coulter 
 J2 MC, Beckman-Coulter 
Vortexer MS1 Minishaker, IKA 
Vacuum pump Mini-Vac E1, Axon Labs 
Water purifier Milli-Q RG, Millipore 
 
2.1.1 Microscopy 
Microscopes A1R 4 laser line confocal microscope, Nikon 
 Axiovert 2 plus, Zeiss 
 Stemi 2000-C, Zeiss 
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2.1.2 Agarose Gelelectrophoresis 
Electrophoresis chamber B1A, B2 ;B3, Owl Scientific 
Power supply Poer Pac 300, BioRad 
Gel photo imager Gene Flash, Syngene 
 
2.1.3 Cell Culture 
Hood Nuair class II 
Cell culture incubator Nuaire US autoflow 
Vacuum pump IBS Integra Biosciences 
Cell culture water bath GFL 
 
2.2 Consumables 
Electroporation cuvettes E.coli Pulser Cuvette, Bio-Rad, Munich 
Laboratory film Parafilm M, American Can Company 
Pasteur-Capillary- Pipettes WU, Mainz 
Plastic syringes Discardit II, Becton Dickinson GmbH 
Petri dishes Greiner-Bio-One GmbH 
Plastic material for cell culture Sarstedt GmbH, Nümbrecht 
Plastic material for cell culture Falcon, Becton Dickinson GmbH, Heidelberg 
Pipette Tips Easy load, Greiner-Bio-One GmbH, Frickenhausen 
Reaction tubes 1,5ml, 2ml, 15ml, 50ml Sarstedt GmbH, Nümbrecht 
PCR tubes Sarstedt GmbH, Nümbrecht 
 
2.3 Chemicals 
The commonly used chemicals had analysis quality (p.A.) and have been sourced by the 
companies listed below: 
Acros Organics, Geel (Belgien) 
AppliChem GmbH, Darmstadt 
Biomol Feinchemikalien GmbH, Hamburg 
Bio Rad GmbH, Munich 
Carl Roth KG, Karlsruhe 
Difco Laboratories, Detroit Michigan (USA) 
Fluka Feinchemikalien GmbH, Neu-Ulm 
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Gerbu Biotechnik GmbH, Gaiberg 
Invitrogen (Gibco) GmbH, Karlsruhe 
J.T. Baker, Deventer (Holland) 
Merck AG, Darmstadt 
Pharmacia Chemikalien GmbH, Dübendorf 
Promega, Mannheim 
Riedel de Haen Laborchemikalien AG, Seelze 
Roche Diagnostics GmbH, Mannheim 
Roth Chemikalien, Karlsruhe 
Serva Feinbiochemika GmbH & Co., Heidelberg 
Sigma-Aldrich GmbH, Seelze 
 
2.4 Antibiotics 
Ampicillin Sigma-Aldrich GmbH, Seelze 
Carbenicillin Roth Chemikalien, Karlsruhe 
Kanamycin Invitrogen (Gibco) GmbH, Karlsruhe 
Chloramphenicol Sigma-Aldrich GmbH, Seelze 
Neomycin G418 Calbiochem by Merck KGaA, Darmstadt 
Ganciclovir Sigma-Aldrich GmbH, Seelze 
 
2.5 Enzymes and Recommended Buffers 
ß-Agarase Fermentas, St. Leon-Roth 
DNA Ligase T4 Fermentas, St. Leon-Roth 
10 x T4 DNA Ligation buffer: 
400 mM Tris-HCl (pH 7,8 at 25°C), 100 mM MgCl2, 
100 mM DTT, 5 mM dATP 
DNA Polymerase T4 Fermentas, St. Leon-Roth 
5 x Reaction Buffer: 
335mM Tris-HCl (pH 8.8 at 25°C), 33mM MgCl2 
5mM DTT, 84mM (NH4)2SO4  
DNA Polymerase Taq Bioron, Ludwigshafen 
PCR-Buffer (10x): 160 mM (NH4)2SO4, 670 mM Tris-
HCl (pH 8.8), 0.1% Tween-20, 25 mM MgCl2 
dNTP-Mix: 10 mM dATP, 10 mM dCTP , 10 mM dGTP,  
10 mM dTTP in ddH2O 
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DNA Polymerase Pwo (proofreading Taq) Roche Diagnostics, Mannheim 
PCR-Buffer (10x) with MgSO4: 
100 mM Tris-HCl (pH 8.85, 20°C), 250 mM KCl, 
50 mM (NH4)2SO4 ,20 mM MgSO4 
Expand Long Range dNTPack, Enzyme Mix 
 
Roche Diagnostics, Mannheim 
PCR-Buffer (5x) with 12.5 mM MgCl2 :  
Proteinase K Qiagen, Hilden 
Reverse Transcriptase Qiagen, Hilden 
Invitrogen, Karlsruhe 
Restriction enzymes Fermentas, St. Leon-Roth 
New England Biolabs, Frankfurt 
RNase A Roche Diagnostics, Mannheim 
Shrimp Alkaline Phosphatase Promega, Mannheim 
10X Reaction Buffer: 
100mM MgCl2, 0.5M Tris-HCl (pH 9.0) 
 New England Biolabs, Frankfurt 
 
2.6 Reaction buffers for restriction endonucleases 
2.6.1 Fermentas Buffers 
1X Buffer B (blue) 
10mM Tris-HCl (pH 7.5 at 37°C) 
10mM MgCl2 
0.1mg/ml BSA 
 
1X Buffer R (red) 
Tris-HCl (pH 8.5 at 37°C 
10mM MgCl2 
100mM KCl 
0,1mg/ml BSA 
1X Buffer G (green) 
10mM Tris-HCl (pH 7.5 at 37°C) 
10mM MgCl2 
50mM NaCl 
0.1mg/ml BSA 
1X Buffer Tango™ (yellow) 
33mM Tris-acetate (pH 7.9 at 37°C) 
10mM magnesium acetate 
66mM potassium acetate 
0.1mg/ml BSA 
1X Buffer O (orange) 
50mM Tris-HCl (pH 7.5 at 37°C) 
10mM MgCl2 
100mM NaCl 
0.1mg/ml BSA 
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2.6.2 New England Biolabs Buffers 
1X NEBuffer 1 
10 mM Bis-Tris-Propane-HCl 
10mM MgCl2 
1 mM DTT  
pH 7.0 at 25°C 
1X NEBuffer 3 
100 mM NaCl 
50 mM Tris-HCl 
10mM MgCl2 
1 mM DTT 
pH 7.9 at 25°C 
1X NEBuffer 2 
50 mM NaCl 
10mM MgCl2 
10 mM Tris-HCl 
1 mM DTT 
pH 7.9 at 25°C 
1X NEBuffer 4 
50 mM potassium acetate 
20 mM Tris-acetate 
10 mM magnesium acetate 
1 mM DTT 
pH 7.9 at 25°C 
 
2.7 Antibody Staining 
2.7.1 Antibodies 
1. Antibody Source Dilution Supplier 
Anti-eGFP rabbit 1:8000 Molecular Probes Invitrogen, # A11122 
Anti-eGFP chicken 1:1000 Chemicon, # AB16901 
Anti-Doublecortin (C-18) goat 1:500 Santa Cruz Biotechnology, # sc-8066 
Anti-GFAP mouse 1:2000 Sigma-Aldrich GmbH, # G3893 
Anti-TPH1 mouse 1:2000 Sigma-Aldrich GmbH, # T0678 
Anti-NeuN mouse 1:4000 Chemicon, # MAB377 
Anti-Sox2 rabbit 1:1500 Chemicon, # AB5603 
Anti-GAD67 mouse 1:100 Chemicon, # MAB5406 
    
2. Antibody    
Alexa Fluor® 488 anti-rabbit IgG (H+L) donkey 1:500 Molecular Probes Invitrogen 
Alexa Fluor® 555 anti-goat IgG (H+L) donkey 1:500 Molecular Probes Invitrogen 
Cy™ 3-conjugated anti-mouse IgG (H+L) donkey 1:200 Jackson Immuno Research Laboratories 
Cy™ 5-conjugated anti-mouse IgG (H+L) donkey 1:500 Jackson Immuno Research Laboratories 
    
Hoechst 33258   - 1:2000 Invitrogene 
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2.7.2 Compounds for Antibody Staining 
Normal Donkey Serum Jackson Immuno Research Laboratories, Inc. 
Albumin Fraktion V Carl Roth GmbH, Karlsruhe 
Triton X100 Sigma-Aldrich GmbH, Seelze 
Vectastain ABC Kit Vector Laboratories, Inc., California 
DAB (3,3`- Diaminobenzidine tetrahydrochloride) Sigma-Aldrich GmbH, Seelze 
Eukitt O. Kindler GmbH & Co., Freiburg 
Dako Fluorescent Mounting Medium Dako Deutschland GmbH, Hamburg 
 
2.8 Nucleic Acids 
2.8.1 Nucleotids 
Deoxyribonucleotids (dNTPs) Fermentas, St. Leon-Roth 
 
2.8.2 DNA Markers 
PFGE Low Range New England Biolabs, Frankfurt 
PFGE Mid Range I & II   New England Biolabs, Frankfurt 
λ/2 HindIII ladder Fermentas, St. Leon-Roth 
1 Kb DNA-ladder Fermentas, St. Leon-Roth 
100bp ladder Fermentas, St. Leon-Roth 
 
2.8.3 Primers 
All primers are ordered from MWG Biotech and are used in a concentration of 100 pmol/µl. 
L3  sense ATAACTTCGTATAAAGTCTCCTATACGAAGTTATGGATCCCG 
L3  antisense ATAACTTCGTATAGGAGACTTTATACGAAGTTATGGATCCCG 
HA-C_for ACGCGTCGACTACTGAATTATTGGTTGAG 
HA-D_rev GGAATTCCTGACTTTGAAAACACATG 
HA-E_for ATAAGAATGCGGCCGCCTCAGTTTGTCAGAAG 
HA-F_rev TCCCCGCGGCCATTGTTGTGCCACACC 
HA-G_for GGGGTACCTTAGCAGTCTGGAATGTGAG 
HA-H_rev TTAGGGCCCGTGGCTAAATATACTCATGGACAC 
HA-I_for ATTTGCGGCCGCAACTTCATAGTGGTAGG 
HA-J_rev ATTCCGCGGCAGCATACCAAATTTTCAAC 
GFP_for CGCACCATCTTCTTCAAGGACGAC 
GFP_rev AACTCCAGCAGGACCATGTGATCG 
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Neo_for TGCTCCTGCCGAGAAAGTATCCATCATGGC 
Neo_rev CGCCAAGCTCTTCAGCAATATCACGGGTAG 
NeoES_for CCGGTAGAATTTCGACGACCTG 
3'HAext_rev2 TGACCATCCAAGTGAGAGCAAGAC 
3'HAint_rev AAGGCCGGCCACGCTAATC 
Neo_Xho-FRT-Xho TGAGGCGGAAAGAACCAG 
Ex2 ES_rev GCTGTTGGGCTGAGAAGTTGGT 
ES3'_for   GGACGTAAACTCCTCTTCAGACCTG 
5`HA_end_for   GGAGTTGTGTATATCTGTTAAGCCATG 
3'HAvorne_rev   CCAGAAGATTCCACTAAAGGTCAT 
eGFP(GATC)_rev CCGTCCAGCTCGACCAG 
CaV1.3-FRT_for   CGATAAGCTTGATATCGAATTCCGAAGTTCC 
CaV_Ex3rev AGCTAAGGCCACACAATTGGC 
 
2.8.4 Plasmids 
Name Origin Resistance 
J14279Q4 RZPD Kan??? 
pBelo.BAC HD Kai Schönig Cm 
pL253 N. Copeland, Frederick, USA Amp 
pL451 N. Copeland, Frederick, USA Amp/Kan 
pL452 N. Copleand, Frederick, USA Amp/Kan 
pUC 18 Stratagene, Heidelberg Amp 
pMCS5 Molecular Probes Amp 
pBlueskript II SK (+) Stratagene, USA Amp 
pMC1-Cre D. Bartsch Amp 
pCaggsFlpE F. Stewart, TU Dresden Amp/Puro 
SA.eGFP.pA+2 Frank Schnütgen, Frankfurt Amp 
 
 
2.9 Bacteria Strains 
DH5a Invitrogen, Karlsruhe ∆(lac)U169, endA1, gyrA46, 
hsdR17(rK-mK+), phi80, 
∆(lacZ)M15, recA1, relA1, supE44, 
thi-1. 
DH10B Invitrogen, Karlsruhe F- mcrA ∆(mrr-hsdRMS-mcrBC) 
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φ80lacZ∆M15; ∆lacX74; recA1 
endA1 araD139 ∆(ara, leu)7697 galU 
galK λ- rpsL nupG  
EL250 Neil G. Copeland, National Cancer 
Institute, Frederick, USA 
DH10B [_cl857 (cro-bioA < > araC-
PBADflpe] 
EL350 Neil G. Copeland, National Cancer 
Institute, Frederick, USA 
DH10B [_cl857 (cro-bioA < > araC-
PBADcre] 
2.10 Cell Lines 
HeLa Human cervix carcinoma cells ATCC-LGC Promochem 
R1 Mouse embryonic stem cells from 
129/SvJ mouse strain 
From A. Nagy, Toronto, Canada 
 
2.11 Mouse Lines 
TgN(EIIa-Cre)C5379Lmgd Adenovirus EIIa promoter directs 
expression of Cre recombinase in 
preimplantation mouse embryos. 
This transgene expresses Cre 
recombinase in nearly all tissues 
H.Westphal, NIH Bethesda, USA 
Tg(ACTFLPe)9205Dym/J  Human ACTB promoter drives the 
expression of FLPe also in the 
germline 
S.Dymecki, Harvard, USA 
B6D2F1/Crl C57BL6/N and DBA2 F1-hybrids for 
ES cell injection foster mothers and 
vasectomised males 
Charles River, Sulzfeld 
C57BL6/NCrl  Charles River, Sulzfeld 
Camkcre4 mice (TgCre4) Cre recombinase expressed 
postnatally under control of the 
CamKIIα gene present in a BAC 
expression vector (8.5 kb promoter 
fragment) 
Günther Schütz, DKFZ, Heidelberg 
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2.12 Buffers, Media and Solutions 
Antibiotics stock solutions:  
Ampicillin (1000x) 100mg/ml in H2O 
Carbenicillin (1000x) 100mg/ml in EtOH 
Doxycyclin-hydrochloride (1000x) 1mg/ml in H2O 
Kanamycin (2000x) 25mg/ml in H2O 
Chloramphenicol (2000x) 25mg/ml in H2O 
D-MEM Dulbecco´s modified Eagle Medium, 
Invitrogen GmbH, Karlsruhe  
with GlutaMAX I4500 mg/L D-Glucose 
Sodium-pyruvate 
10xDNA-loading buffer 30 % (w/v) Glycerol 
0.3 % (w/v) bromine phenol blue 
0.3 % (w/v) xylene-cyanole 
10 mM Tris-HCl; pH 7.5 
Ethidium bromide 10 mg/ml in H2O 
FCS Fetal calw serum, Invitrogen GmbH, Karlsruhe 
In situ ß-Gal-staining solution 1 mg/ml X-Gal 
2 mM MgCl2 
5 mM K4(Fe(CN)6) 
5 mM K3(Fe(CN)6) 
IPTG stock 400mM in H2O 
LB-agar 1.5 % (w/v) Bacto-Agar  
(Difco-Laboratories, Detroit, USA) in LB-medium 
LB-medium 10 g Bacto-Trypton (Difco-Laboratories) 
5 g yeast-extract (Difco-Laboratories) 
10 g NaCl 
adjusted with NaOH to pH 7.5  
ddH2O ad 1000 ml 
Mini-prep solutions solution I: 
50 mM tris-HCl, pH 8.0 
10 mM EDTA 
100µg/ml RNAse 
solution II: 
0.2 M NaOH 
1% SDS 
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solution III: 
2.8 M potassium acetate, pH 5.1 
(adjusted with glacial acetic acid) 
Opti-MEM Serum reduced medium,  Invitrogen GmbH, Karlsruhe 
with GlutaMAX I 
2400 mg/L sodium carbonat, HEPES, Sodium 
pyruvate, Hypoxathine, Thymidin, Growthfactors, 1.1 
mg/L Phenolred 
PBS(1x), pH 7.4 140 mM NaCl 
2.7 mM KCl 
1.5 mM K2PO4 
8.1 mM Na2HPO4 x 2H2O 
Sörensen Buffer 0.1M pH 7.3 350 ml Na2HPO4 0.2M 
650 ml NaH2PO4 0.2M  
1000 ml H2O 
0.5 ml Heparin/l 
TAE(1x) Tris acetate EDTA:  
40 mM Tris-HCl, pH 8.3 
20 mM Sodium acetate 
2 mM EDTA 
TBE(1x) Tris borate/EDTA: 
90 mM Tris-HCl, pH7.8 
90 mM Boric acid 
3 mM EDTA 
TE Tris/EDTA: 
10 mM Tris-HCl pH 7.5 
1 mM EDTA 
Trypsin-EDTA Invitrogen GmbH, Karlsruhe 
0.05% Trypsin 
0.53 mM EDTA x 4Na 
YENB 0.75% Bacto yeast extract 
0.8% Bacto nutrient broth 
 
 
 
 
 
Material 
 
 33
2.12.1 Cell Culture Media 
ES Medium KnockOut DMEM (Invitrogen) 
0.1 mM non-essential amino acids (100x stock, 
Invitrogen) 
0.1 mM ß-mercaptoethanol (Sigma Aldrich) 
2 mM Glutamax (100x stock, Invitrogen) 
1x Penicillin/Streptomycin (100xstock, Invitrogen) 
15 % Fetal bovine serum (FBS), ES qualified 
(Invitrogen) 
1000U/ml ESGRO LIF (Chemicon) 
Trypsin/EDTA 0.05 % trypsin in saline/EDTA (Invitrogen) 
1x Freezing Medium 25 % FBS 
10 % DMSO 
In DMEM 
Feeder Medium DMEM high glucose 
10 % Fetal calf serum (FCS) 
1x Penicillin/streptomycin 
2 mM Glutamax 
Gelatine solution 0.1 %  Gelatine in water, autoclaved (Sigma) 
Gancyclovir 2 µM (5000x stock , 10mM in PBS, sterile filtered) 
G418 200µg/ml (1000x stock, 200mg/ml in PBS, sterile 
filtered) 
ES Lysis buffer 10 mM Tris-HCl, pH 7.5 
10 mM EDTA 
10 mM NaCl 
1 mg/ml Proteinase K (Qiagen) 
0.5 % SDS 
Mineral oil Sigma Aldrich 
NaCl/EtOH mix 15µl of 5M NaCl per 1ml of cold 100 % EtOH(.made 
fresh) 
Mitomycin C 1 mg/ml stock 
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3 Methods 
3.1 Microbiological Methods 
3.1.1 Transformation of Bacteria 
There are two methods to transform E. coli cells with plasmid DNA - chemical 
transformation and electroporation. Chemical competence is conferred to E.coli by re-
suspension in CaCl2 solution. The Ca2+ ion is thought to create pores in the membrane, assist 
binding of the DNA to the cell membrane and mask the negative charge on the DNA, 
facilitating its passage through the hydrophobic cell membrane. Here electroporation is used 
to introduce DNA into bacteria. Electroporation involves the application of an electric pulse 
of several hundred volts across the cell, which creates momentary “pores” in the cell 
membranes and forces the negatively charged DNA into the cells by an electrophoresis-type 
effect.  
3.1.1.1 Generation of electrocompetent E. coli Cells 
The uptake of DNA by E.coli cells can be increased by making cells electrocompetent. 5 ml 
YENB-medium are inoculated with a -80°C single colony stock solution and incubated 
overnight at 37°C. This overnight culture is used to inoculate 1 litre of pre-warmed YENB-
Medium and incubated at 37°C on a shaker until an OD600 of 0.7 to 0.8. The cells are cooled on 
ice for 10 min and centrifuged for 10 min at 4000 x g at 4°C. The bacteria are washed twice 
with 100 ml ice cold ddH2O and centrifuged as described above. The cells are resuspended in 
20 ml ice cold ddH2O with 10% glycerol and centrifuged. Finally the bacteria pellet is 
resuspended in 5ml cold ddH2O containing 10% glycerol. Aliquots of 50µl are pipetted in pre 
chilled tubes, frozen in liquid nitrogen and stored at – 80°C. The transformation efficiency 
ought to be 108-109 colonies/µg plasmid used for the transformation reaction. 
3.1.1.2 Electroporation of competent E.coli cells 
50µl of the electrocompetent E.coli cells are thawed on ice and mixed with 1-2 µl DNA 
(ligation-) solution. This mixture is transferred into a pre-chilled electroporation cuvette with 
a 0.1 cm electrode gap. The electroporation settings are 1250 V, 125 Ω, 50 µF. Immediately 
after the electroporation 900 µl LB-medium without antibiotics is added and the mixture is 
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incubated for 1 hour at 37°C to ensure that the resistance gene expression can take place. 
Following a certain volume of the bacteria solution is plated on LB-agar plates containing the 
corresponding antibiotic.  
 
3.2 Isolation and Purification of DNA 
3.2.1 Isolation of Plasmid DNA (Miniprep) 
This purification method is based on alkaline lysis. Bacteria containing the plasmid are lysed 
by a strong alkaline buffer (S2-buffer) containing detergent and a strong base, which breaks 
the cell membrane and denatures the proteins. Subsequent the pH-value is decreased (as a 
result of S3-buffer) to renature the nucleic acid. Within this process the chromosomal E.coli 
DNA renatures intermolecular by forming a highly complex structure while the plasmid 
DNA renatures intramolecular. Proteins are denatured via SDS in S2-buffer. Membrane 
particles, denatured proteins and chromosomal DNA are separated from plasmid DNA and 
RNA by centrifugation and the plasmid DNA is precipitated and isolated.  
The procedure is performed as followed: 
 5 ml LB-medium containing the appropriate antibiotic is inoculated by a single colony and 
incubated in a shaker at 37°C over night. 
 2 ml overnight culture is transferred into a 2 ml reaction tube and centrifuged for 5 min in a 
table centrifuge at 9000 rpm. The supernatant is carefully discarded. 
 The pellet is resuspended in 100 ml S1-buffer (100 ng/ml RNAseA) and incubated at room 
temperature for 5 min. 
 200 µl S2-buffer is added, mixed gently by inverting the tube and incubated for 2-3 min. 
 150 µl cold S3-buffer is added, mixed by inverting the tube and incubated on ice for 5 min. 
 The sample is centrifuged in a table centrifuge for 15 min at maximum speed. 
 The supernatant is transferred to a fresh microcentrifuge tube and the DNA is precipitated 
with 1 ml 100% ethanol and incubated for 20 min at -20°C. 
 The precipitated DNA is centrifuged for 20 min at maximum speed at 4°C and washed twice 
with 0.5 ml 70% ethanol. 
 The supernatant is carefully removed and the dried pellet resolved in 50 µl Tris-HCl buffer. 
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3.2.2 Isolation of Plasmid DNA on a large scale (Maxiprep) 
For preparation of plasmid DNA in large quantities the Plasmid DNA Purification Kit 
NucleoBond PC 500 (MACHEREY-NAGEL GmbH) is used. This method is based on a 
modified alkaline/SDS lysis procedure followed by binding of plasmid DNA to a silica-based 
anion-exchange resin.  
Both chromosomal and plasmid DNA are denatured under alkaline conditions. Potassium 
acetate is then added to the denatured lysate, which causes the formation of a precipitate 
containing chromosomal DNA and other cellular compounds. The potassium acetate buffer 
also neutralizes the lysate. Plasmid DNA, which remains in solution, can revert to its native 
supercoiled structure. After equilibrating the NucleoBond column with equilibration buffer, 
plasmid DNA is bound to the anion-exchange resin and finally eluted after efficient washing 
of the column. After precipitation of the eluted DNA it can easily be dissolved in TE buffer 
for further use. 
Below the protocol of high-copy plasmid preparation is illustrated: 
 Centrifuge up to 500 ml overnight culture at 4,500 - 6,000 x g for 15 min at 4°C. 
 Carefully resuspend the pellet of bacterial cells in 12 ml buffer S1 + RNase A. 
 Add 12 ml buffer S2 to the suspension. Mix gently by inverting the tube 6-8 times. Incubate 
the mixture at room-temperature (20-25°C) for 2–3 min (max. 5 min). Do not vortex, as this 
will release contaminating chromosomal DNA from cellular debris into the suspension. 
 Add 12 ml pre-cooled buffer S3 (4°C) to the suspension. Immediately mix the lysate gently 
by inverting the flask 6-8 times until a homogeneous suspension containing an off-white 
flocculate is formed. Incubate the suspension on ice for 5 min. 
 Place a NucleoBond folded filter in a small funnel for support, and pre-wet the  
filter with a few drops of buffer N2 or sterile deionised H2O. Load the lysate onto the wet 
filter and collect the flow-through. 
 Equilibrate a NucleoBond column with 6 ml buffer N2. Allow the column to empty by 
gravity flow. Discard flow-through. 
 Load the cleared lysate from onto the column. Allow the column to empty by gravity flow. 
 Wash the column with 32 ml buffer N3. Discard flow-through 
 Elute the plasmid DNA with 15 ml buffer N5. 
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 Add 11 ml room-temperature isopropanol to precipitate the eluted plasmid DNA. Mix 
carefully and centrifuge at ≥ 15,000 x g for 30 min at 12°C. Carefully discard the supernatant. 
 Add 5ml room-temperature 70% ethanol to the pellet. Vortex briefly and centrifuge at ≥ 
15,000 x g for 10 min at room-temperature (20-25°C). 
 Carefully remove ethanol from the tube with a pipette tip. Allow the pellet to dry at room-
temperature (20-25°C), at least for the indicated time. 
 Resolve pellet in an appropriate volume of buffer TE. 
 
3.2.3 Isolation of genomic DNA from tail tissue of the mouse 
The Qiagen DNeasy 96 Tissue Kit provides a fast and easy procedure for high-throughput 
purification of total genomic DNA from rodent tails and animal tissues. The DNeasy 96 
procedure is ideal for simultaneous processing of 96 samples. The eluted DNA is ready for 
use in any downstream application, including PCR, Southern blotting, and other enzymatic 
reactions. DNA can be safely stored at –20°C for later use. The purified DNA is free of 
proteins, nucleases, and other contaminants and enzyme inhibitors. Routinely a 0.5 cm long 
tail biopsy of 3-4 weeks old mice is cut by a kauter to purify the whole genomic DNA. 
The general procedure is performed as follows: 
 A 0.5 cm mouse tail sample is cut with a kauter and placed into a collection microtube. 
 180µl Buffer ATL and 20µl Proteinase K solution are added and mixed by vortexing. 
 The sample is incubated at 55°C overnight or until the sample is completely lysed. 
 The collection tube is shaken vigorously and spun shortly down in a microfuge. 
 400µl buffer AL/E is added, mixed well and spun shortly down. 
 The supernatant is carefully transferred to the DNeasy 96 Plate and centrifuged for 10min at 
6000rpm. 
 500µl Buffer AW1 is added to each well and centrifuged for 5min at 6000rpm. 
 500µl buffer AW2 is added to each well and centrifuged for 5min at 6000rpm. 
 The DNeasy 96 plate is dried at 70°C for 15 min. 
 The genomic DNA is eluted with 200µl of pre-warmed elution buffer AE. 
 The eluted DNA can be stored at -20°C. 
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3.2.4 Phenol-Chloroform extraction of DNA 
To remove proteins from a liquid nucleic acid solution the same volume of equilibrated 
phenol:chloroform:isoamil alcohol (at a ration of 25:24:1 v/v, equilibrated with 100 mM Tris-
HCl to pH8) is added to the sample. The phases are mixed thoroughly for 1 min and 
centrifuged for 4 min (table centrifuge, 13,000 rpm). The mixture is separated into a lower 
phenol phase, an interphase of white, denatured proteins and an upper aqueous phase, 
which contains the nucleic acids. The upper phase is transferred to a new tube and if 
required the phenol extraction can be repeated. The purified DNA is precipitated by 
isopropanol or 100% ethanol. 
 
3.2.5 Photometric analysis of concentration and purity of nucleic acids 
The nucleic acid concentration of an aqueous solution is due to the Beer-Lambert law directly 
proportional to its extinction and absorption, respectively (indicated as the optical density 
OD value). This relation is utilized to quantify the nucleic acid concentration 
spectrophotometrically. The maximum absorption of nucleic acid is at 260 nm whereas 
proteins have their maximum absorption at 280 nm. The absorption/concentration relations 
are: 
 1 OD260 = 50 µg/µl ds DNA 
 1 OD260 = 40 µg/µl ss RNA 
 1 OD260 = 30 µg/µl ss oligo nucleotides  
The purity of a DNA solution is given by the OD260/OD280 ratio, which is supposed to be 
between 1.8 and 2.0 for a pure DNA without protein-contamination.  
By using the NanoDrop ND-1000 Spectrophotometer technology there is no need for 
cuvettes and other sample containing devices. To quantify the nucleic acid concentration, a 
1µl sample is pipetted directly onto the measurement pedestal. The measurement is initiated 
using the NanoDrop software on the PC. A concentration from 2 to 3700 ng/µl is measurable 
without dilution. 
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3.2.6 DNA Extraction from Agarose Gel 
3.2.6.1 Extraction by Silica-Gel Particles 
For DNA extraction of 40-bp to 15-kb DNA fragments from 0.3-2% standard agarose gels in 
TAE buffers the Qiaex II Kit (Qiagen), was used according to the manufacturer’s instructions 
listed below. Purification of DNA fragments with the QIAEX II system is based on 
solubilisation of agarose and selective adsorption of nucleic acids onto QIAEX II silica-gel 
particles in the presence of chaotropic salt. QIAEX II separates DNA from salts, agarose, 
PAA, dyes, proteins, and nucleotides. 
User manuel: 
 The DNA band from the agarose gel is excised with a clean, sharp scalpel. A 1.5-ml 
microfuge tube is used for processing up to 250 mg agarose. 
 The gel slice is weighed in a colourless tube. 3 volumes of Buffer QX1 are added to 1 volume 
of gel for DNA fragments 100 bp - 4 kb; otherwise: 
DNA fragments < 100 bp Add 6 volumes of Buffer QX1 
DNA fragments > 4 kb Add 3 volumes of Buffer QX1 plus 2 volumes of H2O 
> 2% or Metaphor agarose gels Add 6 volumes of Buffer QX1 
 QIAEX II is resuspended by vortexing for 30 sec. QIAEX II is added to the sample according 
to the table below and mixed. 
< 2 µg DNA Add 10 µl of QIAEX II 
2-10 µg DNA Add 30 µl of QIAEX II 
Each additional 10 µg DNA Add additional 30 µl of QIAEX II 
 The sample is incubated at 50°C for 10 min to solubilise the agarose and bind the DNA. It is 
mixed by vortexing every 2 min to keep QIAEX II in suspension.  
 If the colour of the mixture is orange or purple, 10 µl 3M sodium acetate, pH 5.0 is added, 
and mixed. The incubation is then continued for an additional 5 min at least. 
 The adsorption of DNA to QIAEX II particles is only efficient at pH 7.5. Buffer QX1 contains 
a pH indicator which is yellow at pH 7.5, and orange or violet at higher pH, allowing easy 
determination of the optimal pH for DNA binding. 
 The sample is centrifuged for 30 sec and the supernatant is carefully removed with a pipette. 
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 The pellet is washed with 500 µl of Buffer QX1 and the pellet is resuspended by vortexing. 
The sample is centrifuged for 30 sec and all traces of supernatant are removed with a pipette. 
This wash step removes residual agarose contaminants. 
 The pellet is washed twice with 500 µl of Buffer PE to remove residual salt contaminants. 
 The pellet is air-dried for 10-15 min or until the pellet becomes white. If 30 µl of QIAEX II 
suspension is used, the pellet is air-dried for approximately 30 min. Do not vacuum dry, as 
this may cause overdrying. Overdrying the QIAEX II pellet may result in decreased elution 
efficiency. 
 To elute DNA, 20 µl of 10 mM Tris-HCl, pH 8.5 or H2O is added and the pellet is 
resuspended by vortexing. The sample is incubated according to the table below. 
DNA fragments < 4 kb Incubate at room temp. for 5 min 
DNA fragments 4-10 kb  Incubate at 50°C for 5 min 
DNA fragments > 10 kb  Incubate at 50°C for 10 min 
 Elution efficiency is dependent on pH. The maximum elution efficiency is achieved between 
pH 7.0 and 8.5. When using water for elution, the pH should also be within this range and 
the DNA is stored at -20°C as DNA may degrade in the absence of a buffering agent. The 
purified DNA can also be eluted in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) but the 
EDTA may inhibit subsequent enzymatic reactions. 
 The sample is centrifuged for 30 sec and the supernatant is carefully pipetted into a clean 
tube. The supernatant now contains the purified DNA. 
 For fragments larger than 10 kb, the pellet is resuspended by inverting and flicking the tube 
because vortexing can cause shearing of large DNA fragments. 
 
3.2.7 Extraction of DNA by Agarose Digestion 
For recovery of DNA fragments larger than 15 kb from low-melting agarose gels, the enzyme 
Agarase is used. One unit of Agarase completely digests 100 µl (approx. 100 mg) of melted 
1% low melting point agarose in 30 min at 42°C. The recovered nucleic acids can be subjected 
to further manipulations as restriction endonuclease digestion, ligation or sequencing. 
The protocol is as following: 
 The DNA is cut out from a 1% low melting point agarose gel prepared in TAE  buffer 
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 The gel slice is placed into a 1.5 ml microcentrifuge tube and incubated for ~ 10 min at 70°C 
until the agarose is completely melted. 
 The tube is transferred to 42°C and equilibrated for 5 min prior to adding Agarase. 
 1 unit of Agarase per 100 mg (~100 µl) of 1% agarose is added, gently mixed and incubated 
for 30 min- 1h at 42°C. 
 If a higher percentage agarose is used, the amount of Agarase should be proportionally 
increased. 
 
3.3 Purification of DNA 
To clean DNA fragments from primers, nucleotides, enzymes or salts of PCR and other 
enzymatic reactions, the PeqLab E.Z.N.A. Cycle-Pure kit was used.  
The corresponding protocol is listed below: 
 Add 4-5 volumes of CP-buffer to the reaction batch and mix (for DNA fragments <200 bp 
add 6 volumes CP-buffer, for DNA fragments > 4 kb add 3 volumes CP-buffer plus 1 volume 
of ddH2O). 
 Place a HiBind-centrifuge column in a 2 ml collection tube and apply the mixture (reaction 
batch plus CP-buffer) to the column. 
 Centrifuge collection tube with the column for 1 min at 10.000 x g and room temperature. 
Discard the flow-through and place the column back in the same collection tube. 
 To wash, add 750 µl of completed DNA-wash buffer (buffer concentrate plus 1.5 x volumes 
absolute ethanol) to the column and centrifuge 1 min at 10.000 x g and room temperature. 
Discard the flow-through and place the column back in the same collection tube. Repeat the 
washing step once. 
 To dry the column completely, centrifuge the column for an additional 1 min at maximum 
speed. 
 To elute DNA place the column in a clean 1.5 ml microcentrifuge tube, add 50-100 µl ddH2O 
or TE- buffer to the centre of the matrix and centrifuge the column for 1 min at 10.000 x g and 
room temperature. 
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3.4 Analysis of DNA 
3.4.1 Fragmentation of DNA with Restriction Enzymes 
Restriction endonucleases are enzymes, which recognize specific dsDNA sequences and cut 
both DNA strands. These sequences usually cover four to eight base pairs, which are 
characteristic for each enzyme. Hydrolysis of the phosphodiester bond occurs in the 
recognition site whereby the DNA fragment is cleaved at this particular position. Depending 
on the restriction endonuclease, this enzymatic reaction generates blunt end or cohesive end 
termini. Every restriction enzyme requires individual condition for hydrolysis. The 
enzymatic activity is indicated in units (u), whereby 1 u corresponds to the amount of 
enzyme needed for the digestion of 1 µg DNA (depending on the assay: λ phage DNA or 
adenovirus DNA) in one hour. In general these enzymes are used to linearize circular DNA, 
to cut out specific fragment from larger molecules or to cut genomic DNA. The restriction 
reactions are conducted in the recommended buffer and incubated for at least two hours at 
37°C. In addition it is recommended, that the volumetric content of enzyme does not exceed 
10% of the final volume since glycerine is major component of the enzyme solution and 
inhibits the enzymatic activity if its concentration is higher then 5%. If restriction 
endonucleases are used under extreme non-standard conditions (such as to many units, to 
long incubation time or eventually the use of a not recommended buffer), they might be 
capable of cleaving sequences which are similar but not identical to their defined recognition 
sequence, termed “star activity”.  
A typical analytical restriction digest reaction is composed as follows: 
1 µg  DNA in x µl TE 
 2 µl  10x restriction buffer 
 1-10 U restriction endonuclease 
 ddH20 ad 20 µl 
After an appropriate incubation-time the generated DNA fragments can be separated via 
agarose-gel-electrophoresis. 
 
3.4.2 Agarose Gel Electrophoresis 
Agarose gel electrophoresis is used to separate DNA or RNA molecules by size. DNA has a 
negative charge in solution, so it will migrate to the positive pole in an electric field. In 
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agarose gel electrophoresis the DNA is forced to move through a sieve of molecular 
proportions that is made of agarose. Large pieces of DNA move slower through the gel 
matrix than small pieces of DNA. The DNA fragments in the gel can be visualized by 
staining with ethidium bromide (EtBr). EtBr is a fluorescent dye which intercalates between 
bases of the DNA and is excited by light of a wavelength around 300 nm. It is often 
incorporated into the gel but the gel can also be stained after electrophoresis by soaking in a 
solution of ethidium bromide. 
3.4.2.1 Separation of DNA on Agarose gels 
In this thesis agarose gels are used to analyse the size of restriction fragments or PCR 
products. The concentration of the gel ranges from 0.7-2%, depending on the expected size of 
the fragments. The agarose is dissolved in 1 x TAE buffer and boiled in a microwave oven 
until the agarose completely dissolves. After the solution cools down to 50-60°C, ethidium 
bromide is added to a final concentration of 0.5 µg/ml. The agarose solution is poured into a 
horizontal gel-electrophoresis device containing a gel-comb with pockets of appropriated 
size. Upon the gel becomes solid the comb is removed and the gel chamber is filled with TAE 
(1X) buffer. Subsequently the lanes are loaded with the DNA sample together with loading 
buffer. Alternatively 1x TBE buffer can be used. 
The negatively charged DNA is separated according to its size in an electric field (~120 V; 45 
min). The agarose gel electrophoresis allows DNA separation from about 100 bp to several 
1000 bp, depending on the agarose concentration of the gel. In order to determine weight 
and size of the DNA sample it is necessary to apply a molecular DNA marker (100 bp / 1 kb 
DNA ladder, Fermentas GmbH) on a separate lane in the same gel. The ethidium bromide in 
the gel is used to visualize the DNA fragments via ultraviolet irradiation (wavelength 
302nm). 
3.4.2.2 Separation of High-Molecular DNA by PFGE  
(Pulse Field Gel Electrophoresis) 
Pulse field gel electrophoresis is used for DNA fragments larger than 15-20 kb. Molecules of 
that size migrate through a conventional agarose gel in a size-independent manner. 
Therefore, in pulsed field electrophoresis, DNA molecules are subjected to alternating 
electric fields imposed for a period of time called the switch time. Each time the field is 
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switched, the DNA molecules must change direction or reorient in the gel matrix. Larger 
molecules take longer to reorient and have less time to move during each pulse, so they 
migrate slower than smaller molecules. Resolution will be optimal for DNA molecules with 
reorientation times comparable to the pulse time. So, as the DNA size increases, the pulse 
time needs to increase to resolve the molecules.  
Voltage (Field Strength): 
DNA migration increases with increases in voltage or field strength. However, greater 
migration is accompanied by decreased band sharpness. In general, as the size of the DNA 
molecules increases, the field strength should decrease. At high field strengths (6 V/cm) some 
very large DNA (>3 Mb) cannot be resolved on the gel and the field strength must be 
reduced. Moreover, some large DNA molecules will not enter the gels at high field strengths. 
Therefore, in selecting the field strength for an experiment, a compromise between run time 
and resolution has to be made. 
Switch interval: 
The larger the fragment, the longer the intervals in between two electric fields should be 
chosen. In general, a switch interval gradient is used, with short interval in the beginning 
and a longer interval in the end. 
Field Angle: 
The system allows separations to be carried out with electric field vectors oriented in any 
direction in the plane of the gel (90°–120°). With two field vectors, resolution of DNA 
molecules up to 1 mb is independent of the angle between them. It has been shown that 
decreasing the included angle from 120° to 94° increases the velocity of the DNA, with the 
mobility of large DNAs (>1 mb) affected to a greater degree by the change in angle than are 
smaller DNAs (<1 mb). Decreasing the included angle will decrease the resolution of smaller 
DNAs by causing them to pile up on each other. This same effect on small DNA can be seen 
with long switch times. It is recommended that the included angle be decreased (<120°) 
when separating large DNA molecules greater than 2 mb. 
For routine separation of BAC mini-preps the following settings are used: 
 Run time: 15h 
 Voltage: 6V/cm 
 Field angle: 120° 
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 Switch interval: 1-15 sec 
 Temperature: 14°C 
 
3.4.3 Staining of Nucleic Acid Agarose Gels with Ethidium Bromide 
Nucleic acids in agarose gels can be visualized by staining with ethidium bromide (EtBr). 
EtBr intercalates in nucleic acids and emits light after excitation with ultraviolet light 
(optimal excitation wavelength is 254nm). The gel is stained for 10-30 min in an EtBr solution 
(1µg/ml). Unspecific bound EtBr should be removed by washing the gel twice for 10min in 
1x TBE. The nucleic acids can then be visualized on a UV gel documentation system.  
 
3.4.4 Oligonucleotide Annealing 
Annealed oligonucleotides are often used to insert short DNA sequences of 10-60 bp into a 
plasmid. Single stranded DNA oligonucleotides with complementary DNA sequences can 
hybridize to double stranded DNA. For this purpose a 2 µl aliquot of each oligonucleotide 
(100 mM) is added to 10 µl 1x TE, 2 µl KCl (3M), and 24 µl dH2O. The sample is vortexed and 
incubated at 95°C in a thermo block or water bath for 3 minutes. The thermo block/water 
bath is then switched off, so that the block/water cools slowly down to room temperature 
(takes about 1 hour), allowing the oligonucleotides to anneal. The sample can be used 
immediately for a ligation reaction (see below), or stored at -20°C for future use. Since the 
5´termini of synthesized oligonucleotides are not phosphorylated, consequently the 5´ 
termini of a vector used in a ligation reaction together with the synthetic oligonucleotide 
should not be dephosphorylated since otherwise ligation can not occur. 
 
3.4.5 Dephosphorylation of 5’-Ends from DNA by Alkaline Phosphatase 
To prevent linearized DNA plasmids from relegation and recirculation, both phosphate 
groups of the 5’ termini are removed by the shrimp alkaline phosphatase (SAP). One unit of 
enzyme is the amount required to catalyze the hydrolysis of 1 µmol 4-nitrophenyl phosphate 
per minute at 37°C. SAP is completely and irreversibly inactivated by heating at 65°C for 15 
minutes. For a “dephosphorylation reaction” 1 µg DNA is incubated with 3µl 1x SAP buffer 
and 1U SAP for 15 min at 37°C. The reaction is stopped by incubation for 15 min at 37°C. 
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3.4.6 Blunting of DNA Fragments with 5’- or 3’ – Protruding Ends 
For ligation of two DNA fragments with non-compatible ends, it might be necessary to blunt 
the 5’- or 3’ -protruding termini by the enzyme DNA-polymerase of the bacteriophage T4. 
The T4 DNA polymerase catalyzes 5´→3´synthesis of a primed single-stranded DNA 
template and has a 3´→5´ exonuclease activity. It can therefore, in the presence of dNTPs, be 
used to fill 5´ protruding ends with dNTPs. Alternatively due to its exonuclease activity the 
T4 DNA polymerase can be used for the generation of blunt ends from DNA molecules with 
3´ overhangs. To degrade a single-stranded 3´overhang, 1 µf DNA is incubated with 4 µl of 
5x T4 DNA polymerase buffer and 1U of T4 DNA polymerase for 5 min at room temperature 
(or for 20 min at 11°C). The reaction is stopped by incubation for 10 min at 65°C. To fill-in a 
5’-overhang, 1 µl of dNTPs (2mM) is added. 
 
3.4.7 Ligation of DNA Fragments 
The enzyme DNA ligase of the bacteriophage T4 can catalyze the formation of a 
phosphodiester bond between 5' phosphate and 3' hydroxyl termini in double stranded 
DNA. T4 DNA ligase is able to join blunt end and cohesive ends. The enzymatic activity is 
indicated in Weiss units (u), whereupon 1 u is equivalent to approximately 200 cohesive-end 
ligation units. One cohesive–end ligation unit corresponds to the amount of enzyme required 
to ligate 50% of HindIII fragments of λ DNA in 30 min at 16°C in 20 µl of the assay mixture 
and a 5´-DNA termini concentration of 0.12 µM. For a general standard cloning ligation 
purified vector and insert are combined in a molar ratio of 1: 3 (for sticky ends) or 1:5 (for 
blunt ends), using the following equation: 
 ng vector x 3 – 5  x bp insert / bp vector  = ng insert 
A typical ligation reaction was composed as follows: 
 60 ng of a 1 kb insert DNA-fragment 
 60 ng of a 3 kb vector-DNA fragment (backbone) 
 2 µl  10 x ligation buffer 
 1 µl T4-DNA-Ligase (1 Weiss unit / µl) 
 ddH2O ad 20 µl 
The reaction is incubated either for one hour at 22°C or overnight at 16°C. Subsequently the 
enzymatic reaction is stopped by 10 min incubation at 65°C. 
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3.4.8 Polymerase Chain Reaction  
Polymerase chain reaction (PCR) is a method for amplification of specific DNA in vitro. The 
DNA region to be amplified is specified by selected primers. Primers are short 
oligonucleotides complementary to the DNA regions of the 5’ and 3’ ends of the DNA 
region. The length of the primers and their melting temperature is depended on various 
conditions (such as the C/G content within the sequence of the primer).Thermostable DNA-
polymerase binds to the primed single-stranded DNA template and catalyzes the 5´→3´ 
synthesis of the new DNA strand.  
The PCR process consists of a series of twenty to thirty five cycles; each cycle typically 
consists of 3 discrete temperature steps. In the denaturation step, the dsDNA is heated to 94°C 
for 20-30 sec to separate the complementary bases of the DNA strands, resulting in single 
strands of DNA. In the annealing step the temperature is lowered to 50-65°C allowing 
annealing to the ssDNA template. The annealing temperature is typically 3-5°C below the 
melting temperature of the primers. Finally, in the elongation step the DNA polymerase 
synthesizes a new DNA strand complementary to the DNA template strand by adding 
dNTPs that are complementary to the template in 5' to 3' direction. The elongation 
temperature depends on the DNA-polymerase (68-72°C). The extension time depends both 
on the DNA polymerase used and on the length of the DNA fragment to be amplified. At 
optimum temperature, the DNA polymerase will polymerize a thousand bases in one 
minute. The PCR run is completed by a single incubation of 3-7 min at elongation 
temperature. 
A typical PCR reaction is composed as follows: 
50-200 µg template DNA 
5 µl 10 x PCR buffer complete (+ 25mM MgCl2) 
0.5 µl dNTP-mix (10mM each) 
0.25 µl 5´ Primer forward (100pM) 
0.25 µl 3´ Primer reverse (100pM) 
0.5-1.5 units Taq-Polymerase  
Ad 50 µl with ddH2O 
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The reaction is mixed together on ice in special PCR reaction tubes. Following the PCR an 
aliquot of the reaction is analyzed in respect of size and amount via agarose gel 
electrophoresis. 
 
3.4.9 Colony PCR 
In most PCR reactions purified DNA is used as template. However, it is possible to amplify 
specific DNA sequences without DNA purification by starting with a single living E.coli 
colony. This technique is known as colony PCR and provides a powerful and reliable 
method for the rapid detection of transformation success when primers are available which 
allow determination of correct ligation products by size or hybridization.  
For this method, the PCR reaction mix (PCR-buffer, dNTPs, primers and Taq-DNA 
polymerase) is similar to the standard protocol. To inoculate the PCR reaction, a colony is 
picked with a sterile pipette tip and dabbed into the PCR tube and then placed in a 
correspondingly labeled culture tube. Subsequently the PCR reaction mix is added to the 
reaction tube and the PCR is carried out with appropriate conditions for the used primers 
and expected product. It is required to begin the PCR protocol with an extended time at 
95°C, (e.g. 5 minutes) to ensure that complete lysis of the bacterial cells has occurred. 
 
3.4.10 Sequencing of DNA 
The sequencing method is based on a principle of Frederik Sanger according to which 
randomly incorporated dideoxinucleotids (ddNTPs) lead to a termination of the polymerase 
reaction. The four ddNTPs are coupled to dyes fluorescent in different wave length. This 
method is divided into two steps. First the labeling-reaction in order to produce a labeled 
source sample and second the termination-reaction where the synthesis of the fragments 
produced in the first reaction is ended by incorporation of fluorescence-labeled 
dideoyxnucleotides (ddNTPs). The sequencing reaction products are ethanol precipitated 
and the sequencing analysis is carried out with an ABI Prism 3130 xl Sequencer (Applied 
Biosystems). The laser detects the sequence of the fluorescence-labeled DNA fragments 
which are separated by capillary gel electrophoresis.  
The sequencing of plasmid DNA or PCR product takes places according to the “BigDye 
Terminator v3.1 Cycle Sequencing Kit” protocol (Applied Biosystems): 
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Terminator Ready Reaction mix 8µl 
Template 150ng Plasmid or BAC DNA; 10-50ng PCR product 
Primer 3.2 pmol 
ddH2O Ad 20µl 
 
The reaction occurs in analogy to a PCR, however only one primer is added. After the 
reaction the DNA is precipitated, ethanol washed and dried. The DNA is resuspended in 15 
µl HiDi formamide and then ready to use for sequencing. 
 
3.5 In vitro Modification and Recombination in Bacteria 
One major limitation for engineering of large genomic DNA fragments in BACs or PACs is 
that restriction sites for endonucleases are often not located on required positions in the 
gene. A newer and much simpler approach is to use homologous recombination to construct 
the targeting vector. This new form of chromosome engineering is termed “recombineering”.  
Efficient homologous recombineering in E.coli is obtained by the use of phage-encoded 
proteins. These so called Red genes of bacteriophage λ permit linear ds DNA fragments to be 
inserted into DNA cloned on plasmids, BACs or PACs via homologous recombination. Two 
Red genes are required for the recombination: exo, which encodes a 5´–3´ exonuclease (Exo) 
that acts on the 5´ ends of the linear dsDNA fragment to produce 3´ single-strand DNA 
(ssDNA) overhangs, and bet, which encodes a pairing protein (Beta) that binds to the 
3´ssDNA overhangs created by Exo and promotes annealing to its complementary DNA 
strand on the cloned DNA. The recombination functions of Exo and Beta are further assisted 
by λ-encoded Gam protein, which inhibits the RecBCD exonuclease activity of E.coli. In the 
defective prophage expression system the expression of the recombination genes is under 
control a temperature-sensitive repressor. At 32°C, expression of exo, bet, and gam is 
undetectable. However, by shifting the culture temperature to 42°C for 15 minutes, 
expression of exo, bet, and gam can be induced to very high levels.  
In this work the bacterial strains EL 250 and EL 350 are used, which harbour the Red genes 
for homologous recombination and the Cre recombinase (EL 350) or the Flpe recombinase 
(EL250). 
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3.5.1 Transformation of BAC DNA into Recombinant Strains 
5 ml YENB media are inoculated by a single colony of the EL250 or EL350 E.coli strain and 
grown over night at 32°C to suppress the expression of the Red genes. The culture is 
centrifuged at 5000 rpm at 4°C for 5 min, resuspended in 1 ml of ice-cold water and 
transferred in a 1.5 ml microcentrifuge tube. The cells are washed three times with ice-cold 
water by centrifugation in a 4°C benchtop centrifuge for 20 seconds at 13000 x g. Finally the 
bacterial pellet is resuspended in ~50 µl ice-cold water and transferred to a pre-cooled 1 mm 
gap electroporation cuvette. Subsequently ~100 ng of BAC DNA or 1-10 ng of plasmid DNA 
is added and mixed by pipetting. The electroporation conditions are: 1800 V, 25 µF and 200 
Ω. After the electroporation 1ml of LB medium is added, the cells are transferred to a 
microcentrifuge tube and incubated for 1 hour at 32°C. The bacteria are spread on LB plates 
with the appropriate antibiotics. 
 
3.5.2 Recombination through Temperature Control 
Before recombination, EL250 or EL350 bacteria cells are transformed (as described before) 
with the template plasmid or BAC, in which the targeting cassette is to be integrated within 
the following recombination. After successful transformation, 20 ml of YENB medium are 
inoculated with 2 ml overnight bacteria culture containing the template DNA. The culture is 
grown at 32°C until the OD600 reaches 0.6 (2-3h). Half of the culture is transferred into a new 
Erlenmeyer flask and incubated at 42°C for 15 min to activate the expression of the Red 
genes. The other Erlenmeyer flask containing the rest of the culture serves as 32°C control. 
After 15 min the bacteria are immediately cooled down by shaking the flasks in an ice-water 
bath for 2 min. The induced (at 42°C) and the control (at 32°C) bacteria are transferred into a 
15 ml falcon tube, respectively and centrifuged at 4°C for 5 min at 5000 rpm. The pellet is 
resuspended in 1 ml of ice-cold sterile water and transferred to a 1.5 ml microcentrifuge tube. 
The bacteria are washed three times with ice cold water as described above. Finally the 
bacterial cells are resuspended in ~50 µl ice-cold water and mixed with 100 ng of the purified 
targeting cassette and electroporated as described above. After electroporation the cells are 
incubated in 900 µl LB medium for 1 h at 32 °C. The The bacteria were spread on LB plates 
which contained the appropriate antibiotics. The expression of these single site specific 
recombinases can be used to excise loxP or FRT site flanked selection markers. 
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3.5.3 Excision through Arabinose Induction 
The bacterial strains EL350 and EL250 express the Cre recombinase and the Flpe 
recombinase, respectively, under the tight control of an arabinose-inducible promoter.  
1 ml over night culture of BAC-targeted bacteria cells (e.g. EL350) is added to 10 ml YENB 
medium and grown at 32°C for 2-3 h until the OD600 reached 0.5. Then 100 µl 10% L(+) 
arabinose are added to the culture (final concentration, 0.1%) and incubated at 32°C for 1 h, 
in which the Cre-induction should take place. The culture is diluted 104 to 106 to obtain single 
colonies and streaked on plates containing the appropriate antibiotics. 
If a plasmid is used instead of a BAC, the targeted plasmid has to be transformed to 
electrocompetent cells in which the Cre recombinase is already induced. Inducing Cre 
expression in cells which already contain the plasmid will lead to a complete loss of the 
plasmid. 
 
3.6 Immunohistochemistry 
For immunohistochemistry of brain slices and heart tissue the mouse has to be fixed by 
perfusion with paraformaldehyde (PFA) infusion. Mice are anaesthetized by intra-peritoneal 
injection of ketamine hydrochloride and xylazine hydrochloride. The thorax is opened to 
expose the heart. A canula is introduced into the heart and the mouse is perfused through 
the ascending aorta with Sörensen buffer for 3 min to flush out the blood and subsequently 
4% paraformaldehyde fixative for ~ 10 min. The brain is removed from the skull, postfixed 
for 24-36 h in 4% PFA at 4°C and stored in 0,2% PFA in phosphate buffer at 4°C until use. 
The tissues are sliced with a vibratome in 50µm thick sections. 
 
3.6.1 DAB Method 
The DAB staining is based on a peroxidase system with an enhanced sensitivity without 
increased background staining. This technique employs an unlabeled primary antibody, 
followed by biotinylated secondary antibody and then a preformed Avidin and Biotinylated 
horsereadish peroxidise macromolecule Complex (ABC technique), which amplifies the 
signal (Vectastain ABC Kit, Vector Laboratories). Tissue sections are permeabilised in 1% 
H2O2 in 1x PBS for 10 min at room temperature and washed with 1xPBS three times for 10 
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min. For blocking unspecific binding sites sections are incubated in 2% normal goat serum in 
1% BSA/0.3% Triton X-100/1x PBS (day 1 buffer) for 1h at room temperature. The primary 
antibody anti-GFP (Molecular Probes Invitrogen) is 1:5000 diluted in day 1 buffer and the 
slices are incubated at 4°C over night. After two times washing in 0.3% BSA/0.1% Triton X-
100/1x PBS (day 2 buffer) slices are incubated for 1h at room temperature in the secondary 
antibody for the DAB staining: biotinylated anti-rabbit IgG (H+L) (Vector Laboratories) 1:600 
diluted in day 2 buffer. Slices are again washed twice in day 2 buffer. To enhance the 
staining reaction, sections are incubated with an avidin-biotin complex for 1 h followed by 1x 
washing in day 2 buffer and two washing steps with 1xPBS. The sections are incubated in 
DAB solution (0.4 mg/ml) in 20 mM Tris-HCL solution with 0.012% H2O2 until a staining is 
observed. The reaction is stopped by washing three times with 1x PBS. The stained slices are 
mounted on glass slides and cover-slipped with Eukitt. Slices are imaged with the 
stereoscope Stemi 2000-C (Zeiss). 
 
3.6.2 Immune Fluorescence 
For permeabilisation, sections are incubated in 0.1% Triton X-100 for 30 min at 4°C and 
washed with 1x PBS three times for 10 min. Blocking is achieved by incubation in 10% 
normal goat serum (NGS) in 1x PBS for 1h at room temperature. The slices are incubated in 
10% NGS with the primary antibody over night at 4°C. After the sections are washed three 
times in 1% NGS they are incubated with the second antibody in 10% NGS for 1h at room 
temperature to visualize the first antibody. The slices are washed three to four times with 1x 
PBS and mounted on glass slides with Dako fluorescent mounting medium. 
For imaging the fluorescence microscope Axioscop 2 plus (Zeiss) and the Nikon A1R 4 laser 
line confocal microscope at the Nikon Center are used. 
 
3.7 Cultivation of Mammalian Cells 
All tissue culture described is carried out under sterile conditions using sterile plastic ware, 
media and solution. All work is done under a sterile cell culture hood. All cell lines are 
incubated at 37°C in humidified cell culture incubators with 5% C02. 
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3.7.1 Hela Cells 
Hela cells are grown in DMEM medium (Gibco) substituted with 10% FCS and 100 µg/ml 
(1x) Penicillin/Streptomycin (Gibco) to prevent bacterial contamination. 
The cells are passaged by aspirating of the culture medium and by washing the cells with 
PBS. PBS-EDTA without magnesium and calcium is added and the solution is incubated for 
~10 min until the cells start to detach from the bottom of the culture dish. The cell suspension 
is pipetted gently up and down and is transferred to a 15 ml Falcon tube. The cells are 
pelleted by centrifugation at 270xg for 5 minutes. The supernatant is aspirated and the cells 
are resuspended in an appropriate volume of Hela medium to dilute the cells.  
 
3.8 DNA Transfer in Mammalian Cells 
The analysis of gene expression and regulation requires a methodology to transfer foreign 
DNA into cells. This can be done by several chemical or by physical methods. 
3.8.1 Transient Transfection by Lipofection 
Transient transfection is done with the cationic lipid based transfection reagent Lipofectamin 
2000 from Invitrogen. In this method the DNA molecules are enclosed by lipid-like vacuoles, 
which can easily merge with the cell membrane. 
Prior to transfection, cells are growing at 90-95% confluence. Both Lipofectamine 2000 and 
DNA are mixed with serum-free Opti-MEM media. The quantity of each is dependant on the 
type of culture dish. After 5 min incubation in OPTI-MEM, the Lipofectamine 2000 and DNA 
are combined and incubated for 20 minutes at room temperature. 500 µl mixture of 
DNA:Lipofectamine 2000 complexes are then added to the cells, which are already covered 
by 1.5 ml of normal DMEM medium and the cells are incubated overnight. 
 
3.9 Generation of Genetically Modified Mice 
3.9.1 Preparation of Mouse Embryonic Fibroblasts (MEFs) 
To maintain ES cells in a proliferative, undifferentiated state in vitro they should be cultured 
on a monolayer of mitotically inactivated embryonic fibroblast cells. For preparation of MEF 
cell stocks, pregnant mice are sacrificed 13.5 days post-coitus. The uterus is isolated and 
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transferred into a 10 mm dish containing PBS. The embryos are dissected away from the 
uterus and the membranes and transferred into a new dish with PBS. All internal organs and 
the heads are removed. The carcasses are again washed in PBS to remove as much blood as 
possible. The carcasses are then transferred into dry dish and cut into pieces of ~1 mm in 
diameter with scissors and forceps. The pieces are resuspended by adding 2 x 5 ml of 0.05%.  
 
3.9.2 Cultivation of Embryonic Stem Cells (ES cells) 
Embryonic stem cells are pluripotent cells derived from the inner cell mass (ICM) of 
blastocyst-stage embryos. ES cells can be maintained in an undifferentiated stage for many 
passages in vitro by using stringent culture conditions. Permanent mouse carrying genetic 
alterations introduced into ES cells can be obtained by transmitting the mutation through the 
germline by generating ES cell chimeras. 
A number of different ES cell lines are available. For this project the 129/Sv-derived R1 cell 
line (A. Nagy) was used. 
All ES cell culture procedures described must be carried out under sterile conditions using 
sterile materials, media and solutions. All work is done in a laminar flow hood. ES cells are 
cultured in a humidified incubator (5% CO2, 95% rH) at 36.4°C. 
3.9.2.1 Growth and passaging of ES Cells 
ES cells are cultured on monolayers of mitotically inactivated feeder cells or on gelatinized 
tissue culture plated in the presence of leukemia inhibitory factor (LIF). When cells reach 
sub-confluence, they are passaged at a dilution which will permit them to be cultured for 48h 
until this density is reached again. To trypsinize the ES cells, the medium is aspirated and the 
cells are washed twice with 1x PBS and 2 ml of trypsin/EDTA are added. After incubation of 
~5 min at 37°C cells begin to detach from the plate as small clumps. To stop trypsination, 5 
ml of ES cell medium are added and the suspention is pipeted up and down to break the cell 
clumps. The cells are transferred into a 15 ml tube and pelleted by centrifugation for 5 min at 
270 g. The cells are resuspended in an appropriate volume of fresh ES cell medium for a 
dilution of 1:5 to 1:7, depending on their growth rate. The ES cell medium is changed every 
day until the cells reach sub-confluence. 
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3.9.2.2 Freezing and of thawing of ES Cells 
ES cells can be frozen in freezing medium containing 25% FBS and 10% DMSO at a density of 
5-10 x 106 cells/ml. Cells are trypsinized from a 10 mm dish as described before. The pellet is 
resuspended in 3 ml of freezing medium. 1 ml of the cell suspension is aliquoted into 
freezing vials on ice. For slow freezing, the vials are transferred to a Styrofoam box or a slow-
cool container, and then into a -80°C freezer. For longer storage cells are transferred to liquid 
nitrogen.  
For thawing it is important to thaw the cells quickly and to remove the DMSO-containing 
medium as soon as possible. Frozen cells are thawed in a 37°C water bath and transferred 
into a 15 ml tube containing 10 ml of pre-warmed feeder cell medium. After centrifugation at 
270 g for 5 min the supernatant is aspirated and the pellet resuspended in 10 ml of ES cell 
medium and plated on a 10 mm dish with feeder-layer or gelatine-coated. The medium is 
changed the next day to remove any debris. 
 
3.9.3 Homologous recombination in ES cells 
3.9.3.1 Preparation of DNA 
A large scale preparation of the gene targeting vector DNA is prepared (30-40 µg DNA for 
one electroporation). After restriction digest to linearize the gene targeting vector, the DNA 
is purified over a low-melting agarose gel as described before to separate the genomic DNA 
from the BAC DNA. To purify the DNA from the agarose, the gel piece is melted and 
digested by agarase. The DNA is ethanol precipitated, washed twice in 70% ethanol and 
resuspended in an appropriated volume of sterile PBS. 
3.9.3.2 Electroporation of ES cells 
This method is used to introduce DNA into ES cells for gene targeting experiments. 
Technically this method is relatively simple compared to others. DNA can be electroporated 
into ES cells by application of a high voltage electrical pulse to the suspension of cells and 
DNA. After this pulse the DNA enters the cell through pores in the cell membrane. 
The R1 ES cells (Passage #16 from A. Nagy, Toronto, Canada) are freshly thawed and 
cultured for at least two passages on feeder cells as described previously. Then a sub-
confluent 10 cm dish (60-80 % confluence) is trypsinized and pre-plated 20-25 min in the 
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incubator to separate the feeder cells from the ES cells. The ES cells are collected, 
resuspended, counted in a Neubauer chamber and are kept on ice. The cell concentration is 
adjusted to 1x 107 cells/ml with sterile PBS. 
For electroporation 800 µl of ES cells (1x107/ml) are mixed with 30-40µg of digested and 
purified gene targeting DNA. The mixture is transferred to a pre-cooled 4 mm gap 
electroporation cuvette and electroporated at 240 V, 500 µF and 0 Ω in the BTX ECM 630 
electroporator. The cuvettes are removed from the cuvette holder and put on ice for 20 
minutes. The cells from the cuvette are diluted in an appropriate volume of ES medium 
(normally 30 ml of medium for three gelatinized 10 cm dishes). The cells are incubated 
overnight and the next morning the medium was changed. 
3.9.3.3 Selection and isolation of drug-resistant clones 
Two days after electroporation, 200 µg/ml G418 and one day delayed 2 µM Gancyclovir is 
added to the medium to select for recombinant ES cells. The medium is changed every day 
since Gancyclovir can brake down and become toxic. After 3 days of selection, widespread 
cell death appears. After about 8 to 10 days of selection individual drug-resistant colonies 
appear and are large enough for picking (0.5-2 mm). 
For picking, the drug-resistant ES cell colonies are marked on the bottom of the plate. The ES 
cell containing plates are washed twice with PBS and left in PBS during picking. Under a 
dissection microscope drug-resistant colonies of approximately the same size and shape are 
picked up with a Gilson P20 pipette adjusted to a volume of 6 µl with yellow tips. Each 
colony in PBS is transferred into one well of a 96-well V-shaped plate containing 35 µl of 
Trypsin/EDTA at room temperature. After picking 24 clones the plate is incubated for ~10 
min at 37°C in the incubator until cell clumps break up. The reaction is stopped by adding 
100 µl of medium to each well. The cells are mixed by pipetting up and down and 
transferred to a 96-well plate containing feeder cells. Each V-well is washed again with 100µl 
of medium and added to the same well of the 96-well plate with feeders. The plate is 
incubated at 37°C in the incubator and the medium was changed daily. In two to three days 
the cells should have reached ~80% confluence and are passaged, frozen and replicated for 
analysis. If the colonies have not grown to confluence in 2-3 days, the cells are ‘tryplated’ as 
followed: the cells are washed with PBS and trypsinized with 35 µl for 5 minutes at 37°C.  
200 µl of medium is added and the cell clumps are broken up by pipetting up and down. 12-
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24 hours later the medium is changed. The procedure of expansion and freezing of the ES 
cell clones is depicted in Fig. 6. 
 
Fig. 6: Expansion and freezing of drug-resistant clones. 
 
3.9.3.4 Freezing drug-resistant clones and preparation of replica plates 
One set of gelatinized 96-well plate containing 200 µl medium and two sets of V-shaped 
master plates containing 60µl cold 2x freezing medium are prepared and kept on ice. The 
medium is aspirated from the growing ES cells and they are washed twice with 200 µl PBS. 
The cells are trypsinized with 50 µl of Trypsin/EDTA and incubated for 10 minutes at 37°C in 
the incubator. After cells have detached, the reaction is stopped by adding 120 µl of medium. 
60 µl of the cell suspension is transferred in each V-shaped master plate containing 60 µl of 
pre-cooled 2x freezing medium in each well and mixed by pipetting up and down. 100 µl of 
mineral oil is layered on top of each well containing ES cells in freezing medium. The plate is 
completely sealed with Parafilm, wrapped into aluminum foil and was transferred into a 
pre-cooled Styrofoam box to a -80°C freezer. The remaining cell suspension (~50 µl) is 
transferred into the 96-well replica plate containing 200 µl of medium per well and returned 
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into the incubator. When confluent the cells are transferred into a 24-well plate to obtain 
more cells for the following DNA isolation. The ES cells are kept in culture until cells are 
grown overly confluent for DNA isolation.  
 
3.9.4 Identification of Genetically Modified ES cells 
3.9.4.1 Isolation of DNA from ES cell colonies 
The genomic DNA of the drug-resistant ES colonies is extracted from over-confluent cells of 
the replica plates. The medium is aspirated from each well and the cells are washed twice 
with PBS and trypsinized with 35µl of Trypsin/EDTA. When cells have detached they are 
transferred into a reaction tube and centrifuged. For DNA isolation the DNeasy Tissue Kit 
(Qiagen) is used according to the manufacturer´s instructions. The DNesay Tissue Kit uses 
advanced silica-gel membrane technology for fast and efficient purification of total cellular 
DNA. The purified DNA is free of contaminants and enzyme inhibitors and is ready to use 
for PCR and Southern blotting. 
The general procedure is fulfilled as follows: 
 After centrifugation for 5 min at 300 x g, the cells are resuspended in 200 µl PBS. 
 For lysation of the cells 20 µl Proteinase K and 200 µl buffer AL are added to each sample, 
mixed and incubated at 55°C for 1 h. 
 To precipitate the DNA 200 µl ethanol (96-100%) are added and mixed. 
 The mixture is transferred into a DNeasy Mini Spin Column and centrifuged at 8000 rpm for 
1 min. 
 To wash the DNA, 500 µl buffer AW1 is added and centrifuged at 8000 rpm for 1 min. 
 500 µl washing buffer AW2 is added and centrifuged at 13,200 rpm for 3 min to dry the 
DNeasy membrane. 
 For elution the DNeasy column is placed in a clean 1.5 ml reaction tube and 100 µl elution 
buffer AE are pipetted onto the membrane. 
 The membrane is incubated at room temperature for 1 min and then centrifuged for 1 min at 
8000 rpm. 
 The eluted DNA is stored at -20°C. 
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3.9.4.2 PCR genotyping of ES cell clones 
After the selection of single resistant clones and DNA isolation the clones were genotyped by 
PCR. To demonstrate the correct site-directed integration by homologous recombination into 
the genomic locus, two primers were designed; one which binds in the inserted DNA 
sequence of the targeting vector, e.g. the neo cassette, and the other one which binds outside 
of the homology arm. For amplification of the long PCR fragment specific to correct 
integration the Expand Long Range dNTPack from Roche was used. 
3.9.4.3 Expansion and freezing of targeted ES cell clones 
The 96-well plate with the positive targeted ES cell clones is removed from the -80°C freezer 
and unwrapped. The plate is quickly warmed at 37°C in the incubator until the ice crystals 
disappear (~ 5 minutes) and the outside of the plate is cleaned with 70% EtOH. When the 
mineral oil has thawed, 100 µl of pre-warmed ES medium is added under the oil to each well 
containing a targeted positive clone and the cells are transferred to a 6-well plate with 
feeders in 2 ml of ES medium. The original 96-well is rinsed again with 200 µl of ES medium 
and added to the same well in the 6-well plate. The positive cells are incubated at 37°C in the 
incubator and the medium is changed after 6 hours to remove residual DMSO and mineral 
oil. When the cells reach semi-confluence after two days, the cells are passaged to a 10 cm 
plate with feeders. If the cells do not reach semi-confluence they are tryplated as described 
previously. When cells reach semi-confluence, the cells from one 10 cm plated in freezed in 3 
cryo vials as described before. 
 
3.9.5 Cre-mediated Recombination in ES Cells 
The loxP- or FRT-flanked heterozygous positive targeted ES cell clones can be analyzed for 
their functionality by in vitro recombinase-mediated deletion. Therefore the ES cells are 
transiently transfected with a Cre expressing plasmid in cell culture. 
The targeted ES cells are grown for at least two passages in G418 (150-250 µg/ml) to 
eliminate any cell clones that have randomly lost the neo resistant gene. 0.5-1 x 107 G418-
resistent ES cells are electroporated with 20-30 µg supercoiled recombinase vector (pMC1-
Cre) and plated at a low density of 0.5x107 cells per 10 cm dish on feeder in ES medium 
without G418. Two days after electroporation, the cells are trypsinized to obtain single cells 
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and plated at 103 cells/ 10 cm dish. Approximately five days after re-plating at low density, 
when colonies have established, colonies are picked as described before. Following 
trypsination half of the cells are transferred to a master 48 well plate containing feeders and 
ES medium and the other half is transferred to a gelatinized 48 well plate with ES medium 
containing G418. Cre-mediated recombination should transfer G418-sensitivity to the 
colonies. After 3-5 days the desired G418-sensitive clones are identified and the sibling G418-
sensitive clones from the master plate are expanded, frozen and genomic DNA is purified for 
later analysis. 
 
3.9.6 Preparation of positive ES cells for blastocyst injection  
R1 ES cells are derived from the 129/Sv mouse strain, which have an agouti coat colour. 
These cells are injected into blastocysts derived from black C57Bl/6 mice. 
Four days prior to injection, mitomycin treated feeder cells are thawed at 37°C and plated 
onto three 6 cm plates. 3 days before injection a vial containing the correctly targeted ES cell 
clone is thawed and plated onto the 6 cm plate. Two days before injection the subconfluent 
cells are split onto two 10 cm dishes with a ratio of 1/3 and 2/3. 7 am on the injection day, the 
plate with the optimal cell density is chosen (when the colonies are grown to dense the 
quality of the ES cells is affected; when there are too few ES cells on the plate the enrichment 
for injection is difficult. The medium is changed 2 hours before collecting the cells. 9 am on 
the injection day, the plate is washed twice with PBS and trypsinized with 2 ml of 
Trypsin/EDTA. After ~5 minutes the cells are resuspended by gently pipetting up and down 
with a polished Pasteur pipette. The reaction is stopped by adding 2 ml of medium and 
pipetted again to get a single cell suspension. 8 ml of medium is added and the cells are 
centrifuged at 270 x g for 5 minutes. The supernatant is aspirated and the cells are 
resuspended in 10 ml of medium. To separate the ES cells from the feeder cells, the cells are 
pre-plated on a new gelatinized 10 cm plate and incubated at 37°C. After 20-30 min the 
feeder cells attach to the bottom of the plate whereas the ES cells float in the supernatant. The 
supernatant is collected and plated onto a new gelatinized 10 cm plate. The incubation is 
repeated and if there are still too many feeder cells present, the cells are pre-plated for a third 
time. Then the supernatant with the ES cells is centrifuged at 270 x g for 5 minutes and the 
pellet is resuspended with a polished Pasteur pipette in 1 ml of ES medium plus 20µl/ml 1 M 
Methods 
 
 61
HEPES buffer (final concentration 20 mM). The cells in the 15 ml falcon tube are put on wet 
ice and are ready for blastocyst injection. 
 
3.9.7 Germ line transmission of chimeric mice 
The offspring generated through injection of the targeted ES cells into the blasocysts are 
called chimeras. These chimeras are animals with two different populations of genetically 
distinct cells. They harbour a cell population of agouti-coloured R1 ES cells from the 129/SvJ 
mouse strain and a cell population of cells from the blastocyst donor, the black-coloured 
C57Bl6 mouse strain. On the basis of coat colour the contribution of the agouti-coloured ES 
cells to the chimeras can be easily seen and they usually have a more or less speckled coat 
colour of black and agouti. 
The mutant allele of the chimera has to be transmitted through the germ line in order to get a 
genetically modified mouse line. In general the degree of coat colour chimerism of a 
particular animal correlates with the degree of germ line contribution. Therefore male 
chimeras with a high percentage of agouti-coloured coats (> 60%) are mated with female 
C57/BL6 mice. As the agouti colour is genetically dominant over the black coat colour, the 
genetically modified gene can not be transmitted to the offspring with black coats. In 
contrast, the agouty-coloured offspring are heterozygous (129/Sv / C57Bl6), they harbour one 
allele from the 129/Sv and one from the C57Bl6 genome. In these animals either the mutant 
or the wildtype agouti allele can be transmitted, so every agouti offspring mouse has to be 
genotyped.  
For the analysis of the agouti coloured-offspring DNA is prepared from tail biopsies and 
analyzed by PCR or Southern Blot. The animals which are PCR positive for the genetic 
modification become the founders of the mutant mouse line and are backcrossed on the 
C57BL6 strain to get a pure genetic background of C57BL6 for the behavioral analysis of the 
mutant animals. 
 
3.9.8 Animal husbandry and breeding 
The animals are housed in the animal facility of the Central Institute for Mental Health, 
approved by the Regierungspräsidium Karlsruhe for animal husbandry and breeding. The 
animals are maintained under standard housing conditions in line with the guidelines of the 
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FELASA (Federation of European Laboratory Animal Science Association) and the GV-
SOLAS (Society of Laboratory Animal Science). The animal rooms are constantly air-
conditioned with a temperature range of 20-22°C and a humidity of ~50%. A constant 
biorhythm for the animals is guaranteed by fixed light and dark phases (day from 6 am to 6 
pm). The animals are maintained according to their size and the experiment in clear 
Makrolon cages of type II and III and food and water is provided ad libidum. 
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4 Results 
4.1 Generation of the CaV1.3-GFP
flex Mouse Line 
A conditional knockout mouse line of the CaV1.3α1 subunit was generated using the phage 
P1 derived Cre/loxP system for temporal and local restriction of the knockout. Additionally, 
the FLEX system was used (Schnutgen et al., 2003), leading to inactivation of the floxed exon 
by an irreversible inversion between different lox sites after Cre expression, whereas the 
reporter gene eGFP is switched on. Exon 2 was chosen to be flanked by loxP sites, as the 
ubiquitous knockout of CaV1.3α1 showed a complete silencing of the gene by interrupting 
this exon (Platzer et al., 2000). To design a targeting vector for homologous recombination in 
embryonic stem (ES) cells, a genomic fragment containing exon 2 of Cacna1d was obtained. 
We used the mouse genomic DNA clone J14279Q4 (RZPD Berlin), containing the required 
DNA sequence. The vector was a cosmid isolated from a LAWRIST7 129 mouse strain 
genomic library. The genomic insert of the cosmid was tested by restriction digests and 
sequencing to verify the correct genomic DNA fragment containing the required exon 2.  
 
4.1.1 Construction of the Targeting Vector BAC.CaV1.3-GFPflex 
A targeting vector is designed to recombine with and mutate a specific chromosomal locus. 
Here a replacement vector was used which replaced the coding region of the target in the 
genome by the mutated region. The fundamental elements for this vector were the homology 
to the target locus, a positive selection marker and a linearization site outside of the 
homology arm of the vector. Additionally, a negative selection marker was used to enrich the 
populations of transfected cells for targeted homologous integration events.  
 
4.1.1.1 Cloning Strategy of the CaV1.3-GFP
flex Vector 
For this knockout a new strategy was used, monitoring the Cre-mediated recombination in 
the transgenic mouse at the level of individual cells (Schnutgen et al., 2003). The so called 
FLEX switch allows a Cre-dependent genetic switch where the expression of a reporter gene 
like eGFP is switched on, while the expression of the CaV1.3α1 gene is turned off. 
Prerequisite for this switch is the availability of wild-type loxP and non-compatible mutant 
Results 
 
 64
lox sites, which differ in the spacer region, thus illegitimate recombination between these 
different sites can not occur (Wong et al., 2005). The exon 2 of Cacna1d was flanked by one 
pair of WT loxP sites and one pair of mutant L3 sites, with an alternate organization and 
head-to-head orientation within each pair, leading to inversion of the floxed cassette after Cre 
expression. Next to the exon 2 an exon trapping cassette was inserted in inverted orientation. 
The exon trapping cassette consists of a promoterless reporter gene eGFP with an upstream 
general adenovirus splice acceptor and a downstream transcriptional termination sequence 
(polyadenylation sequence) (Schnutgen et al., 2005). As positive selection marker the 
construct contained a FRT-flanked neomycin resistance gene (neo). The 2.6 kb 5’ homology 
arm, containing exon 1a and the 5.6 kb 3’ homology arm, containing exon 3, served for 
homologous recombination. Downstream to the 3’ homology arm a thymidine kinase (TK) 
from Herpes simplex virus was introduced as a negative selection marker (Fig. 7). 
 
 
Fig. 7: Targeting strategy of the conditional knockout CaV1.3-GFPflex. After Cre-expression the 
targeting can be tracked and visualized by the reporter gene eGFP. 
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The protocol for creating the targeting construct was adopted from Neal G. Copeland (Liu et 
al., 2003). Since it may be difficult to insert DNA fragments into large genomic DNAs due to 
the lack of unique restriction enzymes, a system based on phage recombination was used in 
some cloning steps. This homologous recombination system enables genomic DNA in BACs 
to be modified and subcloned, without the need of restriction enzymes and DNA ligase 
(Copeland et al., 2001). This new form of chromosome engineering is called recombineering.  
 
4.1.1.2 Subcloning DNA into a Plasmid 
Modifications of large constructs like BACs or cosmids using restriction enzymes is difficult 
as they are low-copy vectors with low yield. In addition, large DNAs can be unstable and 
break easily during purification. Subcloning a large genomic DNA fragment from a BAC or 
cosmid into a high-copy plasmid can circumvent some of these problems. The DNA 
fragment containing CaV1.3α1 exon 2 was cut out of the cosmid due to the presence of 
unique restriction enzyme sites 2.95 kb upstream (NotI) and 5.8 kb downstream (FseI) of 
CaV1.3α1 exon 2, respectively. This fragment was sticky cloned into the high-copy plasmid 
pMCS-5 that is further referred to as pMCS-5.Ex2. 
 
4.1.1.3 Targeting the First loxP and L3 site into the Subcloned Plasmid DNA 
The first loxP and L3 site were introduced into the subcloned DNA upstream of Cacna1d exon 
2. This was achieved by inserting a L3 site and a loxP-flanked Neo resistant cassette via 
recombineering into the subcloned plasmid DNA, and by subsequent removing of the Neo 
cassette via Cre recombination in E.coli. Therefore a minitargeting vector was cloned using 
the pL452 plasmid. pL452 contains a floxed neo gene which is driven by a hybrid PGK-EM7 
promoter. PGK permits efficient neo expression in mammalian cells, whereas EM7 allows neo 
to be expressed in bacterial cells. Removing the neo cassette by expression of the Cre 
recombinase leaves behind a single loxP site at the target locus. Downstream of the floxed neo 
cassette the L3 site was cloned using the BamHI restriction site. The L3 site was generated by 
annealing oligonucleotides, containing a BamHI restriction site at both ends. The correct 
orientation of L3 was confirmed by sequencing. To introduce the floxed neo gene and the L3 
site into the subcloned genomic DNA, it was flanked by two arms of 100-300 bp DNA 
Results 
 
 66
homologous to the targeting site. These homology arms were generated by PCR 
amplification, using the subcloned genomic DNA in the pMCS-5 plasmid as template. For 
this purpose, primer pairs were designed containing SalI and EcoRI (for homology arm CD, 
180 bp) or NotI and SacII (for homology arm EF, 120 bp). These restriction sites allow for the 
direct cloning of the homology arms into pL452. Following PCR amplification, the products 
were restriction digested and ligated to the pL452 vector, flanking the L3 site and the floxed 
neo cassette. This plasmid was referred to as minitargeting vector (Fig. 8). 
 
 
Fig. 8: Targeting of the first loxP and L3 site into the subcloned genomic DNA in pMCS-5. The first 
targeting cassette including a floxed Neo cassette and a downstream L3 site was introduced upstream 
of CaV1.3α1 exon2. Cre-mediated excision between the two loxP sites leaves behind a single loxP and a 
L3 site. 
 
 
The recombination was achieved in E.coli EL350 cells. Therefore the floxed neo gene and L3, 
together with both homology arms, were excised from the vector backbone by SalI and SacII 
for recombination. 150 ng of the purified cassette was electroporated into EL350 cells which 
were already transfected with pMCS-5.Ex2. In E.coli EL350 cells, the homologous 
recombination functions encoded by the red genes can be controlled by temperature (Lee et 
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al., 2001). Furthermore, these cells contain the Cre recombinase which is under the control of 
an arabinose-inducible promoter. The transfected EL350 cells had been induced for Red 
recombination functions by prior growth at 42°C for 15 min. Transformed cells were selected 
by their kanamycin resistance which were conferred by neo. Six of the resistant colonies were 
picked and examined by restriction enzyme digestion. All six colonies had the correct 
integration. 
Next the floxed neo cassette had to be removed which will lead to a single loxP site. This was 
accomplished by inducing the Cre recombinase in the transfected EL350 cells by prior growth 
in arabinose-containing media for 1h. The cells were plated on ampicillin plates and, as 
control, on kanamycin plates. As Cre-mediated recombination is highly efficient, the 
kanamycin plates should have no or little colonies. The ampicillin plate was full of colonies, 
whereas the kanamycin plate showed only a few colonies. Ampicillin-resistant (Ampr) 
colonies were checked for their kanamycin sensitivity and restriction digestion pattern to 
make sure that the floxed neo gene was properly excised. All picked Ampr colonies were 
kanamycin sensitive and contained a single loxP site at the targeted locus. 
 
4.1.1.4 Insertion of a Second Targeting Vector Downstream of Exon2 
The next step was to introduce the eGFP reporter gene and the second L3 and loxP site into 
the subcloned DNA downstream of CaV1.3α1 exon 2. This was obtained by cloning a second 
targeting vector, using the plasmid pBluescript as backbone. A FRT-flanked neo cassette with 
an additional loxP site was cut out of pL451 and cloned via EcoRI and BamHI into pBluescript 
in that way, that the first and the second loxP site were in head-to-head orientation. Similar 
to the neo cassette used for the first targeting, this neo gene works also efficiently in both E. 
coli and mouse ES cells. FRT is the DNA recognition site for Flp recombinase which catalyzes 
the excision of DNA between these two FRT sites. The second L3 site was cloned via BamHI 
downstream of the FRT-flanked neo cassette, also in head-to-head orientation to the first L3 
site. Next the pA-eGFP-SA was introduced via the XhoI restriction site downstream of exon 2 
and upstream of the second loxP site. The eGFP gene was inserted in an inverted way, so that 
the polyadenylation site (pA) was 5’ and the splice acceptor (SA) 3’ of the gene. This ensures 
that eGFP was not expressed before Cre expression and the resulting switch. The last step of 
generating the second targeting vector was to introduce the two homology arms. Therefore, 
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the primer pairs G and H, containing the restriction sites KpnI and ApaI, respectively, and the 
primer I and J which contain NotI and SacII were generated. With these primers the two arms 
were amplified that are homologue to the targeting locus downstream of exon 2 (Fig. 9). 
Since a plasmid like pMCS-5 would not tolerate such a large insert and become instable, the 
subcloned DNA fragment containing CaV1.3α1 exon 2 and the first loxP and L3 site was 
cloned into a BAC with an already inserted HSV-TK for subsequent negative selection in ES 
cell targeting.  
The cassette with the second loxP and L3 site, eGFP and the FRT-flanked neo gene was 
introduced into the subcloned DNA downstream of exon 2 in the same manner used to 
introduce the first lox sites. This conditional knockout targeting vector was named 
BAC.CaV1.3-GFPflex. 
 
 
Fig. 9: Insertion of the second targeting cassette downstream of CaV1.3α1 exon 2. The second 
targeting cassette contains a promoterless reporter gene eGFP with a universal splice acceptor and a 
polyadenylation site in inverted direction, a reverse loxP and L3 site and a FRT-flanked neo cassette. 
 
 
To functionally test the loxP and L3 sites, the BAC was transformed into E.coli EL350 cells 
and the expression of the Cre recombinase gene was induced by arabinose. This led to an 
inversion of exon 2 and eGFP between the lox sites, whereby the FRT-flanked neo cassette 
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was excised. The Cre-mediated inversion was confirmed by restriction analysis, PCR and 
sequencing. The PCR strategy to test the switch is shown in Fig. 10. 
 
Fig. 10: Cre-mediated inversion and subsequent excision between the loxP and L3 sites in the 
targeting vector BAC.CaV1.3-GFPflex. After transformation in EL350 cells, expression of Cre 
recombinase led to a switch of the lox sites. Primers A and C amplify a product in the unswitched but 
not in the switched version of BAC.CaV1.3-GFPflex. The primer combination B and C amplifies a 
fragment in the inverted version of the BAC. 
 
4.1.2 Functionality of the Targeting Construct BAC.CaV1.3-GFPflex in vitro 
Before ES cell targeting, the functionality of the targeting vector was tested in vitro, to 
examine whether the Cre-mediated switch occurred and the eGFP gene was expressed. In the 
mouse genome the conditional knockout BAC is exchanged with the CaV1.3α1 locus by 
homologous recombination, whereby the endogenous exon 2 is replaced by the targeting 
construct. After Cre-mediated inversion the SA-eGFP-pA is placed in sense orientation and 
forms a fusion transcript with exon 1a, driven by the endogenous CaV1.3α1 promoter. This 
situation is not given when the targeting construct is brought into HeLa cells, since no 
integration into CaV1.3 locus followed by eGFP expression will take place. Furthermore, the 
endogenous CaV1.3α1 promoter is not active in cervical cancer cell-derived HeLa cells. 
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Therefore, a strong eukaryotic promoter with a splice donor, the Caggs promoter (chicken 
beta-actin promoter with CMV enhancer), was cloned into the 5’ homology arm 2 kb 
upstream of eGFP (Fig. 11 A).  
The vector BAC.CaV1.3-GFPflex containing the Caggs promoter was electroporated into HeLa 
cells together with a plasmid containing the MC1-Cre-recombinase. The transfected cells 
displayed a strong green fluorescence, pointing out that the Cre-mediated inversion 
following eGFP expression occurred (Fig. 11 B). As a control the targeting vector was 
transfected into HeLa cells without the Cre-plasmid. As expected no specific fluorescence 
could be detected (Fig. 11 C). 
 
 
 
Fig. 11: Functionality of targeting construct in vitro. (A) Schematic drawing of the switched construct 
CaV1.3-GFPswitch in which eGFP expression is driven by the eukaryotic Caggs promoter. (B) After Cre-
mediated switch, eGFP is driven by the eukaryotic Caggs promoter which leads to a strong expression 
of eGFP in HeLa cells. (C) As control the BAC.CaV1.3-GFPflex construct was transfected into HeLa cells 
without Cre expression. 
 
4.1.3 Production of CaV1.3-GFPflex -Targeted of ES Cell Clones 
For gene targeting the recombinant DNA was introduced into the ES cells to integrate in a 
specific locus via homologous recombination. Therefore, the targeting construct BAC.CaV1.3-
GFPflex was linearized with AscI and 60 µg of the linearized and purified BAC was 
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electroporated into R1 ES cells (Nagy et al., 1993) which are derived from agouti-coloured 
129/SvJ mice. Since homologous recombination is a rare event (< 1:5000), G418 (200 µg/ml) 
for positive and Ganciclovir (2 µM) for negative selection were used to select for colonies 
with homologous integration. After 8-10 days of drug selection 18 drug-resistant colonies 
appeared and were picked into 96 well plates with feeder cells. 
The isolated ES cell clones were analyzed by long-range PCR for specific integration into the 
genome. A specific primer pair was used to amplify a DNA fragment only if the recombinant 
construct was integrated into the targeted locus, not in wildtype allele or with random 
integration outside of the targeted locus. The primers used for this PCR were designed in 
that way that one primer anneals to the neo cassette and the other primer to the region 
directly downstream of the 3’ homology arm of the targeting vector within the endogenous 
locus (Fig. 12). Only ES cell clones in which the endogenous exon 2 of CaV1.3α1 is replaced 
by the targeting construct via homologous recombination should reveal a 5.85 kb long 
amplicon. Primarily, we tried to amplify a fragment in the short homology arm with primers 
binding to a region outside the 5’ homologous arm and to the first loxP site, but due to the 
very high GC content of this sequence the amplification was not possible. 
 
Fig. 12: Screening strategy by long-range PCR for identification of ES cells with locus specific 
CaV1.3-GFPflex integration after homologous recombination. The forward primer NeoES_for binds 
within the neo cassette and the reverse primer 3’HAext_rev2 just outside of the 3’ homologous arm 
(blue line) within the endogenous locus. The 5.85 kb fragment was amplified only in ES cells clones, in 
which the construct was inserted via homologous recombination. 
 
From the 18 drug-resistant ES cell clones 6 were positive for the PCR reaction. The clones #7, 
#8, #10, #11, #12 and #15 showed a 5.85 kb fragment amplified with the primers NeoES_for 
and 3'HAext_rev2 (Fig. 13). As negative controls genomic DNA from wildtype R1 ES cells 
and the targeting vector were used to exclude an unspecific amplicon. In addition, the 
amplified PCR product was purified and sequenced to verify the specificity of the 
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amplification. From all six positive clones the amplified PCR product had the correct 
targeted sequence. 
 
Fig. 13: PCR screening for the targeting construct CaV1.3-GFPflex in the CaV1.3α1 locus in ES cells. 
Long-range PCR over the 3’ homology arm confirmed the correct integration of the CaV1.3-GFPflex 
construct with the presence of the specific 5.85 kb amplicon in 6 ES cell clones. 
 
 
4.1.4 Generation of the Mouse Line CaV1.3-GFPflex 
All 6 positive ES cell clones were expanded and prepared for microinjection into blastocysts. 
The microinjection of the manipulated ES cell clones was done by Ariana Frömmig, a 
laboratory technician. Three independent injections were performed, with two positive ES 
cell clones in each injection session. For injection the clones were prepared following the 
protocol from Frank Zimmermann (ZTL Heidelberg), whereby the ES cells were preplated to 
remove the feeder cells and separated into single cells. The prepared ES cells were injected 
into blastocysts derived from the mouse strain C57Bl6 since the chimeras arised from the ES 
cells will be backcrossed to the C57Bl6 background. The blastocysts with the genetically 
modified ES cells were implanted into the uterus of pseudo-pregnant foster mothers from 
the strain B6D2F1, which gave birth to chimeric offspring. In general the degree of coat 
colour chimerism of a particular animal correlates with the degree of germ line contribution 
by ES cells since the coat colour of the mouse strain from which the R1 ES cells were derived 
(129/SvJ / agouti) differs from the coat colour of the mouse strain for the blastocysts (Fig. 14). 
Seven highly chimeric males where born (F0 generation) which were completely agouti-
coloured. These offspring were generated from the ES cell clones #10, #12 and #15. From each 
clone two agouti-coloured male chimeras were bred with wildtype C57Bl/6N females to 
examine them for germ line transmission. Only male chimeras were bred since the R1 ES 
cells were derived from male embryos and thus a bias towards the male gender can be 
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observed that is reflected by a phenotypic male chimera with a female genotype (Joyner, 
1993). Agouti-coloured progeny (F1 generation) showed successful germ line transmission. 
The mutated allele was not transmitted to F1 offspring with black coats, since the agouti 
colour is genetically dominant over the black coat colour. Table 1 shows the summery of 
chimeric offspring and their contribution to the germ line. 
 
 
 
Fig. 14: Chimeric CaV1.3-GFPflex mice. Since the coat colour of the mouse strain from which the R1 ES 
cells were derived (129/SvJ / agouti) differs from the coat colour of the mouse strain for the blastocysts, 
the coat colour of the chimeras can be used to determine the level of chimerism. The higher the 
amount of agouti coat colour the higher the degree of germ line contribution by ES cells. 
 
 
ES Cell Clone Offspring 
(male) 
Male 
Chimeras  
Agouti (born) PCR- pos 
(GFP+Neo) 
Mouse line 
TierBase #0140 
# 10 12 (6) 5 28 (29)    no CaV1.3-GFP flox 
# 12 11 (6) 3 34 (46)    yes CaV1.3-GFP flox 
# 15  5  (4) 3 30 (30)    yes CaV1.3-GFP flox 
 
Table 1: Summery of chimeric CaV1.3-GFPflex offspring from the ES cell injection and their germ 
line transmission. From each ES cell clone (#10, #12, #15) 2 or 3 highly chimeric males were 
backcrossed with C57Bl/6 females and tested for their contribution to the germ line by agouti-coloured 
fur and PCR. 
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Chimeras from ES cell clone # 10 transmitted the agouti fur colour to almost all F1 offspring, 
28 mice were agouti-coloured, and only one offspring was black. From clone #12 derived 
chimeras had F1 offspring with 34 agoutis out of 46 litters. Chimeras from clone #15 
thoroughly transmitted the agouti fur colour to all offspring.  
 
4.1.5 Genotyping of CaV1.3-GFPflox mice 
The agouti-coloured progeny (F1 generation) was genotyped by PCR using DNA from tail 
tissue. The targeted ES cells were heterozygous for the introduced mutation; the wildtype 
allele or the mutant allele was transmitted to the agouti mice in 50% of animals. To test 
whether the mutated or the wildtype allele was transmitted, the offspring were genotyped 
by PCR using primer pairs that recognize sequences specific to the mutated allele. One 
primer pair binds to the neo cassette (Neo 5’ and Neo 3’) and the other to eGFP (GFP 5’ and 
GFP 3’) (Fig. 15). Additionally, they were genotyped with the primers NeoES_for and 
3’HAext_rev2 used for ES cells after homologous recombination, to ensure again the 
construct has integrated correctly. 
 
Fig. 15: PCR genotypic strategy for CaV1.3-GFPflex mice. The agouti-coloured offspring were 
genotyped using internal GFP and neomycin primers which amplify 360 bp and a 350 bp fragment, 
respectively.  
 
From 55 examined agoutis from 3 chimeras, 28 offspring showed germ line transmission as 
they were PCR-positive for both primer pairs. These 28 mice transmit the conditional 
knockout allele CaV1.3-GFPflox through the germ line. 
 
4.1.6 Removal of the Neomycin cassette by Flpe-recombination 
The neo cassette is required for positive selection in ES cells. After transmission of the 
mutated CaV1.3-GFPflex allele the neomycin cassette has to be removed to avoid gene 
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interference with silencing effects and influences on the phenotype of the genetically 
modified mice. In our case it has been shown that the removal of neo even was essential for 
Cre-mediated FLEX switch to occur (chapter 4.2). In order to remove the FRT-flanked 
neomycin resistance gene, the heterozygous CaV1.3-GFPflex/+ mice were crossed with Flpe-
deleter mice. In these mice the Flpe recombinase is driven by the promoter of the human 
ACTB gene which is active in almost all tissues, even in germ cells. This leads to transmission 
of the neo excision through the germline. Similar to the Cre/loxP system the FRT-flanked neo 
cassette is excised from the allele by Flpe-mediated recombination. The double transgenic 
offspring of the mating CaV1.3-GFPflex x Flpe-deleter mice were analysed by PCR for the 
absence of the neo cassette (Fig. 16). 
 
 
Fig. 16: PCR confirmed the Flpe-mediated excision of the neo cassette in CaV1.3-GFPflex mice. 
Recombination in heterozygous mice was shown by the specific 630 bp PCR product and by the 
absence of the neo-specific PCR product. A littermate positive for the mutated allele but negative for 
the Flpe-recombinase served as control (C). 
 
After excision of the neomycin resistance gene the primer pair eGFP 5’ and 3’HA_rev 
amplified a 630 bp PCR fragment. In single transgenic littermates which served as control (C) 
the fragment would be 2410 bp long and therefore not amplified under these PCR 
conditions. Furthermore, the absence of the neo cassette was confirmed by the absence of the 
neo-specific PCR band using the primer pair Neo 5’ + 3’.  
In all analyzed offspring which harbour the CaV1.3-GFPflex allele and the Flpe-recombinase 
the neo cassette was successfully excised by homologous recombination. 
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4.2 Conditional Knockout of the CaV1.3α1 subunit via the 
FLEX Switch in CaV1.3-GFP
flex mice 
The CaV1.3α1 subunit in the CaV1.3-GFPflex mouse line can be inactivated by Cre-mediated 
recombination. By using the FLEX switch, the floxed exon 2 of Cacna1d will be irreversibly 
inverted and thus inactivated. Simultaneously, the reporter gene eGFP will be activated by 
the inversion, mirroring the expression pattern of the endogenous CaV1.3α1 gene Cacna1d. To 
confirm that we indeed generated a functional knockout of CaV1.3α1 we crossed 
heterozygous CaV1.3-GFPflex/+ animals with Cre-deleter mice in which the Cre recombinase is 
driven by an adenovirus EIIa promoter in all tissues (Williams-Simons and Westphal, 1999). 
The EIIa promoter is already active in the ovum at the time of fertilization which leads to Cre 
recombination when the embryo is still at one-cell zygote stage. Thus, all cells of the 
developing animal, including germ line cells, will have the inverted DNA sequence and the 
mice will give the mutated allele to the next generation. 
By crossing the CaV1.3-GFPflex/+ animals with Cre-deleter mice, the expression of the CaV1.3 
channels can be monitored by eGFP expression in all tissues in which the channel is located. 
Due to the lack of reliable antibodies against CaV1.3α1 for immunohistochemical detection 
the exact expression pattern of CaV1.3 can be determined. Furthermore we crossed the 
CaV1.3-GFPflex/+ mice with CaMKIIa-Cre mice to obtain a tissue-specific deletion. In these mice 
the expression of the Cre recombinase is under the control of the calcium/calmodulin 
dependent protein kinase II alpha promoter. Hence, Cre recombinase is expressed 
postnatally in the forebrain. 
Since the neo resistance cassette will be excised by the switch, we first used CaV1.3-GFPflex/+ 
mice not yet crossed to Flpe-deleter mice. However, no inversion of the floxed allele could be 
detected when crossed to Cre-deleter or CaMKIIa-Cre mice, thus indicating inhibitory effects 
of the neo cassette on recombination. Therefore, all further breedings were done with CaV1.3-
GFPflex/+ mice in which neo was excised first. 
 
4.2.1 PCR Analysis of CaV1.3-GFPflex x Cre-deleter mice 
The Cre-mediated switch of the floxed DNA sequence in the CaV1.3-GFPflex/+ without neo x 
Cre-deleter can be determined with PCR from tail tissue. Therefore, primers were used 
which amplify a fragment specific for the inverted or non-inverted form of the mutant allele 
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(Fig. 17). In mice with the switched allele the primer combinations A/B and C/D amplified a 
fragment, respectively, that was specific for the Cre-mediated inversion. The primer 
combination F/D that gave a positive result for the mutated, non-inverted allele was negative 
for these animals (Fig. 18). As negative control in this PCR analysis served a mouse positive 
for the mutated allele but negative for Cre. This result showed that the floxed sequence in the 
mutated allele could be inverted by the Cre recombinase. 
 
 
 
Fig. 17: PCR strategy for determination of the Cre-mediated inversion. To detect the inversion of the 
floxed sequence in the mutated CaV1.3-GFPflex allele specific primer combinations were used. Primer 
A: 5’HAend_for, B: eGFP_rev, C: Ex2ES_rev, D: 3’HAbegin_rev. 
 
 
 
Fig. 18: Genotyping PCR for detection of animals with an inverted CaV1.3-GFPflex sequence. In 
heterozygous CaV1.3-GFPflex x Cre-deleter mice positive for inversion, the primer combination A/B and 
C/D showed a positive result characteristic for Cre-mediated inversion. 
 
 
4.2.2 Analysis of the mRNA Expression by RT-PCR 
In double transgenic CaV1.3-GFPflex/+ x Cre-deleter mice with the inverted allele the reporter 
gene eGFP with its universal splice acceptor (SA) should be spliced in frame to CaV1.3α1 
exon 1 and subsequently be driven by the endogenous CaV1.3α1 promoter. Due to the 
transcriptional termination site pA (polyadenylation site) downstream to eGFP, CaV1.3α1 
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exon 3 is not transcribed. This leads to an expression of a truncated mRNA and protein. In 
WT mice and single transgenic CaV1.3-GFPflex/+ mice exon 1 is spliced regularly to exon 2 
resulting in a normal expression of the channel CaV1.3α1. To determine the switch on the 
level of mRNA expression, brain RNA from of CaV1.3-GFPswitch/+ mice heterozygous for the 
switch was analyzed by reverse transcription-PCR (RT-PCR). Therefore the brain of these 
animals was divided into two parts. One part was fixated and kept stored for later protein 
analysis. From the second part of the brain, the olfactory bulb and cortex were dissected for 
mRNA analysis. Total RNA of these tissues was isolated and reverse transcribed into single 
stranded cDNA. With PCRs of the cDNA the expression of the activated eGFP spliced in the 
switched CaV1.3α1 allele could be detected. 
For analysis, a primer pair was used with the forward primer binding to Cacna1d exon 1 and 
the reverse primer binding to eGFP (Fig. 19 A). In the case of the switched allele a specific 
PCR fragment of 220 bp was amplified. As negative control littermates with the mutated 
CaV1.3α1 allele but negative for the Cre recombinase (CaV1.3-GFPflex/+) were used. For a 
positive control PCR the forward primer Ex1_for and the reverse primer Exon2_rev specific 
to exon 2 were used which give rise to a 160 bp PCR fragment (Fig. 19 B). In heterozygous 
CaV1.3-GFPswitch/+ mice which still harbour one WT allele this control primer combination 
should always be positive.  
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Fig. 19: RT-PCR analysis of CaV1.3-GFPswitch mice. Schematic drawing of the DNA and mRNA 
structure and RT-PCR of mRNA prepared from olfactory bulb. (A) Structure of the mutated and 
switched CaV1.3α1 locus (CaV1.3-GFPswitch/+) with eGFP with its universal splice acceptor (SA) and poly 
A site and the inverted Cacna1d Exon2. The arrows on the mRNA indicate the binding site of the 
primers Ex1_for and eGFP_rev which give a specific 220bp fragment after RT-PCR. (B) In wildtype 
mice (WT) and in CaV1.3-GFPflex/+ mice exon 1 is regularly spliced to exon 2. As control PCR the 
primers Ex1_for and Ex2_rev were used which gave also a positive result in the heterozygous CaV1.3-
GFPswitch/- mice due to one WT allele. 
 
 
As showed in Fig. 25 the RT-PCR analysis of CaV1.3-GFPswitch/+ mice indicated that the 
reporter gene eGFP was spliced to exon 1 of CaV1.3α1. The reporter gene eGFP was now 
driven by the endogenous CaV1.3α1 promoter. 
 
4.2.3 Expression of eGFP Protein in CaV1.3-GFPswitch Mice 
After the correct splicing of exon 1 and eGFP in heterozygous CaV1.3-GFPswitch/+ mice could be 
verified by RT-PCR analysis, we wanted to analyse the expression of the eGFP protein. To 
test this, the second part of the brain was sagittaly sectioned with a Vibratome and slices 
were analysed by immunohistochemistry with antibodies against eGFP. In addition to the 
analysis of the brain, heart tissue of CaV1.3-GFPflex x Cre-deleter mice was sliced and stained 
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since it has been shown previously that the channel is also expressed in heart. The staining of 
eGFP should represent the endogenous expression pattern of the CaV1.3α1 gene. 
Immunohistochemical DAB staining with antibodies against eGFP revealed a strong 
labelling in several brain regions (Fig. 20). The staining indicated that the eGFP protein was 
functional and could be used as a reporter for expression of the calcium channel. We 
detected a strong staining in the subventricular and periventricular zone (Fig. 20 B). This was 
surprising, since so far expression of the calcium channel in this region has not been 
reported. Strong eGFP-expression was also observed in the superior colliculus (SC), 
including the superficial gray layer and the optic nerve layer of the SC (Fig. 20 D). In the 
upper intermediate white layer of the superior colliculus a more moderate level of eGFP 
expression was observed. Adjacent to the superior colliculus stained cells were detected in 
the optic tract (OT) (Fig. 20 D). In the olfactory bulb (Fig. 20 A) a wide eGFP-expression was 
observed, including the glomerular layer, the mitral cells and the granular cell layer of the 
olfactory bulb. A slightly lower expression of eGFP was shown in the cortex through all 
layers (Fig. 20 B and C). Also in the thalamic regions eGFP-staining was detected (Fig. 20 A). 
In the cerebellum the molecular layer and, more weakly, the Purkinje cell layer was labelled 
(Fig. 20 E). In the CA1 and CA3 region of the hippocampus few cells located in the 
pyramidal cell layer and stratum oriens displayed a strong eGFP-expression (Fig. 20 C). 
Additionally, a moderate staining was observed in the whole stratum oriens and stratum 
radiatum. The dentate gyrus was only slightly stained in the stratum moleculare. As 
negative control a single transgenic littermate CaV1.3-GFPflex, not expressing the Cre 
recombinase, was used that showed no staining for eGFP (Fig. 20 F). 
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Fig. 20: Expression of eGFP protein in the brain of CaV1.3-GFPswitch/+ mice (DAB staining). 
Immunohistochemistry using antibodies against the reporter protein eGFP as an overview in a 
sagittaly sectioned brain. (A). Magnification of eGFP expression in the lateral ventricle (B), 
hippocampus (C), superior colliculus (SC) and optic tract (OT) (D), olfactory bulb (A) and cerebellum 
(E). Immunohistochemistry on a brain section of a single transgenic littermate CaV1.3-GFPflex served as 
negative control (F).  
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Further analysis of the CaV1.3-GFPswitch/+ brain revealed eGFP expression in limbic, 
hypothalamic, thalamic and brainstem areas. CaV1.3-GFPswitch signal was found in several 
regions of the amygdala, like the lateral amygaloid nucleus (LA), the basolateral (BLA) and 
the central amygdaloid nucleus (CeA) (Fig. 21 A). The cells of the bed nucleus of accessory 
olfactory tract (BAOT) displayed a strong labelling (Fig. 21 B). In the brainstem eGFP 
expression was obtained in the facial nucleus (7N), the cuneate nucleus (Cu) and, slightly 
lower, in the locus coeruleus (LC) (Fig. 21 C). Around the third ventricle (3V) the ependymal 
cells were strongly stained (D). eGFP expression was also observed in the hypothalamic 
paraventricular nucleus (PVN) (Fig. 21 D) and the medial (MHb) and lateral habenular 
nuclei (LHb) (Fig. 21 E). Intensely labelled cells were detected in different thalamic regions 
(Fig. 21 F), namely the pregeniculate nucleus (PG), the dorsal lateral geniculate nucleus 
(DLG) and the lateral posterior thalamic nucleus (LP). Furthermore, eGFP expression was 
found in the optic tract (OT) and the medial pretectal nucleus (MPT) (Fig. 21 F). 
 
 
Fig. 21: DAB staining of eGFP expression in coronal (A,B,D-F) and sagittal brain sections (C) of  
CaV1.3-GFPswitch mice. Staining was observed (A) in the lateral amygdaloid nucleus (LA), in the 
basolateral part (BLA) and central amygdaloid nucleus (CeA), (B) in the bed nucleus of accessory 
olfactory tract (BAOT), (C) in the locus coeruleus (LC), the facial nucleus (7N) and the cuneate nucleus 
(Cu), (D) in the paraventricular nucleus (PVN), (E) in the medial (MHb) and lateral habenular nuclei 
(LHb) and (F) in the pregeniculate nucleus (PG), the dorsal lateral geniculate nucleus (DLG), the 
lateral posterior thalamic nucleus (LP), the optic tract (OP) and the medial pretectal nucleus (MPT). 
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Since previous studies revealed a role of CaV1.3α1 channels in sinoatrial pace making activity 
(Platzer et al., 2000; Zhang et al., 2005b), eGFP expression in the heart of CaV1.3-GFPswitch 
animals was examined. We found a strong eGFP staining in the septum of the heart (Fig. 26 
G). Here the bundles of His are located which conduct the electrical impulse from the 
sinoatrial node and the atrioventricular node into the ventricles. 
 
 
Fig. 22: eGFP expression in the heart of CaV1.3-GFPswitch mice. In the heart a strong staining in the 
septum was observed (A). As negative control the heart from a single transgenic littermate was used 
(B). 
 
4.2.4 eGFP Expression in CaV1.3-GFPflex x CaMKIIα-Cre mice 
To verify that the expression pattern of eGFP in CaV1.3-GFPflex/+ x Cre-deleter mice was 
specific to the CaV1.3-GFPflex line, mice were paired with another Cre mouse line. Here we 
used the CaMKIIa-Cre mouse line which is the most-established the Cre line. Offspring of 
CaV1.3-GFPflex/+ x CaMKII-Cre mice were analyzed by PCR to confirm the switch on DNA 
level. Since the Cre recombinase under the CaMKIIα promoter is active in the forebrain, parts 
of the forebrain were removed and DNA was isolated. The Cre-mediated inversion could be 
confirmed by PCR analysis in the same way as displayed above. The animals showed the 
same specific PCR pattern for the switch. For analysis of eGFP expression on mRNA level, 
RNA was isolated from the forebrain and reverse transcribed by RT-PCR. With PCRs on the 
cDNA with specific primers for exon 1 and eGFP as described above we could show that in 
these mice the eGFP gene was spliced to exon 1 of CaV1.3α1 as expected (data not shown). 
Immunolabelling in the mouse brain with antibodies against the eGFP protein revealed a 
similar expression pattern as in animals crossed with Cre-deleter mice. As displayed in Fig. 
Results 
 
 84
23 E, high eGFP expression was detected in the superior colliculus. Also the expression 
pattern in the cortical layers was the same compared to that in CaV1.3-GFPflex/+ x Cre-deleter 
mice, even though here the staining was slightly stronger (Fig. 23 C). In the olfactory bulb a 
defined eGFP expression could be observed in the glomerular layer, the external plexiform 
layer, the mitral cells and the granular cell layer (Fig. 23 A). In the hippocampus very few 
strongly labelled cells were visible in the CA1 and CA3 region, besides a moderate staining 
in the stratum radiatum. The dentate gyrus displayed a slightly stronger staining, both in the 
granular cells and in the stratum moleculare (Fig. 23 D). Consistent with the CaMKIIα 
expression no eGFP labelling was observed in the periventricular zone of the lateral ventricle 
(Fig. 23 B). Also in the cerebellum the CaMKIIα promoter is inactive, even though in that 
brain region a very faint staining in the molecular layer could be noticed (Fig. 23 F). Single 
transgenic CaV1.3-GFPflex/+ littermates served as negative control (Fig. 23 G). 
 
 
Fig. 23: Expression of eGFP protein in the brain of CaV1.3-GFPflex x CaMKIIa-Cre mice. Brain of a 
double transgenic mouse was sagittaly sectioned and analyzed by immunohistochemistry using 
antibodies against the reporter gene eGFP and detection of antigen expression by HRP/DAB. (A) 
Olfactory bulb, (B) overview, (C) magnification of cortex, (D) hippocampus, (E) superior colliculus 
and (F) and cerebellum. (G) Negative control. 
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4.2.5 Analysis of eGFP Protein Expression by Double Immunofluorescence  
CaV1.3α expression was previously described to be found in most brain regions (Hell et al., 
1993). Nevertheless, detailed analysis of CaV1.3α expression in peri- and subventricular 
regions of the lateral ventricle was not described so far. Therefore we used a double 
fluorescence immunohistochemistry approach to determine the distribution and cell type of 
eGFP-labelled cells in brain sections of CaV1.3-GFPflex x Cre-deleter mice. 
Colocalization studies were performed on brain section by double-immunostaining using 
anti-eGFP antibody and following markers: neuronal nuclear antigen (NeuN), doublecortin 
(DCX), glial fibrillary acidic protein (GFAP), SOX2, GAD67 and tryptophan hydroxylase 1 
(TPH1). 
 
4.2.5.1 Localization of eGFP- and NeuN-positive cells 
NeuN recognizes a neuron-specific nuclear protein in vertebrates (Mullen et al., 1992) which 
is considered as a marker for neuronal cells. To investigate whether the eGFP-expressing 
cells were NeuN-positive neurons, localization of eGFP and NeuN were compared. The 
eGFP-positive cells in the periventricular ependyma of the lateral ventricle and the 
subventricular zone were a non-neuronal cell type as they were immunonegative for NeuN 
(Fig. 24 A). In the cortex most of the eGFP-expressing cells were positive for NeuN even 
though in the cortical layer VI a small population remained only stained for eGFP (Fig. 24 B). 
Also in the olfactory bulb the majority of the cells were colabelled for the two markers (Fig. 
24 C). In the CA1 and CA3 region of the hippocampus eGFP-expressing cells were of large 
shape and showed no colocalization with NeuN (Fig. 24 D-E). No eGFP-staining could be 
observed in the stratum oriens and radiatum and dentate gyrus as detected in the DAB 
staining. In the optic tract the eGFP-positive cell group was negative for the neuronal marker 
whereas in the superior colliculus the majority of the eGFP-expressing cells were colabelled 
wit NeuN (Fig. 24 F-G). 
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Fig. 24: Co-staining of eGFP and NeuN in brain sections of CaV1.3-GFPswitch/+ mice. (A) Double 
immunolabelling revealed that the eGFP-positive cells in the ependyma lining the lateral ventricle 
(LV) and the subventricular zone were not stained with the neuronal marker NeuN. (B-C) In the 
cortex and in the olfactory bulb (OB) the majority of the eGFP-expressing cells are immunopositive for 
NeuN. (D-E) In the hippocampal areas CA1 and CA3 no colabelling was detected. (F-G) In the optic 
tract (OT) eGFP-positive cells did not express NeuN whereas in the caudal located superior colliculus 
most of the eGFP-labelled cells colocalised with NeuN. 
 
 
The positive colocalization of eGFP and NeuN in the cortex, the olfactory bulb and the 
superior colliculus indicate that the majority of the CaV1.3α-expressing cells were neurons in 
these brain regions whereas the eGFP-positive cells in the subventricular zone, hippocampus 
and optic tract represented another cell type. 
 
4.2.5.2 Localization of eGFP- and GAD67-positive cells 
It has been shown that CaV1.3α1 is expressed in various types of hippocampal GABAergic 
interneurons (Vinet and Sik, 2006). Since the eGFP-expressing cells in the hippocampus and 
the optic tract could not be characterized as NeuN-positive neurons, we wanted to analyze 
whether these cells could be inhibitory interneurons. Even though NeuN is known to stain 
also interneurons as well, NeuN-negative GABAergic interneurons were reported(Shechter 
et al., 2007). Here an anti-GAD67 antibody was used as marker for GABAergic interneurons. 
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GAD67 is the 67 kDA isoform of the enzyme glutamic acid decarboxylase which catalyzes 
the decarboxylation of glutamate to GABA. Double-immunostainings revealed that in the 
CA3 region of the hippocampus some cells displayed an eGFP/GAD67-colabelling (arrow), 
other eGFP-expressing cells were negative to GAD67 staining (asterisk) (Fig. 25 B1-3). In the 
optic tract a strong co-staining of GAD67 and eGFP was observed (Fig. 25 A1-3), indicating 
that CaV1.3α1 was expressed in GABAergic interneurons in a part of the visual system of the 
brain. 
 
Fig. 25: Double immunofluorescence labelling of eGFP- and GAD67-positive cells in CaV1.3-
GFPswitch/+ brain sections. (A1-3) Staining in the optic tract (OT) displayed an exact coexpression of 
eGFP- and GAD67-labelled cells. (B1-3) In the hippocampal region CA3 some of the eGFP-positive 
cells coexpress GAD67 (white arrow), whereas others are negative for the interneuron marker 
(asterisk). 
 
4.2.5.3 Localization of eGFP- and DCX-positive cells 
The most fascinating finding was the strong eGFP expression in the subventricular zone, 
known as one of the brain region in which adult neurogenesis is located. Therefore we 
analyzed the eGFP-stained cells with markers for neurogenesis. Doublecortin (DCX) is a 
microtubule-associated protein which is specifically expressed in immature neurons. DCX is 
necessary for the migration of neuronal precursor cells during the formation of the 
mammalian neocortex and is therefore used as one indicator for neurogenesis. As displayed 
in Fig. 26 (A) both cell types were present in the same brain area. However, eGFP-positive 
cells did not express DCX (B) in the subventricular zone in CaV1.3-GFPswitch/+ mice. 
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Fig. 26: Immunolabelling against eGFP and Doublecortin (DCX) in the subventricular zone. Cells 
positive for eGFP are located in the same brain region like DCX, nevertheless they do not express the 
neuronal precursor cell marker. 
 
 
4.2.5.4 Localization of eGFP- and GFAP-positive cells 
Immunostaining against the intermediate-filament protein GFAP (glial fibrillary acidic 
protein) strongly labels astrocytes. In addition, neural stem cells have been proposed to be 
part of a GFAP-positive astrocyte population located in the subependymal region of the 
brain which can divide to generate immature precursors and neuroblasts (Doetsch et al., 
1999a). For characterization of eGFP-expressing cells in the subventricular zone and lateral 
ventricle ependyma of CaV1.3-GFPflex/+ x Cre-deleter mice, we performed double 
immunostainings with anti-GFAP antibodies. The antibody against GFAP labelled the 
dendrites whereas eGFP was distributed mainly in the cell somata, which makes it 
challenging to point out a colocalization of the two markers.  
In the lateral ventricle (LV) ependyma most, but not all, eGFP-positive cells expressed also 
GFAP (Fig. 27). The eGFP/GFAP-positive cells were observed in the ependymal cell layer 
directly lining the lateral ventricle (Fig. 27 A1-3) and in the top corner of the LV, where the 
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origin of the rostral migratory stream (RMS) is located (Fig. 27 B1-3). However, the RMS 
itself comprised GFAP-positive but eGFP-negative cells. 
 
 
Fig. 27: Double immunofluorescence characterization of eGFP- and GFAP-expressing cells in the 
ventricular region. Sagittal brain sections of CaV1.3-GFPswitch/+ mice. (A1-3) In the ependymal cell layer 
lining the lateral ventricle (LV) eGFP-positive cells were colabelled with GFAP (white arrows). (B1-3) 
Colocalization of eGFP/GFAP-expressing cells in the top corner of the LV. The beginning rostral 
migratory stream, which is indicated by GFAP-positive cells, comprised no eGFP-expressing cells. 
 
 
4.2.5.5 Localization of eGFP- and SOX2-positive cells 
The transcription factor SOX2 (Sry-related HMG box 2) is a marker for embryonic neural 
stem cells and adult neural precursor cells. Additionally, it is required for the proliferation 
and maintenance of these cells. In the adult brain SOX2 is expressed within most 
proliferating neurogenic regions like the periventricular ependyma and subependyma (Ferri 
et al., 2004).  
For better characterization of eGFP-expressing cells in these neurogenic regions, double-
immunofluorescence experiments against eGFP and SOX2 were performed. A strong 
colabelling was detected in the ependymal cell layer lining the LV (Fig. 28 B) and in the 
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subventricular zone (Fig. 28 A and C). SOX2 was staining the cell nucleus whereas eGFP is 
labelled in the somata and, more weakly, in the dendrites. 
These data suggest that CaV1.3α1 is expressed in the proliferating neuronal precursors in the 
neurogenic region at the lateral ventricle. 
 
 
Fig. 28: Colocalization of eGFP and SOX2-positive cells in the lateral ventricle ependyma and 
subventricular zone. Double-immunofluorescence observed co-staining of eGFP and neuronal stem 
cell marker SOX2 in the ventricular zone. 
 
 
4.2.5.6 Localization of eGFP- and TPH1-positive cells 
A previous immunohistochemical study in the rat brain stem revealed a distinct CaV1.3 
immunoreactivity in the caudal, median and dorsal raphe nuclei (Sukiasyan et al., 2009). To 
examine whether serotonergic neurons expressed eGFP in CaV1.3-GFPswitch/+ mice, double-
immunostaining was carried out using antibodies against eGFP and TPH1. Tryptophan 
hydroxylase 1 is the rate limiting enzyme involved in the synthesis of the monoaminergic 
neurotransmitter 5-HT which marks all serotonergic cells in the central nervous system and 
in the periphery. Serotonergic raphe nuclei were analyzed in three different parts of the brain 
stem, the caudal nuclei in the medulla oblongata and the dorsal and median raphe nuclei in 
the pons and midbrain. As displayed in Fig. 29, eGFP-positive cells did not colocalise with 
TPH1-stained cells in all analysed raphe nuclei. These data indicate that the CaV1.3α1 
channel was not expressed in 5-HT cells. 
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Fig. 29: Immunolabelling of eGFP- and TPH1-positive cells in coronal brain sections of CaV1.3-
GFPswitch/+ mice. No coexpression of eGFP and TPH1 could be detected in the caudal (A), dorsal (B) 
and median (C) serotonergic raphe nuclei. 
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5 Discussion 
The neuronal L-type VGCCs CaV1.2 and CaV1.3 have been implicated in various 
physiological functions as heart development and cardiac pacemaking activity, behaviour, 
learning and memory, depressive-like behaviour, insulin secretion or inner ear development. 
The two isoforms have a similar expression pattern and are both sensitive to 
dihydropyridines (DHPs), a class of organic Ca2+ channel blockers and activators. Although 
pharmacological analyses have provided much insight into the regulation and function of L-
type channels in neurons, all blockers have additional substantial input on the function of 
the CNS by affecting cardiovascular system functions. Moreover, available pharmacological 
tools do not allow the separation of the individual function of the isoforms CaV1.2 and 
CaV1.3.  
Therefore, we used a genetic approach to get deeper insights into CaV1.3 expression and 
function. In recent years, several mouse models that target L-type channel genes were 
generated, including a conventional CaV1.3 knockout. However, limitations of the 
conventional gene targeting are the induction of compensatory gene expression, early 
embryonic lethality or the effect of peripheral phenotypes on the CNS. To circumvent these 
problems we have used the conditional Cre/loxP system as a technology for spatial and 
temporal control of gene inactivation. In our genetic approach, the CaV1.3-GFPflex exon 2 of 
Cacna1d is inactivated using a Cre-dependent genetic switch (FLEX switch), representing an 
elegant way to monitor the cell with the inactivated channels after Cre-recombination. To 
investigate the functionality of the FLEX switch, the mouse line was analysed by breeding 
the conditional CaV1.3 mice with Cre-deleter mice and CamKIIa-Cre mice. Furthermore, the 
expression pattern of the CaV1.3α1 subunit, mirrored by the expression of the reporter gene 
eGFP, was analysed by immunohistochemical methods. 
 
5.1 Targeting Strategy of the CaV1.3-GFP
flex Construct 
The strategy for the conditional mutation of the CaV1.3 channel was the FLEX (Flip Excision) 
switch, which is based on gene trap mutagenesis combined with site-specific recombination. 
Gene trapping was originally a high-throughput approach that can be used to introduce 
insertional mutations into the genome of mouse ES cells. It is performed with gene-trap 
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vectors whose principle element is a gene-trapping cassette consisting of an inverted 
promoterless reporter gene flanked by an upstream splice acceptor and a downstream 
transcriptional termination sequence polyA (polyadenylation site). Additionally, the cassette 
harbours a drug resistant gene as selection marker. When inserted into an intron of an 
expressed gene, the gene-trap cassette is transcribed from the endogenous promoter in form 
of a fusion transcript in which the exon upstream of the insertion site is spliced in frame to 
the reporter gene. However, these gene-trap vectors produce only null mutations which can 
cause embryonic lethal phenotypes. To address this limitation a site-specific recombination 
strategy termed Flip Excision (FLEX) was developed for conditional gene manipulation 
(Schnutgen et al., 2003). The FLEX switch uses two pairs of heterotypic, inversely oriented 
and alternately arranged loxP-type recombination sites. Cre-mediated recombination of either 
homotypic loxP site will cause inversion of the coding sequence (exon) and the reporter gene, 
followed by excision between the two homotypic loxP sites, leading to one of each 
heterotypic recombination sites oppositely oriented and incapable for further recombination. 
This results in inactivation of the coding sequence, while the expression of the reporter gene 
is turned on, and provides a rapid and precise identification of the disrupted gene on cellular 
level. 
The CaV1.3-GFPflex mouse line was generated by a “knock-in” of the FLEX switch vector 
performed by homologous recombination in ES cells. One of the first considerations when 
designing a targeting vector, is to determine the gene region which to delete. Since the 
CaV1.3α1 gene Cacna1d is large (~250 kDa) and distributed, depending on the transcript, to 47 
- 49 exons and thereby spanning over 400 kb, we decided to inactivate an important exon 
close to the 5’ end. The conventional CaV1.3α1 knockout in mice was successfully 
accomplished by disrupting exon 2, by insertion of the Neo resistant cassette into the exon, 
resulting in the generation of a complete null allele (Platzer et al., 2000). For this reason we 
decided to target also exon 2 in the CaV1.3α1 gene. The FLEX-targeting vector was designed 
in that way that upstream of CaV1.3α1 exon 2 two heterotypic loxP sites were located and 
downstream the inverted reporter gene eGFP with the splice acceptor and polyA site, a FRT-
flanked neo resistant gene and the second two loxP sites were introduced. The splice acceptor 
of the eGFP gene was chosen in the same open reading frame like CaV1.3α1 exon 2 so that 
eGFP is spliced in frame to the upstream exon 1 after Cre-mediated inversion. 
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In conditional gene knockouts, the gene has to be unaffected by modifications and must 
function normally like the endogenous one until recombined by Cre recombinase. Thus, 
when introducing the gene targeting elements into the genomic sequence, we had to 
consider that they were placed outside coding regions and did not interfere with regulatory 
intronic regions like splice acceptor and donor sites. When CaV1.3α1 exon 2 was flanked by 
the two heterotypic pairs of loxP sites and the exon-trap cassette, they were inserted 330 bp 
upstream and 230 bp downstream of the exon to do not interfere with regulatory elements 
surrounding the exon.  
As mentioned above, prerequisite for the FLEX system was the availability of heterotypic 
loxP sites. The most commonly used combination of heterotypic loxP sites are WT loxP with 
loxP511, which differ by 1 bp in the core spacer region. Nevertheless, illegitimately 
recombination between them has been reported (Lee and Saito, 1998). Therefore, we used 
lox257 (also referred to as L3), which differs by 3 nucleotides in the spacer sequence from the 
WT loxP site, thereby regarded to be less permissive as well as more efficient (Wong et al., 
2005). When engineering FLEX switch vectors, it is also important to consider that the 
distance between homotypic loxP sites, once inversion has taken place, actually allows 
excision to occur. For successful excision the minimum distance between two homotypic 
recombination sites like two WT loxP or two L3 must be at least 82 bp long (Hoess et al., 
1985). In the CaV1.3-GFPflex targeting construct the loxP sites were arranged in such a way 
that the distance between two homotypic sites after recombination was not closer than 100 
bp, regardless whether the inversion occurred first via the recombination between WT loxP 
or L3 sites. 
 
By recombination in EL350 bacteria cells we could demonstrate the functionality of the Cre-
mediated switch in the FLEX vector. The stable inversion of CaV1.3α1 exon 2 into the 
antisense direction and of eGFP into the sense orientation was successfully confirmed by 
restriction analysis and PCR. Since the reporter eGFP will, after targeting into the mouse 
genome, represent the expression of the CaV1.3α1 channel, we further verified the 
functionality of the eGFP protein in eukaryotic HeLa cells before proceeding to ES cell 
targeting. One difficulty was that in HeLa cells the promoterless reporter gene was not 
inserted into the genome by homologous recombination and therefore was not driven by the 
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endogenous CaV1.3α1 promoter. Moreover, the CaV1.3α1 promoter is presumably inactive in 
cervix carcinoma cells. For this reason we introduced a strong eukaryotic Caggs promoter, 
containing an additional 3’ splice donor, into the intron upstream of exon 2. We could show 
that in the CaV1.3-GFPflex construct, coelectroporated with a MC1-Cre-plasmid into HeLa 
cells, the inversion occurred and the reporter gene encoded for a functional fluorescent 
protein. Importantly, no eGFP fluorescence could be detected in control cells transfected 
without Cre, indicating that the eGFP cassette was fully silent before Cre-mediated 
rearrangement. 
 
5.2 ES Cell Targeting of CaV1.3-GFP
flex 
Homologous recombination of a targeting construct into the mouse ES cell genome is based 
on positive selection of a drug resistance in order to differentiate homologous recombination 
from random integration. In the targeting construct a neomycin resistant gene (neo) was used 
flanked by two FRT sites which allow later removing of the neo cassette. Additional, a 
negative selection marker (MC1-HSV-TK) was introduced downstream of the 5’ homologous 
arm, that selected against random integration events into the genome. The combination of 
the two selection systems provided an efficient targeting of the CaV1.3α1 gene. Six ES cell 
clones out of 18 analysed clones (33%) were identified for correct homologous 
recombination, replacing the endogenous gene. Correctly targeted ES cell clones were 
injected into blastocysts and tested for germline transmission of the targeted CaV1.3α1 allele 
by backcrossing with C57Bl/6 mice. The high transmission to the next generation attested the 
high contribution of manipulated ES cells to the chimeras. Since the loxP sites, the reporter 
gene and neo were inserted into intronic regions flanking exon 2, CaV1.3α1 gene transcription 
should not be disturbed. Heterozygous CaV1.3-GFPflex/+ mice were viable and displayed a 
phenotype comparable to WT. 
Even though the neo resistance cassette was introduced into an intron, it can interfere with 
the expression of the targeted or neighbouring genes. In some cases, it has been determined 
that cryptic splice sites in neo interfere with normal splicing and therefore reduce WT mRNA 
levels or even lead to lethality (Pham et al., 1996; Ren et al., 2002). In CaV1.3-GFPflex/+ mice the 
removal of neo was essential for efficient recombination of the targeted allele. 
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For these reasons neo was excised from the mouse genome by crossing CaV1.3-GFPflex mice 
with Flpe-deleter mice, ubiquitously expressing the Flpe recombinase even in early 
development. After removal of the neo cassette CaV1.3-GFPflex mice were backcrossed to 
C57Bl/6 mice, being the standard strain for genetic and behavioural analysis. Since the R1 ES 
cells were derived from a different mouse strain (129/SvJ) it is important to backcross the 
offspring of chimeric mice up to 10 times with C57Bl/6 mice to avoid genetic and phenotypic 
variation caused by mixed genetic backgrounds (Joyner, 1993). Particularly for future 
behavioural analysis it is essential to have a pure genetic background of at least 99.9%. 
 
5.3 Conditional Knockout of CaV1.3α1 by the Cre-
mediated FLEX switch 
Conditional gene knockout provides the ability to inactivate an endogenous gene in the 
mouse genome in a spatially and temporally controlled manner. It is not only useful to 
circumvent lethal phenotypes but also allows biological questions to be addressed with 
exquisite accuracy. In this study we used the FLEX switch, coupling conditional gene 
ablation to reporter gene activation after Cre-recombination.  
The FLEX switch was first presented in 2003 by Schnütgen et al. presented as a directional 
strategy to detect Cre-dependent gene ablation at single cell level in the mouse genome 
(Schnutgen et al., 2003). He could show the complete Cre-mediated deletion of the retinoic 
acid receptor gene and the simultaneous expression of the reporter gene lacZ. Another study 
used the FLEX switch to target channelrhodopsin-2 for photostimulation of neurons (Atasoy 
et al., 2008). Just recently a study reported the generation of a FLEX switch-based reporter 
line for visualization of recombinase activity in zebra fish (Boniface et al., 2009). Even though 
only few studies are known using this system in animal models, these reports present the 
FLEX strategy as an elegant and efficient way to generate a conditional gene knockout. 
When crossed to Cre-deleter mice we first used CaV1.3-GFPflex/+ mice which still harboured 
the neo cassette, since after Cre-mediated inversion of the floxed sequence neo should be 
located between two homotypic recombination sites and subsequently be excised (Fig. 7). 
However, it required two successive breeding rounds with Cre-deleter mice until the switch 
with an inversion of exon 2 in antisense and eGFP in sense direction could be detected in 
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CaV1.3-GFPflex/+ x Cre-deleter mice (CaV1.3-GFPswitch/+). One reason could be that the Cre 
recombinase must catalyse the recombination of four loxP sites. First the inversion between 
two homotypic loxP sites oriented head-to-head had to take place followed by an excision 
between the other pair of homotypic loxP sites. Possibly the E2a promoter, driving Cre in 
Cre-deleter mice, was too weak and offspring from the second breeding round were 
homozygous for the Cre gene, providing enough recombinase protein to promote the FLEX 
switch. Further PCR analysis revealed that in some animals the switch was stuck in an 
intermediate stage after inversion between L3 sites, without further excision between the WT 
loxP sites (Fig. 5). Here, recombination between mutant L3 sites seems to be more efficient 
than that between WT loxP sites. The L3 site was developed by Wong et al. after the finding 
of illegitimate recombination between the commonly used combination of lox511 and the 
original loxP site (Wong et al., 2005). However, L3 was never tested in the FLEX system 
before, so one has to consider that recombination between L3 could be favoured over 
recombination between loxP. 
Another possibility of the hindered switch was the presence of the neo cassette which may 
have an influenced on Cre recombination. For this reason CaV1.3-GFPflex/+ mice in which the 
neo cassette was already removed were crossed to Cre-deleter mice. Here, the FLEX switch 
occurred immediately in the first mating round. DNA analysis from tail and brain DNA 
revealed a complete switch between the two pairs of heterotypic loxP sites. To confirm our 
results, CaV1.3-GFPflex/+ mice with and without neo were additionally bred with CaMKIIα-Cre 
mice, expressing Cre exclusively in the forebrain. Even though the CaMKIIα promoter is 
well-established to be a very strong promoter the switch did not take place in CaV1.3-GFPflex/+ 
mice which still harboured the neo cassette. After removal of neo, in contrast, also here the 
switch happened efficiently and completely in all CaV1.3-GFPflex/+ x CaMKIIα-Cre mice 
analyzed. These results demonstrate that the Cre-mediated FLEX switch occurred efficiently 
in CaV1.3-GFPflex/+ mice if the neo cassette has previously been excised. 
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5.4 mRNA-Expression of CaV1.3 
The reporter gene eGFP of the FLEX vector is promoterless and instead flanked by an 
upstream universal adenovirus splice acceptor (AdSA) and a downstream transcriptional 
termination sequence, the bovine growth hormone polyadenylation signal (pA). When 
introduced into the CaV1.3α1 locus and stable inverted by the Cre-mediated switch, eGFP 
expression will be driven by the endogenous CaV1.3α1 promoter. Prerequisite for a proper 
reporter gene expression is that exon 1 has to be spliced in frame to eGFP. Therefore it was 
essential to determine the correct open reading frame. The reporter gene was friendly 
provided by the group of Prof. Harald von Melchner from Frankfurt, with the SA in three 
different frames to be able to choose a frame matching the upstream exon. In the endogenous 
CaV1.3α1 gene exon 1 ends with G and exon 2 starts with AG which together form the triplett 
codon GAG coding for the amino acid glutamate. The AdSA with the splice site consensus 
AG was chosen in frame +2 which has two additional nucleotides TG upstream the 
translational start codon of eGFP. After splicing to exon 1, the two additional nucleotides 
from the SA together with G from exon 1 represent the codon GTG, followed by the reporter 
gene start codon ATG.  
By mRNA analysis of CaV1.3-GFPflex/+ mice crossed with Cre-deleter (CaV1.3-GFPswitch/+ mice) 
we could show the correct splicing of CaV1.3α1 exon 1 to the eGFP transcript. RT-PCR 
confirmed the exon1-eGFP transcript with a specific 220 bp amplification product. 
Contamination of genomic DNA can be excluded as exon 1 is located more than 1900 bp 
from the inverted locus which would result in a 2060 bp PCR fragment.  
Because eGFP is further flanked by a downstream polyA sequence, transcription of CaV1.3α1 
is terminated prematurely at this site, leading to a fusion transcript that encodes a functional 
reporter protein but a truncated, non-functional CaV1.3α1 protein. Additionally, the 
inversion of exon 2 inserts to several stop codons, which ensure translational termination in 
the case of the failure of polyA to terminated expression of CaV1.3α1. These RT-PCR 
experiments showed that, after stable inversion, eGFP is spliced to CaV1.3α1 exon 1, which 
leads to eGFP expression driven by the endogenous CaV1.3α1 promoter. 
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5.5 Expression pattern of CaV1.3α1 mRNA represented by 
eGFP staining 
The FLEX system allows monitoring the ablation of a gene of interest by simultaneous 
activation of a reporter gene. In this study, after the FLEX switch CaV1.3α1 exon 2 was 
replaced by eGFP. Thus, eGFP expression represents the expression pattern of the CaV1.3α1 
calcium channel. As CaV1.3α1 is widely expressed in brain, brain slices of heterozygous 
CaV1.3-GFPswitch/+ mice were analysed for eGFP expression. Immunohistochemistry using 
antibodies against eGFP observed expression in many parts of the brain. However, the direct 
autofluorescence of eGFP was too weak to be detected under a fluorescent microscope. This 
may be due to the low protein concentration in heterozygous mice. Further examinations of 
homozygous CaV1.3-GFPswitch/switch mice will elucidate this issue. In contrast, the CaV1.3-
GFPflex/Cre-transfected HeLa cells had displayed strong eGFP autofluorescence. Here, the 
HeLa cells contained both the CaV1.3-GFPflex vector and the Cre-plasmid episomally in many 
copies which may lead to strong eGFP expression and fluorescence.  
Taken together, the expression of the FLEX reporter gene in CaV1.3-GFPflex/+ x Cre mice 
demonstrates the functionality of the conditional FLEX switch in vivo and that eGFP is 
functionally expressed and driven by the endogenous CaV1.3α1 promoter.  
 
The FLEX switch mediated gene deletion of CaV1.3 which was visualised by eGFP 
expression. This feature can be utilised to examine the exact expression pattern and 
distribution of the inactivated gene. So far, most data of CaV1.3α1 localization in the brain 
were based on immunohistochemistry studies using CaV1.3α1 antibodies. However, no 
reliable CaV1.3 antibodies are available so far and potential cross-immunoreactivity with 
other proteins may influence the results. Moreover, the immunolabelling data are in many 
parts of the brain contradicting to in situ hybridization studies investigating localization and 
level of CaV1.3α1 gene expression (Tanaka et al., 1995). To address this problem, CaV1.3-
GFPflex/+ mice were crossed with Cre-deleters (CaV1.3-GFPswitch/+), which express Cre 
recombinase ubiquitously from early development on and generating germline deletion, 
thus providing an elegant tool for monitoring CaV1.3α1 in all tissues where the channel is 
normally expressed. Additionally, we crossed CaV1.3-GFPflex/+ mice with CamKIIa–Cre mice 
to investigate CaV1.3 expression specific to the forebrain. 
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5.5.1 eGFP Expression in Neurons 
Analysis of the distribution of eGFP stained cells exposed, in parts, a so far unknown 
expression pattern of the calcium channel. We observed eGFP labelling in mainly the cell 
bodies in all regions of the cerebral cortex, corresponding to the data of Hell et al. Co-
staining with NeuN confirmed the neural cell type of these cells. In the olfactory bulb (OB) 
eGFP labelling was detected in the glomerular layer, in the granular layer and slightly in the 
mitral cells. L-type Ca2+ channel expression in the OB has been described controversially in 
the literature. Three different studies, using in situ hybridization and pharmacological 
studies as well as Ca2+ current recordings, provided evidence for the presence of L-type 
channels in olfactory bulb neurons (Davila et al., 2003; Tanaka et al., 1995; Wang et al., 1996), 
while other data argued against it (Yuan et al., 2004).  
In the cerebellum of CaV1.3-GFPswitch/+ mice eGFP expression was observed in the Purkinje 
cells and in small cells in the molecular cell layer, whereas in the granular cell layer no eGFP-
positive cells were found. In the literature, prominent expression of CaV1.3 in the cerebellum 
was reported in the cell bodies of the Purkinje cells and its dendrites projecting to the 
molecular layer, and a more moderate expression of small cells in the molecular and 
granular cell layer (Kim et al., 2004). Unlike our findings Hell et al. described intense staining 
in the granule layer (Hell et al., 1993). In contrast to our strategy to monitor CaV1.3 
expression via reporter gene, thereby mirroring mRNA expression, the previous localization 
study was done by immunohistochemistry.  
 
Previous findings observed intense CaV1.3α1 expression in pyramidal neurons in the CA1-
CA3 areas and granule cells in the dentate gyrus as well as in interneurons of the these 
regions (Hell et al., 1993). Several functions in the hippocampus have been accredited to 
CaV1.3 channels. It could be shown that working memory impairment is correlated with age-
related increase in CaV1.3α1 expression in area CA1 (Veng et al., 2003). Studies using 
conventional CaV1.3 knockout mice revealed that this channel mediates consolidation of 
contextually conditioned fear in mice (McKinney and Murphy, 2006). However, FOS 
expression studies as marker for neuronal activation observed only low contribution of 
CaV1.3 to c-Fos induction in area C1-C3 and the dentate gyrus (Hetzenauer et al., 2006). This 
is consistent with analysis of CaV1.2 and CaV1.3 knockout mice which suggested the CaV1.2 
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but not CaV1.3 isoform to play the prominent role in NMDA receptor-independent synaptic 
plasticity and memory formation (Clark et al., 2003; Moosmang et al., 2005).  
Contrary to previous localization studies, we found only moderate expression of the eGFP 
reporter gene in the hippocampus of CaV1.3-GFPflex/+ x Cre-deleter and CaMKIIa-Cre mice. In 
the stratum oriens and stratum radiatum in the CA1-CA3 region as well as the stratum 
moleculare and radiatum of the dentate gyrus a slight staining could be detected by DAB 
immunohistochemistry against eGFP. Though, this moderate staining could not be detected 
in direct immunofluorescence staining. This might be due to the more sensitive DAB 
staining, where the immunoreaction is amplified by the biotin-avidin system. It also has to 
be considered that the weak labelling might be background staining. However, the non-
stained negative control of single-transgenic CaV1.3-GFPflex/+ mice argues against it. 
Interestingly, some strongly stained large cells were observed in the pyramidal cell layer and 
stratum oriens. Double immunofluorescence indentified at least some eGFP-expressing cells 
as GABAergic interneurons. Also their large size and morphology argues for inhibitory 
neurons. Evidence for CaV1.3 expression in various GABAergic interneurons in the CA1 
pyramidal cells and stratum oriens was provided by an immunohistochemical approach by 
Vinet et al. (Vinet and Sik, 2006).  
 
We further found eGFP expression in several regions of the amygdala, the paraventricular 
nucleus (PVN), the locus coeruleus (LC) and different thalamic subregions like the lateral 
posterior thalamic nucleus, the dorsal lateral geniculate nucleus and the pregeniculate 
nucleus. These results are consistent with further observations measuring BayK-induced 
CaV1.3 mediated c-Fos activation in most of the described regions (Hetzenauer et al., 2006). In 
particular the amygdala, the locus coeruleus and the hypothalamic PVN are brain areas 
associated with emotion-related behaviour like anxiety- and depression-related behaviour 
and processing of stress (Millan, 2003). This is also conform with the findings that BayK-
induced activation of these regions elicits increased depression-like behaviour (Sinnegger-
Brauns et al., 2004) and that CaV1.3-/- null mutants display a suppressed anxiety-like 
behaviour (Nguyen et al., 2005). An interesting observation was the eGFP expression in the 
habenular nuclei. It has been proposed that the habenula is implicated in human major 
depressive episodes (Sartorius and Henn, 2007). The increased activation of the lateral 
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habenular nucleus leads to stimulation of the hypothalamic-pituitary-adrenal (HPA) axis and 
to the down regulation of the serotonergic, noradrenergic, dopaminergic systems.  
Even though eGFP expression was found in regions involved in depression-like behaviour, 
no staining could be detected in the raphe nuclei, the brain regions from which the 
serotonergic fibres originate. Double-immunofluorescence studies revealed no coexpression 
of the 5-HT marker TPH1 and eGFP.  
 
Apart from brain areas associated with cognitive behaviour, eGFP expression was noted in 
brain areas implicated in sensory processing. A specific staining was observed in the bed 
nucleus of accessory olfactory tract (BAOT), a vomeronasal system structure, which is 
involved in the maternal behaviour in female rats (Del Cerro et al., 1991). In the brainstem, 
the cuneate nucleus of the medulla and the facial nucleus of the pons were found to be eGFP-
positive. This corresponds well to CaV1.3 immunoreactivity studies by Sukiasyan et al. who 
reported a strong labelling in the facial nucleus 7N and the cuneate nucleus (Sukiasyan et al., 
2009). Furthermore, we detected an intense eGFP-staining in the superficial gray layer and 
the optic layer of the superior colliculus (SC) in CaV1.3-GFPswitch/+ mice. The superior 
colliculus plays an important role in the development of retinotopic maps. It receives retinal 
ganglion cell projections that form a precise point-to-point map of visual space. Consistent 
with our results, c-fos expression studies revealed CaV1.3-mediated Fos activation in the 
superficial gray layer and optic layer of the SC (Hetzenauer et al., 2006). Moreover, 
immunohistochemistry studies of Mize et al. showed expression of CaV1.2 in the SC, a 
channel with an expression pattern very similar to that of CaV1.3 (Mize et al., 2002). Several 
studies provided evidence for a role of L-type calcium channels in developmental synapse 
refinement of visual system structures by mediating long term potentiation (LTP) and long-
term depression (LTD) in the SC (Cork et al., 2001; Lo and Mize, 2000, 2002). A recent study 
reported, that simultaneous activity of L-type channels and NMDA receptors are essential 
for induction of LTP in the juvenile superior colliculus in rodents (Zhao et al., 2006). This 
LPT was found to be activated by exceptionally low frequency of 20 Hz. That might argue 
for the involvement of CaV1.3 channels which have a relatively low activation threshold 
compared to CaV1.2. Further investigations will be necessary to clarify the function of CaV1.3 
in retinotopic map formation. 
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5.5.2 eGFP Staining in the Periventricular zone 
The most intense and at the same time unexpected eGFP expression in CaV1.3-GFPflex/+ x Cre-
deleter mice was observed in the peri- and subventricular zone of the lateral ventricle wall. 
The anterior part of the subventricular zone (SVZ) is, beside the dentate gyrus subgranular 
zone of the hippocampus, the brain region where adult neurogenesis is located (Taupin and 
Gage, 2002). The SVZ is the mitotically active region immediately adjacent to the lining of the 
lateral ventricle where neural stem cells and progenitor cells reside. These cells migrate to 
the olfactory bulb via the rostral migratory stream (RMS) where they differentiate into 
interneurons. The source of RMS neuroblasts are GFAP-positive neural stem cells (NSCs) 
adjacent to the ventricles (Ghashghaei et al., 2007). One attribute of NSC is that they express 
characteristic proteins which can be used for identification of these cells. Besides GFAP, 
neural stem/precursor cells (NPCs) also express SOX2, which is implicated in precursor-cell 
proliferation and NSC maintenance (Episkopou, 2005).  
Double-immunohistochemistry analysis revealed eGFP/GFAP- and eGFP/SOX2- expressing 
cells in the layers adjacent to the lateral ventricle. It is difficult to distinguish whether these 
cells are ependymal cells directly lining the cells and/or cells in the subventricular zone as 
both cells types express the NPC markers GFAP and SOX2. Type B cells for example, the 
SVZ proliferating astrocytes, interact closely with ependymal cells and occasionally contact 
the ventricle lumen (Doetsch et al., 1999b). But also ependymal cells have been suggested to 
divide in vivo and function as stem cells (Johansson et al., 1999). Interestingly, whereas 
GFAP-expressing cells were labelled also in the RMS, eGFP-positive cells could not be 
detected to be migrating in CaV1.3-GFPswitch/+ mice. This can be explained that the endogenous 
CaV1.3 promoter might not be active anymore when the cells change their phenotype to 
migrating cells. The co-staining of eGFP with the NPC markers GFAP and SOX2 argue for an 
expression of the calcium channel CaV1.3α1 in the proliferating, neurogenic region. 
It is well established that Ca2+ influx through neuronal L-type VGCCs results in signalling 
that affects the expression of genes involved in cell proliferation and neuronal differentiation 
(Hardingham et al., 1998; Weick et al., 2003). D’Ascenzo et al. hypothesized that these Ca2+ 
signals may also influence the differentiation of neural stem/progenitor cells toward the 
neural phenotype (D'Ascenzo et al., 2006). This neuronal differentiation from the NSCs 
derived from brain cortex of postnatal mice was strongly inhibited by the L-type channel 
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blocker nifedipine, and conversely, increased by the activator Bay K 8644. A similar study 
reported that exposure to extremely low-frequency electromagnetic fields promotes in vitro 
neurogenesis by upregulating the expression and activity of CaV1.2 and CaV1.3 (Piacentini et 
al., 2008). Also here the neuronal differentiation of NSCs was significantly increased by 
nifedipine.  
Some studies also reported an implication of L-type VGCCs in adult neurogenesis. It has 
been shown that L-type channels are involved in ischemia-induced neurogenesis in the 
dentate gyrus and SVZ by upregulating inducible nitric oxide synthase expression in adult 
mice (Luo et al., 2005). Furthermore, Deisseroth et al. found that neurogenesis from adult 
NPCs promoted by excitation (excitation-neurogenesis coupling) is mediated by 
CaV1.2/CaV1.3 channels and NMDA receptors in vivo and in vitro (Deisseroth et al., 2004). 
Excitation through these channels acts to increase the expression of proneural phenotype 
genes and inhibit expression of glial fate genes. Neural precursors tent to have a more 
depolarized resting potential (in the -55 mV range) than mature neurons (Wang et al., 2003). 
This may lead to a partial opening of CaV1.2/CaV1.3 channels even in the resting, non-
stimulated condition (Deisseroth et al., 2004). The relative resistance to inactivation at a more 
hyperpolarized state is characteristic for these channels, especially for CaV1.3, and makes 
them therefore well-suited to this type of chronic signalling.  
Taken together, our findings of CaV1.3 expression in the peri- and subventricular zone 
together with previous observations suggest a role of CaV1.3α1 in adult neurogenesis and 
NSC proliferation. Further experiments using BrdU (bromodeoxyuridine) labelling will 
provide more information about the nature of eGFP expressing cells in the neurogenic 
subventricular zone. 
 
5.5.3 eGFP Expression in Other Tissues 
Besides neurons, CaV1.3 expression has been reported in several tissues like the heart, inner 
ear or pancreatic ß-cells. In the heart CaV1.3 is known to be located in the sinoatrial node 
(SAN), where it is required for cardiac pace making (Platzer et al., 2000). However, we have 
found eGFP expression also in the septum of the heart, which separates the right and left 
ventricle. This is conceivable as in the septum the bundles of His are located which conduct 
the electrical impulse from the sinoatrial node and the atrioventricular node into the 
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ventricles. Since the isolation and staining of the SAN requires specific skills, these analysis 
will be done by cooperation with Matteo Magnoni (University Montpellier) who is 
specialised on the mouse heart and this method.  
Furthermore, CaV1.3 channels are expressed in the cochlea, where they are essential for the 
development of outer (OHC) and inner hear cells (IHC) and for almost all Ca2+ currents in 
the IHCs (Brandt et al., 2003; Platzer et al., 2000). To investigate eGFP expression in cochlear 
hair cells in CaV1.3-GFPflex mice we have provided these mice to the group of Marlies Knipper 
in Tübingen. There the mice will be crossed to IHC/OHC-specific Cre mice which will result 
in a deletion of the channel restricted to the inner ear.  
So far, the role of CaV1.3 VGCCs in the pancreas has been discussed controversially. 
However, recent findings revealed that, whereas CaV1.2 mediates the first high peak of 
insulin release, CaV1.3 is implicated in the maintenance of persistent insulin secretion (Eric 
Rennström, Lund University, personal communication). To gain more insights into 
pancreatic functions, ß-cells of CaV1.3-GFPflex mice will be investigated by cooperation with 
this group. 
 
5.6 Conclusion and Outlook 
The CaV1.3-GFPflex mice we have generated provide an important tool to inactivate CaV1.3 in 
specific tissues with simultaneous reporter gene expression, identifying cells with the gene 
ablation. This presents a new and interesting tool to elucidate the role of this calcium channel 
in living tissues in vivo. So far, existing immunoreactivity studies using anti-CaV1.3 
antibodies and in situ hybridization studies reported partially inconsistent expression and 
distribution of CaV1.3 (Hell et al., 1993; Sukiasyan et al., 2009; Tanaka et al., 1995). Since in 
CaV1.3-GFPswitch mice eGFP is directly spliced to the upstream exon 1a and thereby driven by 
the endogenous CaV1.3 promoter, we propose that the labelling we observed represents the 
actual expression of the CaV1.3 mRNA.  
However, in some brain areas like the hippocampus and the neurogenic region of the lateral 
ventricle the pattern we found differed from the previously published data. The eGFP 
expression reflects the activation state of the CaV1.3 promoter. This may explain that we 
found in some brain areas a remarkably high, in other areas an unexpected low expression.  
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Additionally, it has to be considered that the insertions of gene targeting elements into 
intronic sequences may have disturbed regulatory elements which may influence the 
expression pattern of the channel. Analysis of homozygous CaV1.3-GFPflex/flex will show 
whether the CaV1.3 channel is expressed normally like in wildtype mice. Another possibility 
could be the presence of an alternative splice form of exon 2 that we might have targeted. 
Homozygous CaV1.3-GFPswitch/switch knockout mice will again clarify whether the CaV1.3α1 
deletion is complete. Furthermore, in situ hybridisation studies using a probe for exon 2 
sequence will be helpful. 
Several studies have linked CaV1.3 channels to various diseases like cardiac arrhythmia and 
bradycardia, Parkinson’s disease, anxiety- and depression-related behaviour and diabetes. 
Due to the lack of currently available selective L-type VGCC blockers, CaV1.3-GFPflex mice 
will provide a new and useful tool to dissect the physiological role of L-type VGCCs. The 
mouse line may serve as basis for the development of specific calcium channel modulators 
for future therapeutic use. 
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6 Abbreviations 
α alpha 
β beta 
µ micro 
A Ampere 
aa amino acids 
Ad Adeno virus 
Amp ampicillin 
AMPA L-α-amino-3-hydroxy-5-methyl-isoxazolpropionic acid 
ATP Adenosine triphosphate 
BAC Bacterial artificial chromosome 
bla gene for the enzyme ß-Lactamase (ampicillin resistance) 
bp base pairs 
BrDU bromodeoxyuridine 
BSA bovine serum albumin 
C  Celsius 
Ca2+ calcium 
CA1-3 Cornus ammonis fields 1-3 
CaMKIIa Ca2+/Calmodulin-dependent protein kinase II α 
cAMP Cyclic adenosine monophosphate 
Carb carbenicillin 
C-terminal Carboxy-terminal of a protein 
cDNA copy DNA 
Cm chloramphenicol 
cre gene for the Cre-recombinase 
DA Dalton 
DAB diaminobenzidine 
DCX doublecortin 
DMSO dimethylsulfoxide 
DNA deoxyribonucleic acid 
DNAse deoxyribonuclease 
dNTP 2´-deoxyribonucleotide 
dsDNA double stranded DNA 
E.coli Escherichia coli 
EDTA ethylenediaminetetraacetic acid 
eGFP enhanced green fluorescent protein 
ES embryonic stem cells 
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et al. et alii 
EtBr ethidium bromide 
EtOH ethanol 
FBS fetal bovine serum 
FCS fetal calf serum 
fig. figure 
g gram 
G418 Geneticin 
GAD glutamic acid decarboxylase 
GFAP Glial fibrillary acidic protein 
h hours 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HRP horse radish peroxidise 
HS horse serum 
IgG immunoglobulin G 
IHC Inner hair cell 
i.p. intraperitoneal 
k kilo 
KAc potassium acetate 
Kan kanamycin 
kb kilo base pairs 
l liters 
lacZ gene for the ß-galactosidase of E.coli 
LB Luria broth 
LIF Leukemia inhibitory factor 
loxP locus of crossing over for phage P 
LTP long term potentiation 
m Meter(s) 
m milli 
M molar (mol/l) 
min Minute(s) 
mRNA messenger RNA 
N-terminal Amino-terminal of a protein 
n nano 
NaAc sodium acetate 
neo Neomycin resistance gene 
NMDA N-methyl-D-aspartate 
NPC Neural stem/precursor cell 
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nt nucleotides 
NTP nucleoside triphosphate 
OD optical density 
OHC Outer hair cell 
ori origin of replication 
P promoter 
p plasmid 
pA polyadenylation signal 
PFA paraformaldehyde 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
pH negative base-10 logarithm of H+-ion concentration 
PKA Protein kinase A 
r resistant 
RNA ribonucleic acid 
RNase ribonuclease 
rpm Rounds per minute 
RT room temperature 
SA splice acceptor 
SAP shrimp alkaline phosphatase 
sec Second(s) 
Sox2 Sry-related HMG box 2 
ssDNA single stranded DNA 
SV40 simian virus 40 
TAE Tris-acetate-EDTA 
Taq thermos aquaticus 
TBE Tris-borate-EDTA 
TE Tris-EDTA 
Tm melting point 
TPH1 tryptophane hydroxylase 1 
Tris tris-hydroxymethylaminomethane 
U Enzyme activity 
UTR untranslated region 
V Volt 
VGCC Voltage-gated calcium channel 
WT wildtype 
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